
<!DOCTYPE html>
<html lang="en" >
    <head >

        <meta charset="UTF-8" />
        <meta http-equiv="X-UA-Compatible" content="IE=edge" />
        <meta name="HandheldFriendly" content="True" />
        <meta name="MobileOptimized" content="320" />
        <meta name="viewport" content="width=device-width, initial-scale=1.0" />

        
        

        
        
  <link rel="stylesheet" href="/static/assets/style-8258669d.css" />
<script type="module" crossorigin="" src="/static/assets/base_style-f4a99799.js"></script>

  <link rel="stylesheet" href="/static/assets/style-ef962842.css" />
<link rel="stylesheet" href="/static/assets/style-3ade8b5c.css" />
<script type="module" crossorigin="" src="/static/assets/article_style-d757a0dd.js"></script>

  
  
    <style>
  
  
  @media screen and (min-width: 64em) {
    div.pmc-wm {
      background: repeat-y;
      background-image: url("data:image/svg+xml,%3Csvg xmlns='http://www.w3.org/2000/svg' width='20' height='350' xmlns:xlink='http://www.w3.org/1999/xlink'%3E%3Cdefs%3E%3Cfilter x='-.02' y='0' width='1.05' height='1' id='c'%3E%3CfeFlood flood-color='%23FFF'/%3E%3CfeComposite in='SourceGraphic'/%3E%3C/filter%3E%3Ctext id='b' font-family='Helvetica' font-size='11pt' style='opacity:1;fill:%23005ea2;stroke:none;text-anchor:middle' x='175' y='14'%3E%3C/text%3E%3Cpath id='a' style='fill:%23005ea2' d='M0 8h350v3H0z'/%3E%3C/defs%3E%3Cuse xlink:href='%23a' transform='rotate(90 10 10)'/%3E%3Cuse xlink:href='%23b' transform='rotate(90 10 10)' filter='url(%23c)'/%3E%3C/svg%3E");
      padding-left: 3rem;
    }
  }
</style>

  



        
            <link rel="apple-touch-icon"
                  sizes="180x180"
                  href="/static/img/favicons/apple-touch-icon.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="48x48"
                  href="/static/img/favicons/favicon-48x48.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="32x32"
                  href="/static/img/favicons/favicon-32x32.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="16x16"
                  href="/static/img/favicons/favicon-16x16.png" />
            <link rel="manifest" href="/static/img/favicons/site.webmanifest" />
            <link rel="mask-icon"
                  href="/static/img/favicons/safari-pinned-tab.svg"
                  color="#0071bc" />
            <meta name="msapplication-config"
                  content="/static/img/favicons/browserconfig.xml" />
            <meta name="theme-color" content="#ffffff" />
        

        <title>
            A research roadmap for SCN8A-related disorders: addressing knowledge gaps and aligning research priorities across stakeholders - PMC
        </title>

        
        
  
  <!-- Logging params: Pinger defaults -->
<meta name="ncbi_app" content="cloudpmc-viewer" />
<meta name="ncbi_db" content="pmc" />
<meta name="ncbi_phid" content="AE5342EE8AF3F7C30542EE003F9A92F5.m_1" />
<meta name="ncbi_pinger_stat_url" content="https://pmc.ncbi.nlm.nih.gov/stat" />
<!-- Logging params: Pinger custom -->
<meta name="ncbi_pdid" content="article" />
  
    <link rel="preconnect" href="https://www.google-analytics.com" />

    
        <link rel="preconnect" href="https://cdn.ncbi.nlm.nih.gov" />
    

    <!-- Include USWDS Init Script -->
    <script src="/static/assets/uswds-init.js"></script>


    <meta name="ncbi_domain" content="orphjrdis">
<meta name="ncbi_type" content="fulltext">
<meta name="ncbi_pcid" content="journal">
<meta name="ncbi_feature" content="associated_data">
<link rel="canonical" href="https://pmc.ncbi.nlm.nih.gov/articles/PMC12366098/">
<meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE">
<meta name="citation_journal_title" content="Orphanet Journal of Rare Diseases">
<meta name="citation_title" content="A research roadmap for SCN8A-related disorders: addressing knowledge gaps and aligning research priorities across stakeholders">
<meta name="citation_author" content="The SCN8A Research Consortium">
<meta name="citation_author_institution" content="Tucson, AZ USA">
<meta name="citation_publication_date" content="2025 Aug 19">
<meta name="citation_volume" content="20">
<meta name="citation_firstpage" content="444">
<meta name="citation_doi" content="10.1186/s13023-025-03672-w">
<meta name="citation_pmid" content="40830973">
<meta name="citation_abstract_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12366098/">
<meta name="citation_fulltext_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12366098/">
<meta name="citation_pdf_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12366098/pdf/13023_2025_Article_3672.pdf">
<meta name="description" content="Despite significant scientific progress since the 2012 discovery that variants in the SCN8A gene can cause human epilepsy, disease mechanisms and best practices for management of SCN8A-related disorders (SCN8A-RD) remain incompletely understood. To ...">
<meta name="og:title" content="A research roadmap for SCN8A-related disorders: addressing knowledge gaps and aligning research priorities across stakeholders">
<meta name="og:type" content="article">
<meta name="og:site_name" content="PubMed Central (PMC)">
<meta name="og:description" content="Despite significant scientific progress since the 2012 discovery that variants in the SCN8A gene can cause human epilepsy, disease mechanisms and best practices for management of SCN8A-related disorders (SCN8A-RD) remain incompletely understood. To ...">
<meta name="og:url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12366098/">
<meta name="og:image" content="https://cdn.ncbi.nlm.nih.gov/pmc/cms/images/pmc-card-share.jpg?_=0">
<meta name="twitter:card" content="summary_large_image">
<meta name="twitter:site" content="@ncbi">
    
    

    </head>
    <body >
        
    <a class="usa-skipnav " href="#main-content">
      Skip to main content
    </a>


        
            

<section class="usa-banner " aria-label="Official website of the United States government" >
    <div class="usa-accordion">
        <header class="usa-banner__header">
            <div class="usa-banner__inner">
                <div class="grid-col-auto">
                    <img aria-hidden="true"
                         class="usa-banner__header-flag"
                         src="/static/img/us_flag.svg"
                         alt="" />
                </div>

                <div class="grid-col-fill tablet:grid-col-auto" aria-hidden="true">
                    <p class="usa-banner__header-text">
                        An official website of the United States government
                    </p>
                    <span class="usa-banner__header-action">Here's how you know</span>
                </div>

                



















    
        <button
            type="button"
        
    
    class="usa-accordion__button usa-banner__button
           

           
               
               
               
               
            

           
           
           
           "
    aria-expanded="false"
    aria-controls="gov-banner-default"
    
    data-testid="storybook-django-banner"
    
    >
    
        

        
                    <span class="usa-banner__button-text">Here's how you know</span>
                

        
    
        
            </button>
        


            </div>
        </header>

        <div class="usa-banner__content usa-accordion__content"
             id="gov-banner-default"
             hidden>
            <div class="grid-row grid-gap-lg">
                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-dot-gov.svg"
                         alt=""
                         aria-hidden="true" />
                    <div class="usa-media-block__body">
                        <p>
                            <strong>Official websites use .gov</strong>
                            <br />
                            A
                            <strong>.gov</strong> website belongs to an official
                            government organization in the United States.
                        </p>
                    </div>
                </div>

                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-https.svg"
                         alt=""
                         aria-hidden="true" />

                    <div class="usa-media-block__body">
                        <p>
                            <strong>Secure .gov websites use HTTPS</strong>
                            <br />
                            A <strong>lock</strong> (
                            <span class="icon-lock">
                                <svg xmlns="http://www.w3.org/2000/svg"
                                     width="52"
                                     height="64"
                                     viewBox="0 0 52 64"
                                     class="usa-banner__lock-image"
                                     role="graphics-symbol"
                                     aria-labelledby="banner-lock-description"
                                     focusable="false">
                                    <title id="banner-lock-title">Lock</title>
                                    <desc id="banner-lock-description">
                                    Locked padlock icon
                                    </desc>
                                    <path fill="#000000"
                                          fill-rule="evenodd"
                                          d="M26 0c10.493 0 19 8.507 19 19v9h3a4 4 0 0 1 4 4v28a4 4 0 0 1-4 4H4a4 4 0 0 1-4-4V32a4 4 0 0 1 4-4h3v-9C7 8.507 15.507 0 26 0zm0 8c-5.979 0-10.843 4.77-10.996 10.712L15 19v9h22v-9c0-6.075-4.925-11-11-11z" />
                                </svg>
</span>) or <strong>https://</strong> means you've safely
                                connected to the .gov website. Share sensitive
                                information only on official, secure websites.
                            </p>
                        </div>
                    </div>
                </div>
            </div>
        </div>
    </section>

        

        
    
    
    

<div class="usa-overlay">
</div>



<header class="usa-header usa-header--extended usa-header--wide" data-header data-testid="header"    >
    <div class="ncbi-header">
        <div class="ncbi-header__container">
            <a class="ncbi-header__logo-container"
               href="https://www.ncbi.nlm.nih.gov/">
                <img alt="NCBI home page"
                     class="ncbi-header__logo-image"
                     src="/static/img/ncbi-logos/nih-nlm-ncbi--white.svg"
                     width="410"
                     height="100" />
            </a>

            <!-- Mobile menu hamburger button -->
            



















    
        <button
            type="button"
        
    
    class="usa-menu-btn ncbi-header__hamburger-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Show menu"
    data-testid="navMenuButton"
    
    >
    
        

        
                <svg aria-hidden="true"
                     class="ncbi-hamburger-icon"
                     fill="none"
                     focusable="false"
                     height="21"
                     viewBox="0 0 31 21"
                     width="31"
                     xmlns="http://www.w3.org/2000/svg">
                    <path clip-rule="evenodd"
                          d="M0.125 20.75H30.875V17.3333H0.125V20.75ZM0.125 12.2083H30.875V8.79167H0.125V12.2083ZM0.125 0.25V3.66667H30.875V0.25H0.125Z"
                          fill="#F1F1F1"
                          fill-rule="evenodd" />
                </svg>
            

        
    
        
            </button>
        



            
                <!-- Desktop buttons-->
                <div class="ncbi-header__desktop-buttons">
                    
                        <!-- Desktop search button -->
                        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button
           "
    aria-expanded="false"
    aria-controls="search-field-desktop-navigation"
    aria-label="Show search overlay"
    data-testid="toggleSearchPanelButton"
    data-toggle-search-panel-button
    >
    
        

        
                            



    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true" >
        
        <use xlink:href="/static/img/sprite.svg#search" />
    </svg>


                            Search
                        

        
    
        
            </button>
        


                    

                    <!-- Desktop login dropdown -->
                    
                        <div class="ncbi-header__login-dropdown">
                            



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button ncbi-header__login-dropdown-button
           "
    aria-expanded="false"
    aria-controls="login-dropdown-menu"
    aria-label="Show login menu"
    data-testid="toggleLoginMenuDropdown"
    data-desktop-login-button
    >
    
        

        
                                



    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true" >
        
        <use xlink:href="/static/img/sprite.svg#person" />
    </svg>



                                <span data-login-dropdown-text>Log in</span>

                                <!-- Dropdown icon pointing up -->
                                



    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-less ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true" data-login-dropdown-up-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_less" />
    </svg>



                                <!-- Dropdown icon pointing down -->
                                



    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-more ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true" data-login-dropdown-down-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_more" />
    </svg>


                            

        
    
        
            </button>
        



                            <!-- Login dropdown menu -->
                            <ul class="usa-nav__submenu ncbi-header__login-dropdown-menu"
                                id="login-dropdown-menu"
                                data-desktop-login-menu-dropdown
                                hidden>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
        

        
            Dashboard
        

        
    </a>


                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
        

        
            Publications
        

        
    </a>


                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
        

        
            Account settings
        

        
    </a>


                                    </li>
                                
                                <li class="usa-nav__submenu-item">
                                    



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--outline ncbi-header__login-dropdown-logout-button
           "
    
    
    
    data-testid="desktopLogoutButton"
    data-desktop-logout-button
    >
    
        

        Log out

        
    
        
            </button>
        


                                </li>
                            </ul>
                        </div>
                    
                </div>
            
        </div>
    </div>

    <!-- Search panel -->
    
        <div class="ncbi-search-panel ncbi--show-only-at-desktop"
             data-header-search-panel
             hidden>
            <div class="ncbi-search-panel__container">
                <form action="https://www.ncbi.nlm.nih.gov/search/all/"
                      
                      autocomplete="off"
                      class="usa-search usa-search--big ncbi-search-panel__form"
                      data-testid="desktop-navigation-search-form"
                      method="GET"
                      role="search">
                    <label class="usa-sr-only" for="search-field-desktop-navigation">
                        Search…
                    </label>
                    <input class="usa-input"
                           id="search-field-desktop-navigation"
                           name="term"
                           
                               placeholder="Search NCBI"
                           
                           type="search"
                           value="" />
                    



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                        <span class="usa-search__submit-text">
                            Search NCBI
                        </span>
                    

        
    
        
            </button>
        


                </form>

                
            </div>
        </div>
    

    <nav aria-label="Primary navigation" class="usa-nav">
        <p class="usa-sr-only" id="primary-navigation-sr-only-title">
            Primary site navigation
        </p>

        <!-- Mobile menu close button -->
        



















    
        <button
            type="button"
        
    
    class="usa-nav__close ncbi-nav__close-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Close navigation menu"
    data-testid="navCloseButton"
    
    >
    
        

        
            <img src="/static/img/usa-icons/close.svg" alt="Close" />
        

        
    
        
            </button>
        



        
            <!-- Mobile search component -->
            <form class="usa-search usa-search--small ncbi--hide-at-desktop margin-top-6"
                  action="https://www.ncbi.nlm.nih.gov/search/all/"
                  
                  autocomplete="off"
                  data-testid="mobile-navigation-search-form"
                  method="GET"
                  role="search">
                <label class="usa-sr-only" for="search-field-mobile-navigation">
                    Search
                </label>

                <input class="usa-input"
                       id="search-field-mobile-navigation"
                       type="search"
                       
                           placeholder="Search NCBI"
                       
                       name="term" />

                



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                    <!-- This SVG should be kept inline and not replaced with a link to the icon as otherwise it will render in the wrong color -->
                    <img src="data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIGhlaWdodD0iMjQiIHZpZXdCb3g9IjAgMCAyNCAyNCIgd2lkdGg9IjI0Ij48cGF0aCBkPSJNMCAwaDI0djI0SDB6IiBmaWxsPSJub25lIi8+PHBhdGggZmlsbD0iI2ZmZiIgZD0iTTE1LjUgMTRoLS43OWwtLjI4LS4yN0E2LjQ3MSA2LjQ3MSAwIDAgMCAxNiA5LjUgNi41IDYuNSAwIDEgMCA5LjUgMTZjMS42MSAwIDMuMDktLjU5IDQuMjMtMS41N2wuMjcuMjh2Ljc5bDUgNC45OUwyMC40OSAxOWwtNC45OS01em0tNiAwQzcuMDEgMTQgNSAxMS45OSA1IDkuNVM3LjAxIDUgOS41IDUgMTQgNy4wMSAxNCA5LjUgMTEuOTkgMTQgOS41IDE0eiIvPjwvc3ZnPg=="
                         class="usa-search__submit-icon"
                         alt="Search" />
                

        
    
        
            </button>
        


            </form>

            
        

        <!-- Primary navigation menu items -->
        <!-- This usa-nav__inner wrapper is required to correctly style the navigation items on Desktop -->
        

        
            <div class="ncbi-nav__mobile-login-menu ncbi--hide-at-desktop"
                 data-mobile-login-menu
                 hidden>
                <p class="ncbi-nav__mobile-login-menu-status">
                    Logged in as:
                    <strong class="ncbi-nav__mobile-login-menu-email"
                            data-mobile-login-email-text></strong>
                </p>
                <ul class="usa-nav__primary usa-accordion">
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
        

        
            Dashboard
        

        
    </a>


                        </li>
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
        

        
            Publications
        

        
    </a>


                        </li>
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
        

        
            Account settings
        

        
    </a>


                        </li>
                    
                </ul>
            </div>
        

        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           ncbi-nav__mobile-login-button ncbi--hide-at-desktop
           "
    
    
    
    data-testid="mobileLoginButton"
    data-mobile-login-button
    >
    
        

        Log in

        
    
        
            </button>
        


    </nav>
</header>

    
    
        

<section class="pmc-header pmc-header--basic" aria-label="PMC Header with search box">
    <div class="pmc-nav-container">
        <div class="pmc-header__bar">
           <div class="pmc-header__logo">
               <a href="/" title="Home" aria-label="PMC Home"></a>
           </div>
            <button
                    type="button"
                    class="usa-button usa-button--unstyled pmc-header__search__button"
                    aria-label="Open search"
                    data-ga-category="search"
                    data-ga-action="PMC"
                    data-ga-label="pmc_search_panel_mobile"
            >
                <svg class="usa-icon width-4 height-4 pmc-icon__open" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#search"></use>
                </svg>
                <svg class="usa-icon width-4 height-4 pmc-icon__close" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
            </button>
        </div>
        <div class="pmc-header__search">
            


<form class="usa-search usa-search--extra usa-search--article-right-column  pmc-header__search__form" id="pmc-search-form" autocomplete="off" role="search">
<label class="usa-sr-only" for="pmc-search">Search PMC Full-Text Archive</label>
<span class="autoComplete_wrapper flex-1">
<input class="usa-input width-full maxw-none" required="required" placeholder="Search PMC Full-Text Archive" id="pmc-search"  type="search" name="term" data-autocomplete-url="https://pmc.ncbi.nlm.nih.gov/autocomp/search/autocomp/"/>
</span>
<button
class="usa-button"
type="submit"
formaction="https://www.ncbi.nlm.nih.gov/pmc/"
data-ga-category="search"
data-ga-action="PMC"
data-ga-label="PMC_search_button"
>
<span class="usa-search__submit-text">Search in PMC</span>
<img
src="/static/img/usa-icons-bg/search--white.svg"
class="usa-search__submit-icon"
alt="Search"
/>
</button>
</form>
            <div class="display-flex flex-column tablet:flex-row tablet:flex-justify flex-justify-center flex-align-center width-full desktop:maxw-44">
                <ul class="pmc-header__search__menu">
                    <li>
                        
                            <a class="usa-link" href="/journals/" data-ga-action="featured_link" data-ga-label="journal list">
                                Journal List
                            </a>
                        
                    </li>
                    <li>
                        
                            <a class="usa-link" href="/about/userguide/" data-ga-action="featured_link"
                            data-ga-label="user guide">
                                User Guide
                            </a>
                        
                    </li>
                </ul>
                
                    <button form="pmc-search-form" formaction="https://pmc.ncbi.nlm.nih.gov/search/" type="submit" class="usa-button usa-button--unstyled hover:text-no-underline text-no-underline width-auto margin-top-1 tablet:margin-top-0">
     <span class="bg-green-label padding-05 text-white">New</span><span class="text-underline text-primary">Try this search in PMC Beta Search</span>
</button>
                
            </div>
        </div>
    </div>
</section>

    


        
        

       
  <div class="usa-section padding-top-0 desktop:padding-top-6 pmc-article-section" data-article-db="pmc" data-article-id="12366098">

    

   



<div class="grid-container pmc-actions-bar" aria-label="Actions bar" role="complementary">
    <div class="grid-row">
        <div class="grid-col-fill display-flex">
             <div class="display-flex">
                <ul class="usa-list usa-list--unstyled usa-list--horizontal">
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <button
                                type="button"
                                class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                                aria-label="Open resources"
                                data-extra-class="is-visible-resources"
                                data-ga-category="resources_accordion"
                                data-ga-action="click"
                                data-ga-label="mobile_icon"
                        >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#more_vert"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <a
                                href="https://doi.org/10.1186/s13023-025-03672-w"
                                class="usa-link display-flex usa-tooltip"
                                role="button"
                                target="_blank"
                                rel="noreferrer noopener"
                                title="View on publisher site"
                                data-position="bottom"
                                aria-label="View on publisher site"
                                data-ga-category="actions"
                                data-ga-action="click"
                                data-ga-label="publisher_link_mobile"
                        >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#launch"></use>
                                </svg>
                        </a>
                    </li>
                    
                    
                        <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                             <a
                                     href="pdf/13023_2025_Article_3672.pdf"
                                     class="usa-link display-flex usa-tooltip"
                                     role="button"
                                     title="Download PDF"
                                     data-position="bottom"
                                     aria-label="Download PDF"
                                     data-ga-category="actions"
                                     data-ga-action="click"
                                     data-ga-label="pdf_download_mobile"
                             >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                                </svg>
                            </a>
                        </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button
                            class="usa-button usa-button--unstyled  usa-tooltip collections-dialog-trigger collections-button display-flex collections-button-empty"
                            title="Add to Collections"
                            data-position="bottom"
                            aria-label="Save article in MyNCBI collections."
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="collections_button_mobile"
                            data-collections-open-dialog-enabled="false"
                            data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC12366098%2F%3Freport%3Dclassic%23open-collections-dialog"
                            data-in-collections="false"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button role="button" class="usa-button usa-button--unstyled usa-tooltip citation-dialog-trigger display-flex"
                            aria-label="Open dialog with citation text in different styles"
                            title="Cite"
                            data-position="bottom"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="cite_mobile"
                            data-all-citations-url="/resources/citations/12366098/"
                            data-citation-style="nlm"
                            data-download-format-link="/resources/citations/12366098/export/"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="pmc-permalink display-flex" >
                         <button
                                 type="button"
                                 title="Permalink"
                                 data-position="bottom"
                                 class="usa-button usa-button--unstyled display-flex usa-tooltip"
                                 aria-label="Show article permalink"
                                 aria-expanded="false"
                                 aria-haspopup="true"
                                 data-ga-category="actions"
                                 data-ga-action="open"
                                 data-ga-label="permalink_mobile"
                         >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#share"></use>
                            </svg>
                        </button>
                        

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC12366098/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
                    </li>
                </ul>
            </div>
            <button
                    type="button"
                    class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                    aria-label="Open article navigation"
                    data-extra-class="is-visible-in-page"
                    data-ga-category="actions"
                    data-ga-action="open"
                    data-ga-label="article_nav_mobile"
            >
                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#list"></use>
                </svg>
            </button>
        </div>
    </div>
</div>
    <div class="grid-container desktop:padding-left-6">
      <div id="article-container" class="grid-row grid-gap">
        <div class="grid-col-12 desktop:grid-col-8 order-2 pmc-layout__content">
            <div class="grid-container padding-left-0 padding-right-0">
                <div class="grid-row desktop:margin-left-neg-6">
                    <div class="grid-col-12">
                        <div class="pmc-layout__disclaimer" role="complementary" aria-label="Disclaimer note">
    As a library, NLM provides access to scientific literature. Inclusion in an NLM database does not imply endorsement of, or agreement with,
    the contents by NLM or the National Institutes of Health.<br/>
    Learn more:
    <a class="usa-link" data-ga-category="Link click" data-ga-action="Disclaimer" data-ga-label="New disclaimer box" href="/about/disclaimer/">PMC Disclaimer</a>
    |
    <a class="usa-link" data-ga-category="Link click" data-ga-action="PMC Copyright Notice" data-ga-label="New disclaimer box" href="/about/copyright/">
        PMC Copyright Notice
    </a>
</div>
                    </div>
                </div>
                <div class="grid-row pmc-wm desktop:margin-left-neg-6">
                    <!-- Main content -->
                    <main
                      id="main-content"
                      class="usa-layout-docs__main usa-layout-docs grid-col-12 pmc-layout pmc-prose padding-0"
                    >

                      
                        <section class="pmc-journal-banner text-center line-height-none" aria-label="Journal banner"><img src="https://cdn.ncbi.nlm.nih.gov/pmc/banners/logo-orphjrdis.png" alt="Orphanet Journal of Rare Diseases logo" usemap="#pmc-banner-imagemap" width="500" height="75"><map name="pmc-banner-imagemap"><area alt="Link to Orphanet Journal of Rare Diseases" title="Link to Orphanet Journal of Rare Diseases" shape="default" href="https://ojrd.biomedcentral.com/" target="_blank" rel="noopener noreferrer"></map></section><article lang="en"><section aria-label="Article citation and metadata"><section class="pmc-layout__citation font-secondary font-xs"><div>
<div class="display-inline-block"><button type="button" class="cursor-pointer text-no-underline bg-transparent border-0 padding-0 text-left margin-0 text-normal text-primary" aria-controls="journal_context_menu">Orphanet J Rare Dis</button></div>. 2025 Aug 19;20:444. doi: <a href="https://doi.org/10.1186/s13023-025-03672-w" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">10.1186/s13023-025-03672-w</a>
</div>
<nav id="journal_context_menu" hidden="hidden"><ul class="menu-list font-family-ui" role="menu">
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/pmc/?term=%22Orphanet%20J%20Rare%20Dis%22%5Bjour%5D" class="usa-link" role="menuitem">Search in PMC</a></li>
<li role="presentation"><a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Orphanet%20J%20Rare%20Dis%22%5Bjour%5D" lang="en" class="usa-link" role="menuitem">Search in PubMed</a></li>
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/nlmcatalog?term=%22Orphanet%20J%20Rare%20Dis%22%5BTitle%20Abbreviation%5D" class="usa-link" role="menuitem">View in NLM Catalog</a></li>
<li role="presentation"><a href="?term=%22Orphanet%20J%20Rare%20Dis%22%5Bjour%5D" class="usa-link" role="menuitem" data-add-to-search="true">Add to search</a></li>
</ul></nav></section><section class="front-matter"><div class="ameta p font-secondary font-xs">
<hgroup><h1>A research roadmap for SCN8A-related disorders: addressing knowledge gaps and aligning research priorities across stakeholders</h1></hgroup><div class="cg p">
<span class="collab">The SCN8A Research Consortium</span><sup>1</sup>
</div>
<ul class="d-buttons inline-list">
<li><button class="d-button" aria-controls="aip_a" aria-expanded="false">Author information</button></li>
<li><button class="d-button" aria-controls="anp_a" aria-expanded="false">Article notes</button></li>
<li><button class="d-button" aria-controls="clp_a" aria-expanded="false">Copyright and License information</button></li>
</ul>
<div class="d-panels font-secondary-light">
<div id="aip_a" class="d-panel p" style="display: none"><div class="p" id="Aff1">
<sup>1</sup>Tucson, AZ USA</div></div>
<div id="anp_a" class="d-panel p" style="display: none"><div class="notes p"><section id="historyarticle-meta1" class="history"><p>Received 2025 Jan 3; Accepted 2025 Mar 17; Collection date 2025.</p></section></div></div>
<div id="clp_a" class="d-panel p" style="display: none">
<div>© The Author(s) 2025</div>
<p><strong>Open Access</strong> This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit <a href="https://creativecommons.org/licenses/by/4.0/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">http://creativecommons.org/licenses/by/4.0/</a>. The Creative Commons Public Domain Dedication waiver (<a href="https://creativecommons.org/publicdomain/zero/1.0/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">http://creativecommons.org/publicdomain/zero/1.0/</a>) applies to the data made available in this article, unless otherwise stated in a credit line to the data.</p>
<div class="p"><a href="/about/copyright/" class="usa-link">PMC Copyright notice</a></div>
</div>
</div>
<div>PMCID: PMC12366098  PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/40830973/" class="usa-link">40830973</a>
</div>
</div></section></section><section aria-label="Article content"><section class="body main-article-body"><section class="abstract" id="Abs1"><h2>Abstract</h2>
<section id="sec1"><h3 class="pmc_sec_title">Background</h3>
<p id="Par1">Despite significant scientific progress since the 2012 discovery that variants in the <em>SCN8A</em> gene can cause human epilepsy, disease mechanisms and best practices for management of SCN8A-related disorders (SCN8A-RD) remain incompletely understood. To accelerate the rate of progress, the <em>International SCN8A Alliance</em> sponsored a conference in Boston, Massachusetts, on August 16–18, 2024. The goals were to identify core knowledge gaps and research priorities, and to establish a collaborative research strategy to improve quality of life. In addition to a number of family leaders representing caregiver priorities, the meeting included laboratory scientists, clinicians, and representatives from the biopharmaceutical industry.</p></section><section id="sec2"><h3 class="pmc_sec_title">Main body</h3>
<p id="Par2">The scientific literature and requests for proposals from epilepsy funding agencies were reviewed prior to the meeting. Stakeholder-specific surveys were conducted focusing on knowledge gaps, research priorities, and scientific roadblocks. Interviews with biotechnology leaders were conducted to identify their priorities. These data were analyzed to assess responsiveness to caregiver concerns and to identify top research priorities for advancing the field. The Caregiver survey (n = 175) revealed top challenges and identified novel therapeutics and management of non-seizure phenotypes/comorbidities as top priorities. Clinician (n = 46) and scientist (n = 23) surveys identified a number of common research priorities, partially overlapping with caregiver concerns. Five core areas emerged from integrated analysis of all four stakeholder surveys and became the focus areas of five <em>Working Groups</em>: (1) Transformative Therapeutics, (2) Non-Seizure Outcomes, (3) Current Therapeutics, (4) Biomarkers, and (5) Whole Brain/Whole Body.</p></section><section id="sec3"><h3 class="pmc_sec_title">Conclusions</h3>
<p id="Par3">Taking account of the concerns and priorities of the caregiver community, the five working groups identified research directions to address knowledge gaps that include both short- and long-term priorities to improve understanding of disease mechanisms and management for the spectrum of SCN8A-RD phenotypes. Challenges included identification of suitable funding mechanisms and the lack of expertise in certain methodologies and research areas. This Research Roadmap is expected to accelerate progress toward the goals of improved quality of life and transformative care for all those with SCN8A-RD.</p></section><section id="sec4"><h3 class="pmc_sec_title">Supplementary Information</h3>
<p>The online version contains supplementary material available at 10.1186/s13023-025-03672-w.</p></section><section id="kwd-group1" lang="en" class="kwd-group"><p><strong>Keywords:</strong> Pediatric epilepsy, Voltage-gated sodium channnel, Disease spectrum, Knowledge gaps, Research priorities, Stakeholders, Caregivers, Disease management, Disease mechanism</p></section></section><section id="Sec1"><h2 class="pmc_sec_title">Introduction</h2>
<p id="Par4">Pathogenic variants in the voltage-gated sodium channel gene, <em>SCN8A</em> (encoding Na<sub>V</sub>1.6), underlie a wide spectrum of clinical phenotypes ranging from neurodevelopmental delays (NDD) with or without seizures—to severe developmental and epileptic encephalopathy (DEE). While Na<sub>V</sub>1.6 was known to play a critical role in neuronal excitability since the mid-1990’s [<a href="#CR1" class="usa-link" aria-describedby="CR1">1</a>, <a href="#CR2" class="usa-link" aria-describedby="CR2">2</a>], it wasn’t until 2012 that the first pathogenic <em>SCN8A</em> variant was identified in a child with DEE and sudden unexpected death in epilepsy (SUDEP) [<a href="#CR3" class="usa-link" aria-describedby="CR3">3</a>]. Soon thereafter the <em>SCN8A</em> gene was included on commercial epilepsy gene panels and an online patient registry (the <em>International SCN8A Registry</em>) was established [<a href="#CR4" class="usa-link" aria-describedby="CR4">4</a>, <a href="#CR5" class="usa-link" aria-describedby="CR5">5</a>].</p></section><section id="Sec2"><h2 class="pmc_sec_title">Brief history of progress</h2>
<section id="Sec3"><h3 class="pmc_sec_title">Case reports, cohort and registry studies</h3>
<p id="Par5">The majority of initial cases experienced severe DEE, characterized by early onset seizures, global developmental delay, intellectual disability, and motor function impairment [<a href="#CR6" class="usa-link" aria-describedby="CR6">6</a>–<a href="#CR8" class="usa-link" aria-describedby="CR8">8</a>]. As an increasing number of case reports and cohort studies were published the disease spectrum widened to include patients with milder forms of epilepsy and neurodevelopmental delays (NDD) without seizures [<a href="#CR7" class="usa-link" aria-describedby="CR7">7</a>, <a href="#CR9" class="usa-link" aria-describedby="CR9">9</a>–<a href="#CR17" class="usa-link" aria-describedby="CR17">17</a>], including patients with gain of function (GoF), loss of function (LoF) and mixed GoF/LoF variants [<a href="#CR15" class="usa-link" aria-describedby="CR15">15</a>, <a href="#CR18" class="usa-link" aria-describedby="CR18">18</a>–<a href="#CR21" class="usa-link" aria-describedby="CR21">21</a>]. Studies making use of large cohorts and <em>Registry</em> data identified genotype–phenotype correlations [<a href="#CR9" class="usa-link" aria-describedby="CR9">9</a>, <a href="#CR14" class="usa-link" aria-describedby="CR14">14</a>, <a href="#CR15" class="usa-link" aria-describedby="CR15">15</a>, <a href="#CR19" class="usa-link" aria-describedby="CR19">19</a>, <a href="#CR22" class="usa-link" aria-describedby="CR22">22</a>, <a href="#CR23" class="usa-link" aria-describedby="CR23">23</a>], as well as phenotypic subgroups [<a href="#CR10" class="usa-link" aria-describedby="CR10">10</a>, <a href="#CR15" class="usa-link" aria-describedby="CR15">15</a>, <a href="#CR24" class="usa-link" aria-describedby="CR24">24</a>]. The application of machine learning (ML) methods to classify <em>Registry</em> participants into phenotypic subgroups based on early clinical features resulted in promising new methods to inform treatment decisions [<a href="#CR18" class="usa-link" aria-describedby="CR18">18</a>] and improve prognosis [<a href="#CR24" class="usa-link" aria-describedby="CR24">24</a>, <a href="#CR25" class="usa-link" aria-describedby="CR25">25</a>].</p></section><section id="Sec4"><h3 class="pmc_sec_title">Incidence and prevalence</h3>
<p id="Par6">In a recent survey of autosomal dominant de novo monogenic rare neurodevelopmental disorders, SCN8A-RD had an estimated prevalence of 2.96/100,000 individuals (95% CI 2.63–3.24/100,000 individuals) [<a href="#CR26" class="usa-link" aria-describedby="CR26">26</a>]. The incidence of SCN8A-RD is reported to be just over 1 in 56,000 births [<a href="#CR15" class="usa-link" aria-describedby="CR15">15</a>]. Based on the 2021 Centers for Disease Control and Prevention data [<a href="#CR27" class="usa-link" aria-describedby="CR27">27</a>], we infer a birth rate of ~ 65 SCN8A-RD cases per year in the United States (U.S.). There are known to be over 700 cases worldwide with pathogenic variants in <em>SCN8A</em>, accounting for ~ 1% of all cases of epilepsy with encephalopathy [<a href="#CR15" class="usa-link" aria-describedby="CR15">15</a>].</p></section><section id="Sec5"><h3 class="pmc_sec_title">Consensus guidelines for diagnosis, phenotypes, and treatment</h3>
<p id="Par7">Beginning in 2021, the <em>International SCN8A Alliance</em> (<em>Alliance</em>) convened a core panel of more than 30 experts to develop the first global consensus for diagnosis and management of SCN8A-RD. The panel investigated the extent of agreement in a modified-Delphi process that addressed diagnosis, treatment, phenotypes, comorbidities, and clinical management [<a href="#CR28" class="usa-link" aria-describedby="CR28">28</a>], as well as comorbidities and prognosis [<a href="#CR29" class="usa-link" aria-describedby="CR29">29</a>].</p></section><section id="Sec6"><h3 class="pmc_sec_title">Preclinical models: mechanisms</h3>
<p id="Par8">Preclinical and laboratory models for SCN8A have been instrumental in advancing understanding of disease mechanisms and facilitating therapeutic development for SCN8A-RD [<a href="#CR30" class="usa-link" aria-describedby="CR30">30</a>, <a href="#CR31" class="usa-link" aria-describedby="CR31">31</a>]. In vitro models, including heterologous expression systems and patient-derived induced pluripotent stem cells (iPSCs) differentiated into neurons, have enabled detailed electrophysiological studies of mutant Nav1.6 channels [<a href="#CR20" class="usa-link" aria-describedby="CR20">20</a>, <a href="#CR32" class="usa-link" aria-describedby="CR32">32</a>–<a href="#CR34" class="usa-link" aria-describedby="CR34">34</a>]. Genetically modified mice and zebrafish models have also been used [<a href="#CR35" class="usa-link" aria-describedby="CR35">35</a>, <a href="#CR36" class="usa-link" aria-describedby="CR36">36</a>]. Mouse models, such as constitutive and conditional knock-in mice carrying human <em>SCN8A</em> mutations, have been crucial in identifying disease mechanisms, including sex differences [<a href="#CR31" class="usa-link" aria-describedby="CR31">31</a>, <a href="#CR37" class="usa-link" aria-describedby="CR37">37</a>–<a href="#CR42" class="usa-link" aria-describedby="CR42">42</a>]. These diverse models have yielded significant insights into the altered channel kinetics and neuronal hyperexcitability associated with mutant SCN8A and elucidated the role of Na<sub>V</sub>1.6 in different neuron types and brain regions [<a href="#CR43" class="usa-link" aria-describedby="CR43">43</a>, <a href="#CR44" class="usa-link" aria-describedby="CR44">44</a>].</p></section><section id="Sec7"><h3 class="pmc_sec_title">Therapeutics</h3>
<p id="Par9">Several studies have been instrumental in identifying treatments for GoF-associated SCN8A-RD: with the development of novel small molecule inhibitors that directly target Na<sub>V</sub>1.6, use of modulators of neuronal excitability, and the repurposing of existing medications [<a href="#CR34" class="usa-link" aria-describedby="CR34">34</a>, <a href="#CR45" class="usa-link" aria-describedby="CR45">45</a>–<a href="#CR48" class="usa-link" aria-describedby="CR48">48</a>]. Preclinical studies have demonstrated that reduction in the levels of <em>Scn8a</em> transcripts with GoF variants by antisense oligonucleotides (ASOs) can prevent seizures and extend survival in a <em>Scn8a</em>-DEE mouse model [<a href="#CR49" class="usa-link" aria-describedby="CR49">49</a>], even when treatment is initiated after seizure onset [<a href="#CR50" class="usa-link" aria-describedby="CR50">50</a>]. Down-regulation of <em>Scn8a</em> by viral delivery of an <em>Scn8a</em>-shRNA was also seizure protective [<a href="#CR51" class="usa-link" aria-describedby="CR51">51</a>]. In addition, allele-specific inactivation of the mutant allele by CRISPR/Cas9 also rescued dominant lethality in <em>Scn8a</em><sup><em>N1768D</em></sup>/ + mice [<a href="#CR52" class="usa-link" aria-describedby="CR52">52</a>]. While promising as a therapeutic strategy for variants with GoF effects, there are currently no published preclinical studies on the potential of small molecule or genetic therapies in the context of <em>SCN8A</em> LoF variants.</p></section><section id="Sec8"><h3 class="pmc_sec_title">Industry advances in clinical trials</h3>
<p id="Par10">There are currently two small molecules in clinical trials for GoF variants in <em>SCN8A</em> that lead to excess Na<sub>V</sub>1.6 sodium current: NBI-921352, which directly targets Na<sub>V</sub>1.6 channels [<a href="#CR45" class="usa-link" aria-describedby="CR45">45</a>] (<a href="https://clinicaltrials.gov/ct2/show/NCT04873869" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NCT04873869</a>) and PRAX-562 [<a href="#CR53" class="usa-link" aria-describedby="CR53">53</a>], which primarily targets persistent sodium currents in both Na<sub>v</sub>1.6 and Na<sub>v</sub>1.2 (<a href="https://clinicaltrials.gov/ct2/show/NCT05818553" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NCT05818553</a>).</p></section></section><section id="Sec9"><h2 class="pmc_sec_title">Knowledge gaps and critical barriers to progress</h2>
<p id="Par11">Despite these gains, critical knowledge gaps remain in the basic understanding of disease mechanisms and clinical management. The relationships between in vitro and in vivo functional effects for <em>SCN8A</em> variants [<a href="#CR54" class="usa-link" aria-describedby="CR54">54</a>] are poorly understood and there are currently no known biomarkers to track disease progression or treatment response. Treatment approaches to the multifarious manifestations of the disease are hindered by the (1) non-selective mechanisms of currently used sodium channel blockers (SCB), (2) paucity of knowledge on polypharmacy, (3) poor understanding of the relationships between epilepsy and non-seizure outcomes [<a href="#CR7" class="usa-link" aria-describedby="CR7">7</a>, <a href="#CR55" class="usa-link" aria-describedby="CR55">55</a>], and (4) lack of therapeutic choices for managing non-seizure comorbidities and the high premature death rate (Table <a href="#Tab1" class="usa-link">1</a>). Furthermore, efficient clinical trial design and the production of orphan products is stymied by: (1) incomplete knowledge of disease natural history; (2) selection of appropriate outcome measures for the full disease spectrum; and (3) a “floor” effect on existing developmental scales that limits application to the most severely impacted patients [<a href="#CR7" class="usa-link" aria-describedby="CR7">7</a>].</p>
<section class="tw xbox font-sm" id="Tab1"><h3 class="obj_head">Table 1.</h3>
<div class="caption p"><p>Critical knowledge gaps</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups"><tbody>
<tr>
<td align="left" rowspan="4" colspan="1">Disease mechanisms</td>
<td align="left" colspan="1" rowspan="1">Mechanisms of epileptogenesis</td>
</tr>
<tr><td align="left" colspan="1" rowspan="1">Relationships between in vitro and in vivo functional effects for SCN8A variants</td></tr>
<tr><td align="left" colspan="1" rowspan="1">Relationships between epilepsy and non-seizure outcomes</td></tr>
<tr><td align="left" colspan="1" rowspan="1">Lack of biomarkers to track disease progression or treatment response</td></tr>
<tr>
<td align="left" rowspan="4" colspan="1">Clinical management</td>
<td align="left" colspan="1" rowspan="1">Non-selective mechanisms of sodium channel blockers</td>
</tr>
<tr><td align="left" colspan="1" rowspan="1">Use of polypharmacy</td></tr>
<tr><td align="left" colspan="1" rowspan="1">Therapies for non-seizure comorbidities</td></tr>
<tr><td align="left" colspan="1" rowspan="1">Prevention of premature death</td></tr>
<tr>
<td align="left" rowspan="3" colspan="1">Clinical trial design</td>
<td align="left" colspan="1" rowspan="1">Disease natural history</td>
</tr>
<tr><td align="left" colspan="1" rowspan="1">Outcome measures for the full disease spectrum</td></tr>
<tr><td align="left" colspan="1" rowspan="1">Floor effect of developmental scales for severely affected</td></tr>
</tbody></table></div>
<div class="p text-right font-secondary"><a href="table/Tab1/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div></section></section><section id="Sec10"><h2 class="pmc_sec_title">The SCN8A research roadmap meeting</h2>
<p id="Par12">The <em>Alliance</em> sponsored an <em>SCN8A</em> Research Roadmap meeting that was held in Boston, MA on August 16–18, 2024, with the overarching goal to rapidly advance the field, taking into consideration caregiver priorities for improved quality of life (QoL). The meeting brought together caregivers, clinicians, scientists, and biotechnology industry partners to (1) identify knowledge gaps in the mechanisms of epileptogenesis and a multitude of non-seizure outcomes, (2) prioritize research strategies to fill these gaps, and (3) promote collaborative efforts among stakeholders to simulate the development of therapies with potential to have the largest impact for improved QoL.</p></section><section id="Sec11"><h2 class="pmc_sec_title">Stakeholder survey results</h2>
<section id="Sec12"><h3 class="pmc_sec_title">Survey design</h3>
<p id="Par13">Extensive review of the SCN8A literature (more than 460 publications since 2012) and requests for proposals from epilepsy funding agencies were performed (e.g., CURE, Epilepsy Foundation, NINDS). Stakeholder-specific surveys were crafted focusing on research priorities, scientific roadblocks, current gaps in research and clinical care. Interviews with biotech leaders were also conducted to identify priorities from the biopharma perspective. One of the meeting organizers (CBB) interviewed 8 biotech companies interested in SCN8A. Full survey results can be found in Supplemental Material and are briefly summarized below.</p></section><section id="Sec13"><h3 class="pmc_sec_title">Caregivers</h3>
<p id="Par14">The caregiver survey received responses from 175 families living in 27 countries. The top five challenges that affected QoL involved seizures, cognition and speech, motor disabilities (including hypotonia), sleep and behavioral issues (Fig. <a href="#Fig1" class="usa-link">1</a>A). Behavioral issues were more commonly a top challenge for caregivers of patients with LoF variants. Caregivers prioritized research to improve seizure control over that for non-seizure outcomes by 60:40. To control seizures, caregivers prioritized research on the development of new effective antiseizure medications (ASMs) (Fig. <a href="#Fig1" class="usa-link">1</a>B), followed by alternative therapies (e.g., CBD), and ASM combinations (Fig. <a href="#Fig1" class="usa-link">1</a>C). Regarding research into disease mechanisms, caregivers gave the top rank to research that would increase understanding of the effect of individual genetic variants on disease phenotype or severity (Fig. <a href="#Fig1" class="usa-link">1</a>D).</p>
<figure class="fig xbox font-sm" id="Fig1"><h4 class="obj_head">Fig. 1.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12366098_13023_2025_3672_Fig1_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9780/12366098/98508346e9fb/13023_2025_3672_Fig1_HTML.jpg" loading="lazy" id="MO1" height="462" width="770" alt="Fig. 1"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig1/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Caregiver survey responses. <strong>A</strong> Rankings of the top five challenges affecting quality of life (QoL), <strong>B</strong> priorities for controlling seizures, <strong>C</strong> interventions warranting further investigation, <strong>D</strong> priorities for research into disease mechanisms</p></figcaption></figure></section><section id="Sec14"><h3 class="pmc_sec_title">Clinicians</h3>
<p id="Par15">Clinicians (n = 46) were asked about clinical experience and expertise in SCN8A-RD (Figs S1A and S1B). They emphasized the importance of detailed characterization of the phenotypic spectrum to improve diagnosis and phenotyping (Fig S2A). To improve treatment, clinicians prioritized research to guide selection of first line and adjunctive ASMs (their doses and combinations) (Fig S2B). To improve prognosis, clinicians prioritized the identification of features that predict clinical outcome (Fig S2C). Regarding research to improve QoL, clinicians prioritized movement disorders (e.g., ataxia) (30.4%), followed by speech/communication and behavioral issues (17.4%) (Fig. <a href="#Fig2" class="usa-link">2</a>). Clinicians also prioritized registry-based longitudinal research and prospective natural history studies to advance the ability to accurately diagnose, predict outcomes, and tailor treatments (Fig S2D–F).</p>
<figure class="fig xbox font-sm" id="Fig2"><h4 class="obj_head">Fig. 2.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12366098_13023_2025_3672_Fig2_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9780/12366098/7c1870579087/13023_2025_3672_Fig2_HTML.jpg" loading="lazy" id="MO2" height="330" width="797" alt="Fig. 2"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig2/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Clinician ranking of importance of research on 10 comorbidities to improve QoL</p></figcaption></figure></section><section id="Sec15"><h3 class="pmc_sec_title">Scientists</h3>
<p id="Par16">Scientists (n = 23) with expertise in a variety of subfields participated in the survey. This group had a median of 5.5 years in SCN8A-related research with a median of 20% effort. They reported nearly equal feasibility in studying GoF and LoF mechanisms (Fig S3A) and greater feasibility for studies of seizure-related <em>versus</em> non-seizure-related mechanisms in their respective labs (Fig S3B).</p>
<p id="Par17">Overall, the scientists ranked the development of targeted therapies for seizures as the most important, followed by investigating the mechanisms driving GoF and LoF phenotypes (Fig. <a href="#Fig3" class="usa-link">3</a>A). Importantly, there was a different rank order for the feasibility of accomplishing these goals (Fig. <a href="#Fig3" class="usa-link">3</a>B). For instance, developing targeted therapies for seizures was ranked 1st in importance but 4th in terms of feasibility. Model development to study seizures was ranked lowest in terms of importance but highest in terms of feasibility given the current availability of seizure models for SCN8A-RD.</p>
<figure class="fig xbox font-sm" id="Fig3"><h4 class="obj_head">FIg 3.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12366098_13023_2025_3672_Fig3_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9780/12366098/459ca7e2cc1e/13023_2025_3672_Fig3_HTML.jpg" loading="lazy" id="MO3" height="680" width="797" alt="FIg 3"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig3/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Scientist ranking of research goals to fill knowledge gaps: Importance (<strong>A</strong>) versus feasibility (<strong>B</strong>) of current models</p></figcaption></figure><p id="Par18">Scientists ranked molecular and cellular-based research on seizures as the top priority to understand disease mechanisms (Fig S3C). Regarding improved understanding of mechanisms to improve therapeutics, research into whole brain circuitry and the development of biomarkers were ranked as top priorities (Fig S3D). ASOs were ranked as the top research priority to develop and deliver genetic therapies for variants with both GoF and LoF properties (Fig S4A). The "Goldilocks" problem (i.e., disease phenotypes caused by ‘too little or too much’ Na<sub>V</sub>1.6 activity) was ranked the most critical issue to overcome in order to successfully develop targeted genetic therapies (Fig S4B).</p>
<p id="Par19">To improve clinical outcomes, scientists reached a strong consensus on the importance developing laboratory models for the purpose of designing and delivering selective Na<sub>V</sub>1.6 therapies (e.g., novel small molecules), specifically transgenic mouse models (Fig S5A, B). For the purpose of filling knowledge gaps in disease mechanisms in relation to therapeutics (i.e., testing selective ASMs and genetic therapies), transgenic mouse models also ranked as the most important model type (Fig S5C). The survey also emphasized the importance of developing models to study non-seizure phenotypes (Fig S5D); however, scientists also acknowledged limitations of current animal models in recapitulating comorbidities commonly observed in patients and the challenge to develop such models (Fig. <a href="#Fig3" class="usa-link">3</a>).</p></section><section id="Sec16"><h3 class="pmc_sec_title">Biotech perspective</h3>
<p id="Par20">Companies are drawn to drug development for SCN8A-RD for a variety of reasons, including a clear unmet medical need, the well-organized patient community, and the collective expertise of scientists and clinicians in CNS and ion channels. Challenges for biotech include the rarity of the disease and the crowded space of existing drugs, which complicates clinical trial design and execution. Similar to GoF strategies favored by scientists, biotech favored approaches that would inhibit channel activity, knockdown expression, and promote inhibitory neuron activity. Favored approaches in the case of LoF included blocking "poison exons" or microRNA target sites with ASOs, and potentially using CRISPR activation. Biotech also acknowledged challenges in the risk of excessive knockdown, the need for delivery to relevant brain regions, and the need to classify patients as carrying variants with GoF or LoF function based on clinical phenotype.</p>
<p id="Par21">Priorities for research that would help de-risk investment included better classification and understanding of variant biology and pathophysiology, determination of the range of Na<sub>V</sub>1.6 levels compatible with brain health, development of additional animal models for various variant classes, and implementation of natural history studies that do not preclude clinical trial participation. Companies also expressed interest in more information on phenotype-genotype correlations and the development of an iPSC resource managed by an organization like ATCC. Collaboration opportunities were also identified, including increased interaction with other channelopathies (e.g., SCN2A) and assistance in determining measurable clinical trial endpoints.</p></section></section><section id="Sec17"><h2 class="pmc_sec_title">Integration of survey results</h2>
<section id="Sec18"><h3 class="pmc_sec_title">Compare and contrast caregiver, clinician and scientist surveys</h3>
<section id="Sec19"><h4 class="pmc_sec_title">Points of agreement</h4>
<p id="Par22">All stakeholder groups prioritized improving seizure control as a primary research goal. There was also a shared interest in advancing genetic therapy approaches, which are seen as promising avenues for targeted treatment. All groups also recognized the importance of studying both seizure and non-seizure outcomes, as well as the need for more personalized treatment strategies (e.g., tailored to specific variants and/or their effects on Na<sub>V</sub>1.6 activity). Stakeholders also were consistent in the recognition of the need for more data collection and interdisciplinary collaboration (Table <a href="#Tab2" class="usa-link">2</a>).</p>
<section class="tw xbox font-sm" id="Tab2"><h5 class="obj_head">Table 2.</h5>
<div class="caption p"><p>Points of agreement among stakeholders and responsiveness to caregiver priorities</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<thead><tr>
<th align="left" colspan="1" rowspan="1">Priority area (alignment)</th>
<th align="left" colspan="1" rowspan="1">Points of agreements</th>
<th align="left" colspan="1" rowspan="1">Clinician responsiveness</th>
<th align="left" colspan="1" rowspan="1">Scientist responsiveness</th>
</tr></thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1">Seizure vs. Non Seizure Outcomes (Partial)</td>
<td align="left" colspan="1" rowspan="1">All recognize importance of both; caregivers prioritize non-seizure outcomes, clinicians and scientists focus more on seizure control</td>
<td align="left" colspan="1" rowspan="1">Recognize importance of comorbidities, seizures remain top priority</td>
<td align="left" colspan="1" rowspan="1">Primary focus on seizure therapies</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Comorbidities (High)</td>
<td align="left" colspan="1" rowspan="1">All recognize importance</td>
<td align="left" colspan="1" rowspan="1">Prioritize sleep, movement, and behavioral issues</td>
<td align="left" colspan="1" rowspan="1">Recognize importance, not primary focus</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Genetic Therapies vs. Conventional ASMs (Partial)</td>
<td align="left" colspan="1" rowspan="1">Caregivers strongly prefer research into genetic therapies, clinicians prioritize ASMs, scientists focus on both</td>
<td align="left" colspan="1" rowspan="1">Prioritize traditional ASM approaches over genetic therapies</td>
<td align="left" colspan="1" rowspan="1">More focus on genetic therapies then on other targeted treatments</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Novel ASMs (High)</td>
<td align="left" colspan="1" rowspan="1">All see importance, different emphasis</td>
<td align="left" colspan="1" rowspan="1">Top priority, first line and adjunctive top priority</td>
<td align="left" colspan="1" rowspan="1">Focus on novel small molecules repurposed drugs</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Research Models (Partial)</td>
<td align="left" colspan="1" rowspan="1">Agreement on natural history studies, different emphases; Caregivers interested in participating in studies, scientists focus on lab models</td>
<td align="left" colspan="1" rowspan="1">Align well with caregiver interest in participation; Emphasize registries and digital health technology involving patients</td>
<td align="left" colspan="1" rowspan="1">Focus on transgenic mouse models (do not directly involve patients), less on patient-involved studies</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/Tab2/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div></section></section><section id="Sec20"><h4 class="pmc_sec_title">Caregiver priorities</h4>
<p id="Par23">In contrast to scientists and clinicians, caregivers tended to prioritize immediate, practical interventions to improve daily life, including alternative therapies (e.g., Fig. <a href="#Fig1" class="usa-link">1</a>C vs Figs S2B and S5A). While all groups recognized the importance of non-seizure outcomes and comorbidities, caregivers placed higher importance on cognitive impairment, communication difficulties, and behavioral problems; clinicians prioritized sleep, movement, and behavioral issues; and scientists focused more on cognitive aspects and SUDEP. Clinicians also recognized the importance of research on non-seizure phenotypes, while scientists prioritized research on fundamental mechanisms, particularly through the use of cellular and animal models.</p></section><section id="Sec21"><h4 class="pmc_sec_title">Research priorities of clinicians and scientists</h4>
<p id="Par24">Disease mechanisms and treatment development represent top research priorities for both clinicians and scientists (Table <a href="#Tab3" class="usa-link">3</a>). Both groups also recognized the importance of biomarkers as crucial research tools for understanding disease mechanisms and the impact of therapeutics. The value of registries and natural history studies represents another area of strong alignment, as was the importance of interdisciplinary collaboration and partnerships between clinics and laboratories. While both groups prioritized seizure control, clinicians tended to emphasize research on first line and adjunctive ASMs, while scientists focused on selective Na<sub>V</sub>1.6 therapies, repurposed drugs, and genetic therapies. In terms of research tools, scientists placed emphasis on transgenic mouse models for testing therapeutics, while clinicians focused on the development of clinical data pipelines and predictive modeling.</p>
<section class="tw xbox font-sm" id="Tab3"><h5 class="obj_head">Table 3.</h5>
<div class="caption p"><p>Points of Agreement on Research Priorities of Clinicians and Scientists</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<thead><tr>
<th align="left" colspan="1" rowspan="1">Research area</th>
<th align="left" colspan="1" rowspan="1">Clinician priority</th>
<th align="left" colspan="1" rowspan="1">Scientist priority</th>
<th align="left" colspan="1" rowspan="1">Agreement level</th>
</tr></thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1">Disease Mechanisms</td>
<td align="left" colspan="1" rowspan="1">Recognized as Important research area</td>
<td align="left" colspan="1" rowspan="1">Top research priority</td>
<td align="left" colspan="1" rowspan="1">High</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Treatment and Therapeutics</td>
<td align="left" colspan="1" rowspan="1">Top research priority (mostly ASMs)</td>
<td align="left" colspan="1" rowspan="1">Top priority (targeted therapies for seizures)</td>
<td align="left" colspan="1" rowspan="1">High</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Genetic Therapies</td>
<td align="left" colspan="1" rowspan="1">Recognized as Important research area</td>
<td align="left" colspan="1" rowspan="1">Top research priority</td>
<td align="left" colspan="1" rowspan="1">High</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Biomarkers</td>
<td align="left" colspan="1" rowspan="1">High priority for research tools and methods</td>
<td align="left" colspan="1" rowspan="1">Important research question for disease mechanisms and therapeutics</td>
<td align="left" colspan="1" rowspan="1">High</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Registries and Natural History Studies</td>
<td align="left" colspan="1" rowspan="1">SCN8A registry as top priority for research tools</td>
<td align="left" colspan="1" rowspan="1">Recognized value of registry data to guide lab research</td>
<td align="left" colspan="1" rowspan="1">High</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Electrophysiology and Neurophysiology</td>
<td align="left" colspan="1" rowspan="1">Recognized as crucial</td>
<td align="left" colspan="1" rowspan="1">Listed as key areas of expertise</td>
<td align="left" colspan="1" rowspan="1">High</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Interdisciplinary Collaboration</td>
<td align="left" colspan="1" rowspan="1">Emphasized interclinic partnerships and multidisciplinary collaboration</td>
<td align="left" colspan="1" rowspan="1">Highlighted importance of lab clinic collaborations</td>
<td align="left" colspan="1" rowspan="1">High</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Cell Types and Brain Regions</td>
<td align="left" colspan="1" rowspan="1">Implicit support through emphasis on disease mechanisms</td>
<td align="left" colspan="1" rowspan="1">Ranked as important for understanding epileptogenesis</td>
<td align="left" colspan="1" rowspan="1">Moderate</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Pharmacology and Drug Development</td>
<td align="left" colspan="1" rowspan="1">Prioritized research on first line and adjunctive ASMs</td>
<td align="left" colspan="1" rowspan="1">Focused on selective Nav1.6 therapies and repurposed drugs</td>
<td align="left" colspan="1" rowspan="1">Moderate</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Prioirtized Research (non-seizure)</td>
<td align="left" colspan="1" rowspan="1">Sleep, Movement, Speech, Behavior</td>
<td align="left" colspan="1" rowspan="1">Cognitive, behavioral, movement, SUDEP, hypotonia</td>
<td align="left" colspan="1" rowspan="1">Moderate</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Non-Seizure Outcomes</td>
<td align="left" colspan="1" rowspan="1">Comorbidities recognized at important research area (patients)</td>
<td align="left" colspan="1" rowspan="1">Non-seizure phenotypes recognized as Important research area (models)</td>
<td align="left" colspan="1" rowspan="1">Partial</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Research Tools</td>
<td align="left" colspan="1" rowspan="1">Electrophysiology, neurophysiology, predictive models, biomarkers</td>
<td align="left" colspan="1" rowspan="1">Transgenic mouse for testing therapeutics, Registry, Lab-Clinic collaboration, biomarkers</td>
<td align="left" colspan="1" rowspan="1">n/a</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Prioirtized Research (seizure)</td>
<td align="left" colspan="1" rowspan="1">1st line ASMs &amp; adjunctive, polypharmacy, off-label ASMs, repurposed drugs</td>
<td align="left" colspan="1" rowspan="1">Disease mechanism, ASO genetic therapy/ Goldilocks problem</td>
<td align="left" colspan="1" rowspan="1">Low</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/Tab3/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div></section></section></section><section id="Sec22"><h3 class="pmc_sec_title">Emergence of core knowledge gaps</h3>
<p id="Par25">Integration across stakeholder surveys yielded several core knowledge gap areas. Leaders with expertise in five core areas were identified and asked to represent the importance of each area to participants at the meeting. The following research areas were adopted to be the focus of five <em>Working Groups (WG)</em>:</p>
<dl class="def-list">
<dt>WG1</dt>
<dd><p id="Par26">Advancing Transformative Therapeutics: Development and Delivery</p></dd>
<dt>WG2</dt>
<dd><p id="Par27">Non-Seizure Outcomes: Mechanisms, Management, and Therapies</p></dd>
<dt>WG3</dt>
<dd><p id="Par28">Improving Current Therapeutics: First line, adjunctive, combination, and alternative approaches</p></dd>
<dt>WG4</dt>
<dd><p id="Par29">Application of Biomarkers: Tracking disease progression and treatment response</p></dd>
<dt>WG5</dt>
<dd><p id="Par30">Whole Brain/Whole Body: Brain regions, cell types, circuitry, neuromodulation &amp; epileptic body</p></dd>
</dl>
<p id="Par31">The working groups were assigned the following tasks: (1) define core knowledge gaps in each area, (2) design a research strategy to fill these knowledge gaps, and (3) ensure that the strategy facilitated improvement in patient outcomes and addressed caregiver priorities. Cross-disease comparisons (e.g., <em>SCN2A</em>) was suggested as a sixth area. Registries and natural history studies were also recognized as a core area of importance [<a href="#CR56" class="usa-link" aria-describedby="CR56">56</a>]. However, given the existence of a mature registry [<a href="#CR4" class="usa-link" aria-describedby="CR4">4</a>, <a href="#CR15" class="usa-link" aria-describedby="CR15">15</a>] and ongoing efforts to initiate prospective natural history studies [<a href="#CR57" class="usa-link" aria-describedby="CR57">57</a>], this was not a focus of the Working Group sessions.</p></section></section><section id="Sec23"><h2 class="pmc_sec_title">Working group summaries</h2>
<section id="Sec24"><h3 class="pmc_sec_title">WG1: advancing transformative therapeutics: development and delivery</h3>
<section id="Sec25"><h4 class="pmc_sec_title">Background</h4>
<p id="Par32">Current ASMs have limited effectiveness for the treatment of SCN8A-RD, with a significant portion of patients exhibiting refractory seizures [<a href="#CR9" class="usa-link" aria-describedby="CR9">9</a>]. Further, current ASMs do not address the wide range of cognitive and motor comorbidities that patients experience [<a href="#CR29" class="usa-link" aria-describedby="CR29">29</a>]. Transformative therapeutics that can manage refractory seizures and also improve non-seizure outcomes are needed. Both small molecules that directly target Na<sub>V</sub>1.6 or genetic therapies that directly correct the DNA or mRNA to restore protein function or alter he DNA or mRNA to mitigate deleterious effects caused by mutant protein could be transformative therapies. However, studies suggest that <em>SCN8A</em> is a “Goldilocks” gene, where too much or too little activity can cause abnormal phenotypes. In the case of GoF variants, only a small proportion of mutant transcript is sufficient to induce spontaneous seizures [<a href="#CR58" class="usa-link" aria-describedby="CR58">58</a>], while reduced expression or haploinsufficiency is associated with a range of symptoms such as seizures, ataxia, and intellectual disability [<a href="#CR15" class="usa-link" aria-describedby="CR15">15</a>, <a href="#CR18" class="usa-link" aria-describedby="CR18">18</a>, <a href="#CR21" class="usa-link" aria-describedby="CR21">21</a>, <a href="#CR29" class="usa-link" aria-describedby="CR29">29</a>, <a href="#CR59" class="usa-link" aria-describedby="CR59">59</a>].</p></section><section id="Sec26"><h4 class="pmc_sec_title">Knowledge gaps</h4>
<p id="Par33">Given the Goldilocks nature of SCN8A, a major knowledge gap centers around levels of expression that are compatible with healthy brain function. Further research is required to identify safe and effective levels of <em>SCN8A</em> transcript that would restore normal neuronal activity without causing adverse effects. The lack of precise information also discourages biotech from investing in <em>SCN8A</em> drug development. Other areas needing further study concern the developmental stage(s) for optimal intervention, as well as the best physical location(s) in the brain to target. For example, <em>SCN8A</em> expression is low during early fetal development, increases approximately two months before birth, and plateaus at approximately one year of age [<a href="#CR60" class="usa-link" aria-describedby="CR60">60</a>]. Similarly, the effects of altering <em>SCN8A</em> expression in different circuits and brain regions has not been studied. Further, delivery methods will have to be optimized. Finally, it is uncertain whether therapies that directly target <em>SCN8A</em> in the CNS would lead to improved non-seizure outcomes.</p></section><section id="Sec27"><h4 class="pmc_sec_title">Research priorities</h4>
<p id="Par34">This working group agreed that the top priority is to address the safety concern regarding excessive downregulation or upregulation of <em>SCN8A</em> expression. Varied levels of Scn8a expression can be introduced in wildtype mice by varying the doses of genetic therapeutics, such as ASO, CRISPR-KO, shRNA, and gene replacement followed by evaluation of seizure activity, motor function, behavior, cognitive function and survival. These studies should be carried out in whole brain and in specific brain regions of wildtype mice.</p>
<p id="Par35">A second goal is to determine the effectiveness of genetic therapies in disease models of different severity with both LoF and GoF variants, and to determine the impact of timing of intervention during development. If early treatment has significant therapeutic advantages, these data will be useful for clinicians to advocate for early genetic screening, diagnosis, and intervention.</p>
<p id="Par36">A third priority is to investigate the regulation of <em>SCN8A</em> expression, including transcriptional and epigenetic regulation. These studies could identify new targets and strategies for manipulating its expression, that could allow for more precise and tunable control over <em>SCN8A</em> expression in the CNS.</p>
<p id="Par37">A fourth priority centers around the importance of non-seizure outcomes as highlighted in the caregiver survey. More research on existing mouse models is needed to assess the effects of new therapies on motor, behavior, cognition and other phenotypes. In addition, there is a need for new animal models that recapitulate the non-seizure phenotypes of importance in patients and that could be used for outcome measures in preclinical trials.</p></section></section><section id="Sec28"><h3 class="pmc_sec_title">WG2: non-seizure outcomes: mechanisms, management, and therapies</h3>
<section id="Sec29"><h4 class="pmc_sec_title">Background</h4>
<p id="Par38">Non-seizure morbidities are a significant concern in SCN8A-RD, with multiple studies showing high prevalence of symptoms such as communication and developmental delays, hypotonia, ataxia, and autistic-like behavior, as well as feeding, gastrointestinal and sleep difficulties (Fig. <a href="#Fig1" class="usa-link">1</a>A). These are challenges that are often more concerning to caregivers than seizures themselves because of their enormous impact on QoL. Giving more attention to non-seizure challenges aligns with FDA guidance emphasizing the need to focus on disease features most important to patients in clinical trials.</p></section><section id="Sec30"><h4 class="pmc_sec_title">Knowledge gaps</h4>
<p id="Par39">While non-seizure outcomes are becoming more recognized as significant challenges for SCN8A-RD families, there is still limited understanding of their causation and the best practices to manage them. Appropriate outcome measures are also needed to accelerate trial readiness. For example, a major gap is that current Clinical Outcome Assessments (COAs) are psychometrically unfit for use in SCN8A and other severely affected DEE populations, with existing measures like the VABS-3 Communication Scores showing extreme floor effects and decreasing standardized scores with age.</p></section><section id="Sec31"><h4 class="pmc_sec_title">Research priorities</h4>
<p id="Par40">The working group agreed that a first priority is to comprehensively document the non-seizure outcomes adversely affecting the entire spectrum of patients with SCN8A-RD. This will involve collaborations with clinicians and families to create a detailed catalog of comorbidities, their prevalence, and their impact on QoL.</p>
<p id="Par41">A second priority is to select appropriate outcome measures for non-seizure phenotypes. This requires a multidisciplinary approach, involving specialists from various fields such as neurology, developmental pediatrics, orthopedics, psychology, speech and language pathology, and occupational and physical therapy. It is important that these assessment tools capture the full spectrum of abilities and challenges in this patient population, from basic neurological function to adaptive behaviors. Consistent with the goals of the Inchstone Project [<a href="#CR61" class="usa-link" aria-describedby="CR61">61</a>], special attention should be given to finer-scale developmental measures that are more appropriated for severely affected individuals who may not show progress on traditional scales.</p>
<p id="Par42">Given that many comorbidities are not unique to SCN8A-RD patients, a third priority is to collect data across channelopathies and DEEs to increase our understanding of comorbidities along the spectrum of neurodevelopmental disorders. This work will require strong collaboration between clinicians and caregivers. Leveraging existing data from multiple sources, including the PERC network [<a href="#CR62" class="usa-link" aria-describedby="CR62">62</a>], Ciitizen database [<a href="#CR63" class="usa-link" aria-describedby="CR63">63</a>], and the International SCN8A Patient Registry [<a href="#CR4" class="usa-link" aria-describedby="CR4">4</a>] will be essential to provide real-world evidence to inform which non-seizure phenotypes to prioritize based on both frequency and severity.</p>
<p id="Par43">A fourth priority is to work with researchers who are involved in obtaining multisource data (see WG3) in standardized format to include non-seizure phenotypes with the goal of documenting the progression of these symptoms over time and how they are associated with seizures.</p></section></section><section id="Sec32"><h3 class="pmc_sec_title">WG3: improving current therapeutics</h3>
<section id="Sec33"><h4 class="pmc_sec_title">Background</h4>
<p id="Par44">Currently, there are over 30 drugs  on the market for treating epilepsy [<a href="#CR64" class="usa-link" aria-describedby="CR64">64</a>]. These ASMs are used as first line, adjunctive, and combination treatments, creating substantial heterogeneity in potential treatment regimens. In addition to these ASMs, alternative therapies including the ketogenic diet, vitamin supplementation, and surgical procedures can be employed to reduce seizure burden and improve QoL.</p></section><section id="Sec34"><h4 class="pmc_sec_title">Knowledge gaps</h4>
<p id="Par45">Despite the numerous potential treatment options, there is little known about the optimal treatment regimens for individuals with SCN8A-RD [<a href="#CR6" class="usa-link" aria-describedby="CR6">6</a>, <a href="#CR28" class="usa-link" aria-describedby="CR28">28</a>]. There are multiple potential sources of data that can inform clinical management, such as data collected in the Registry [<a href="#CR4" class="usa-link" aria-describedby="CR4">4</a>] and electronic medical records (EMRs). However, these sources collect seizure frequency data only a few times a year, making it difficult to generate high-quality, high-resolution longitudinal profiles documenting seizure frequency changes associated with changes in medication regimens. These limitations also reduce the potential of new and promising machine learning (ML) approaches that can handle large amounts of data to identify trends in medication response [<a href="#CR65" class="usa-link" aria-describedby="CR65">65</a>, <a href="#CR66" class="usa-link" aria-describedby="CR66">66</a>]. Therefore, this WG focused on discussion of a unified infrastructure to allow for efficient collection of high-quality multisource data that would provide the framework for improved understanding of the efficacy of single ASMs, combinations of ASMs, alternative therapies, and transformative therapeutics.</p></section><section id="Sec35"><h4 class="pmc_sec_title">Research priorities</h4>
<p id="Par46">The first priority is to design a strategy to collect granular data on seizure frequency in a prospective manner to advance knowledge about optimal medication combinations. The recommended procedure is to collect daily seizure data via a smartphone app to reduce the burden placed on caregivers. The minimum number of daily questions to be answered with a simple yes/no/number include: (1) did your child experience a seizure today, (2) if yes, how many, and (3) how many rescue medications were administered, if any?</p>
<p id="Par47">Additional simple questions that could be incorporated into an electronic diary include the seizure type(s), sleep quality, and confirmation that the daily regimen of ASMs had been administered. Caregivers would also be prompted to provide more details on changes in development skills, QoL measures, etc. in an extended survey, which could be requested less frequently. The WG recommended the use of a well-vetted commercial application for seizure tracking with backend data processing capabilities [<a href="#CR67" class="usa-link" aria-describedby="CR67">67</a>]. The focus of the work would then be on efforts to merge the daily data with other sources of data, including those that come from analysis of biofluids (see WG4).</p>
<p id="Par48">The second priority is to design a strategy to collect multisource data in a standardized format that would be deposited into an accessible repository. Since much of the data infrastructure already exists, albeit isolated in separate locations, it was proposed that a single repository host the data to more easily cross-reference and curate specific datasets on request.</p>
<p id="Par49">There are additional advantages to the creation of this data infrastructure, including easy access of high-quality data for each patient prior to treatment, and enhanced attractiveness of the SCN8A-RD community for clinical trials. Such trials will have the capacity for more refined statistical designs, more appropriate inclusion criteria, and greater capacity to measure success. This infrastructure could potentially serve as a blueprint for other rare disease communities and enable better cross-disease studies.</p></section></section><section id="Sec36"><h3 class="pmc_sec_title">WG4: Application of biomarkers: tracking disease progression and treatment response</h3>
<section id="Sec37"><h4 class="pmc_sec_title">Background</h4>
<p id="Par50">The development of pharmaceutical agents and devices to treat, cure, and prevent epilepsy is greatly benefited by the identification of definitive biomarkers capable of reducing the cost of discovery and validation of new therapies for epilepsy. In principle, biomarkers may facilitate the development of interventions to prevent epilepsy, reverse progression of epilepsy, and potentially even cure epilepsy after it is established [<a href="#CR68" class="usa-link" aria-describedby="CR68">68</a>, <a href="#CR69" class="usa-link" aria-describedby="CR69">69</a>]. Biomarkers may also play a role in identifying and effectively treating refractory epilepsy.</p></section><section id="Sec38"><h4 class="pmc_sec_title">Knowledge gaps</h4>
<p id="Par51">While some biomarkers exist in the broader field of epilepsy, such as EEG-based markers and neurofilament light chain [<a href="#CR68" class="usa-link" aria-describedby="CR68">68</a>, <a href="#CR70" class="usa-link" aria-describedby="CR70">70</a>–<a href="#CR72" class="usa-link" aria-describedby="CR72">72</a>], there are substantial gaps in biomarker availability for SCN8A-RD. Challenges include: (1) a lack of predictive biomarkers reflecting disease progression and treatment response, (2) limited understanding of the correlation between potential biomarkers and clinical outcomes, (3) technical challenges in developing highly sensitive and specific biomarker assays, and (4) regulatory hurdles in biomarker validation, particularly concerning FDA requirements.</p></section><section id="Sec39"><h4 class="pmc_sec_title">Research priorities</h4>
<p id="Par52">To address these gaps, this WG discussed a multi-phased biomarker discovery and validation study. The initial discovery phase should focus on broad data collection from patients with pathogenic <em>SCN8A</em> variants, utilizing protein/cytokine/immune panels and omics-based approaches to analyze biofluids (e.g., blood and cerebrospinal fluid). Concurrently, advanced neuroimaging and EEG analysis should be conducted to identify potential biomarkers linked to seizure activity and disease progression [<a href="#CR70" class="usa-link" aria-describedby="CR70">70</a>]. ML models could be employed to integrate multisource data, aiming to identify complex biomarker signatures that may not be apparent through traditional analysis methods [<a href="#CR73" class="usa-link" aria-describedby="CR73">73</a>].</p>
<p id="Par53">Rigorous validation would then be needed to determine which biomarkers faithfully reflect disease progression, treatment efficacy, and overall patient improvement. Special attention should be given to exploring Transcranial Magnetic Stimulation (TMS) has potential for measuring cortical excitation/inhibition ratios and ASM pharmacodynamics, which could provide valuable insights into disease mechanisms and treatment responses [<a href="#CR74" class="usa-link" aria-describedby="CR74">74</a>, <a href="#CR75" class="usa-link" aria-describedby="CR75">75</a>].</p>
<p id="Par54">Partnering with biotech and pharmaceutical companies could be initiated to accelerate biomarker discovery and integration into drug development pipelines. Patient and family engagement will be important for sample collection and to ensure that patient-reported outcomes are considered in biomarker validation. The creation of a centralized repository for biomarker data would facilitate data sharing and collaboration among researchers worldwide, potentially accelerating discoveries and validation processes.</p></section></section><section id="Sec40"><h3 class="pmc_sec_title">WG5: whole brain/whole body: brain regions, cell types, circuitry, neuromodulation an epileptic body</h3>
<section id="Sec41"><h4 class="pmc_sec_title">Background</h4>
<p id="Par55">The Na<sub>V</sub>1.6 channel is expressed in excitatory and inhibitory neurons throughout the CNS, as well as in many organs and cell types outside the brain [<a href="#CR76" class="usa-link" aria-describedby="CR76">76</a>]. <em>SCN8A</em> expression increases following birth and maintains expression in multiple brain regions commonly associated with epilepsy, such as the hippocampus, cortex, and thalamus [<a href="#CR77" class="usa-link" aria-describedby="CR77">77</a>]. These regions interact through circuitry networks that regulate cognition and behavior [<a href="#CR78" class="usa-link" aria-describedby="CR78">78</a>]. Little is understood about the impact of pathogenic <em>SCN8A</em> variants on whole-brain dynamics, including network synchronization and long-term neuroplasticity, and how these alterations govern the complex symptomatology observed in affected individuals. Moreover, there is uncertainty on whether many non-seizure outcomes are associated with central or peripheral aspects of SCN8A expression [<a href="#CR79" class="usa-link" aria-describedby="CR79">79</a>].</p></section><section id="Sec42"><h4 class="pmc_sec_title">Knowledge gaps</h4>
<p id="Par56">This WG identified several knowledge gaps relating to genotype–phenotype relationships at the level of circuit biology and cellular physiology. Investigation is needed on the specific impact <em>SCN8A</em> variants have on different brain regions and on critical brain circuits, such as the thalamocortical network, and how these alterations contribute to seizure initiation and propagation. The differential impact of pathogenic SCN8A variants with GoF and LoF effects on various neuronal subtypes and how these contribute to overall network dysfunction are not fully elucidated, nor is the impact of such variants on physiology of organs and cells outside of the central nervous system. The role of glial cells, particularly astrocytes and microglia, in modulating the hyperexcitability caused by pathogenic <em>SCN8A</em> variants is poorly understood. Moreover, the mechanisms underlying the variability in treatment response are not well-characterized, hindering the development of personalized therapeutic approaches. Finally, there is a need to understand how other genes can modify SCN8A-RD phenotypes and whether targeting such modifiers may have therapeutic potential.</p></section><section id="Sec43"><h4 class="pmc_sec_title">Research priorities</h4>
<p id="Par57">A primary goal is to perform detailed electrophysiological studies using both animal models and human tissue samples. In mouse models, single neuron measurements should be conducted to investigate how changes in Na<sub>V</sub>1.6 channel properties associated with both GoF and LoF variants lead to alterations in neuronal excitability in both excitatory and inhibitory neuronal systems. Patch-clamp recordings from brain slice preparations can provide crucial insights into how these variants affect neuronal firing patterns and synaptic transmission.</p>
<p id="Par58">The second priority is to complement mouse studies by using CRISPR/Cas9 genome editing to create isogenic engineered <em>SCN8A</em> and control human iPSCs (hiPSCs). Expanded use of hiPSCs derived from patients offers the opportunity to study the effects of pathogenic variants on different human genetic backgrounds. Single-cell transcriptomics and multi-electrode array recordings of these neurons could reveal cell type-specific alterations in gene expression and network activity. Human iPSC models also provide an excellent platform for high-throughput screening of compound libraries to identify potential variant- or patient-specific therapeutic candidates.</p>
<p id="Par59">The third goal is to investigate the role of different brain cell types, including neurons and glia, in both mouse and human models. This could involve using cell type-specific manipulations in mouse models and generating different neural cell types including the more complex brain organoids from human iPSCs. Single-cell RNA sequencing on these organoids would help to identify alterations in pathway activation. Further work using immune-altered mice could also allow for the study of human-derived neurons from hiPSCs transplanted and networked into the mouse brain.</p>
<p id="Par60">The fourth goal is to map brain regions and circuits involved in epileptogenesis. Advanced in vivo electrophysiology techniques, such as multi-site recordings in freely behaving animals, can provide insights into how <em>SCN8A</em> variants impact circuit dynamics and seizure propagation. These studies should be complemented by ex vivo investigations using brain slice preparations, which allow for detailed examination of local circuit properties. The hiPSC derived brain organoids can also contribute to our understanding of basic circuits, where more advanced brain region specific organoids can elucidate novel network dynamics.</p>
<p id="Par61">A fifth priority is to study whole brain dynamics using advanced neuroimaging approaches in both animal models and human patients. High-resolution structural and functional MRI, as well as diffusion tensor imaging, can map alterations in brain connectivity. These imaging approaches should be combined with transcranial magnetic stimulation, EEG and MEG studies to understand how SCN8A variants affect brain-wide synchronization and oscillatory patterns.</p></section></section></section><section id="Sec44"><h2 class="pmc_sec_title">Discussion</h2>
<section id="Sec45"><h3 class="pmc_sec_title">Integration of stakeholder perspectives</h3>
<p id="Par62">The SCN8A Research Roadmap Meeting brought together global stakeholders to address critical knowledge gaps and to establish research priorities for improving clinical care of patients suffering with SCN8A-RD. Through comprehensive surveys of caregivers, clinicians, and scientists, and representatives of biotech, this initiative illuminated both challenges and opportunities in advancing therapeutic development and patient care. Coordinated surveys highlighted the desires of caregivers for improved seizure control and better management of non-seizure phenotypes. The promise of genetic therapies interested a good portion of the caregiver community, despite the length of time before such therapies would become available. Clinicians also tended to balance shorter-term improvements in care with longer-term research objectives. While clinicians were positive on the shorter-term potential of current therapeutics via improved application of polypharmacy, repurposing of drugs, and new evidence-based off-label treatments, scientists prioritized research aimed at understanding basic disease mechanisms with the primary goal of improving seizure control through the development of transformative therapeutics. Scientists and clinicians also highlighted the importance of interdisciplinary collaborations to advance understanding of disease mechanisms and management of seizure-related and non-seizure outcomes. Biotech representatives agreed with the potential of these varied research efforts, emphasizing the importance of natural history studies, biomarker discovery, variant classification, and measurements of non-seizure phenotypes.</p>
<p id="Par63">The workshop also highlighted areas where the research community could be more responsive to caregiver needs. These include placing greater emphasis on non-seizure outcomes, QoL measures, and considering a broader range of treatment options. Differences between caregiver priorities and current research focus areas echo findings from other rare epilepsy communities [<a href="#CR80" class="usa-link" aria-describedby="CR80">80</a>–<a href="#CR84" class="usa-link" aria-describedby="CR84">84</a>]. It was acknowledged that current efforts to expand research to improve the understanding and management of non-seizure phenotypes is limited by current animal models and cellular systems.</p></section><section id="Sec46"><h3 class="pmc_sec_title">Interconnected priorities</h3>
<p id="Par64">The working groups identified several interconnected priorities that align with those identified in other epilepsy research initiatives, such as the EpiPM Consortium [<a href="#CR85" class="usa-link" aria-describedby="CR85">85</a>] and the Epilepsy Learning Healthcare System [<a href="#CR86" class="usa-link" aria-describedby="CR86">86</a>]. A key research priority of WG1 to address the "Goldilocks" challenge [<a href="#CR87" class="usa-link" aria-describedby="CR87">87</a>] parallels challenges faced in other channelopathies, especially among those with phenotypes associated with GoF and LoF variants [<a href="#CR88" class="usa-link" aria-describedby="CR88">88</a>]. The need to develop better understanding and treatment strategies for non-seizure outcomes discussed in WG2 [<a href="#CR89" class="usa-link" aria-describedby="CR89">89</a>] is shared in many other epilepsies that are associated with movement disorders, communication difficulties, and behavioral issues [<a href="#CR84" class="usa-link" aria-describedby="CR84">84</a>, <a href="#CR85" class="usa-link" aria-describedby="CR85">85</a>, <a href="#CR89" class="usa-link" aria-describedby="CR89">89</a>–<a href="#CR91" class="usa-link" aria-describedby="CR91">91</a>]. The proposed infrastructure for multisource data integration put forward by WG3 builds upon successful models from other rare epilepsies [<a href="#CR92" class="usa-link" aria-describedby="CR92">92</a>–<a href="#CR94" class="usa-link" aria-describedby="CR94">94</a>], which would be enhanced by the discovery of reliable biomarkers (WG4). Such efforts also align with WG1 priorities, as well as with the broader initiative to identify biomarkers in other epilepsy syndromes [<a href="#CR68" class="usa-link" aria-describedby="CR68">68</a>–<a href="#CR72" class="usa-link" aria-describedby="CR72">72</a>, <a href="#CR95" class="usa-link" aria-describedby="CR95">95</a>]. The whole brain/whole body perspective advanced in WG5 represents a parallel effort that synergizes with the goals of other working groups striving to improve seizure and non-seizure outcomes. The comprehensive strategy proposed by WG5 to determine the functional roles played by <em>SCN8A</em> across different cell types, brain regions, and body systems has dual has potential to reveal cellular and neurophysiological aspects of brain function [<a href="#CR41" class="usa-link" aria-describedby="CR41">41</a>, <a href="#CR42" class="usa-link" aria-describedby="CR42">42</a>, <a href="#CR95" class="usa-link" aria-describedby="CR95">95</a>–<a href="#CR100" class="usa-link" aria-describedby="CR100">100</a>], as well as mechanisms underlying non-seizure phenotypes and effects on other organs. While most studies of mouse models have focused mainly on seizure burden and early death, some have demonstrated non-seizure phenotypes observed in patients, including impaired gait, tremor, ataxia, motor learning and coordination, deficits in associative learning or memory, hyperactivity, and impairments in social discrimination [<a href="#CR31" class="usa-link" aria-describedby="CR31">31</a>, <a href="#CR35" class="usa-link" aria-describedby="CR35">35</a>, <a href="#CR39" class="usa-link" aria-describedby="CR39">39</a>, <a href="#CR101" class="usa-link" aria-describedby="CR101">101</a>, <a href="#CR102" class="usa-link" aria-describedby="CR102">102</a>]. While seminal research demonstrated that global knockout of Scn8a in mice was associated with motor impairment and other deficits (1), a recent  conditional knockout of Na<sub>v</sub>1.6 specifically in peripheral sensory neurons was shown to result in severe ataxia and other motor coordination impairments [<a href="#CR79" class="usa-link" aria-describedby="CR79">79</a>]. Further research utilizing similar approaches promises to reveal the extent to which knockin variants with GoF or mixed GoF/LoF properties contribute to these impairments. This will also help to dissect the involvement of the central <em>versus</em> peripheral nervous system in non-seizure outcomes.</p></section><section id="Sec47"><h3 class="pmc_sec_title">Implementation challenges and opportunities</h3>
<p id="Par65">Several challenges must be addressed to successfully implement this roadmap. Some of the goals require sustained collaboration among members of different disciplines, for example, in the standardization and transmittal of medical data from clinicians to data scientists. New collaborative networks and research tools are needed to advance the study of non-seizure outcomes, including the recruitment of researchers with expertise in methods to develop and characterize animal models recapitulating these phenotypes. There is a need for increased research funding to understand SCN8A-RD and related epilepsies [<a href="#CR103" class="usa-link" aria-describedby="CR103">103</a>]. For severely affected individuals, the development of appropriate outcome measures will require new methodological approaches [<a href="#CR81" class="usa-link" aria-describedby="CR81">81</a>, <a href="#CR86" class="usa-link" aria-describedby="CR86">86</a>, <a href="#CR104" class="usa-link" aria-describedby="CR104">104</a>]. For some of the highlighted projects, funding mechanisms may already exist, while for others it will be necessary to seek novel funding sources. These challenges are balanced by significant opportunities that emerge from patient-centric collaborative research initiatives among laboratories and clinics, and that can be broadened to include cross-disease comparisons [<a href="#CR105" class="usa-link" aria-describedby="CR105">105</a>, <a href="#CR106" class="usa-link" aria-describedby="CR106">106</a>]. Promising templates for transformative therapeutics are represented by advances in genetic therapies for SMA [<a href="#CR107" class="usa-link" aria-describedby="CR107">107</a>] and Dravet syndrome [<a href="#CR108" class="usa-link" aria-describedby="CR108">108</a>], and by other innovative modalities [<a href="#CR109" class="usa-link" aria-describedby="CR109">109</a>].</p></section></section><section id="Sec48"><h2 class="pmc_sec_title">Conclusion</h2>
<p id="Par66">This research roadmap workshop delineated a series of steps to accelerate research progress toward improving the health and well-being of patients with SCN8A-RD. This effort is especially well-timed given the urgent needs of patients and caregivers and the longer-term time frame required to translate research discovery into clinical practice. Importantly, the key stakeholders worked together to ensure incorporation the priorities of the caregiver community. Success in implementing these priorities over the next several years could significantly improve both seizure and non-seizure outcomes and provide a model for similar initiatives in other rare diseases. While the ultimate goal is to cure the disease, it was recognized that charting a realistic series of shorter-term benchmarks will help to monitor progress and set realistic expectations of the community of caregivers and patients. The comprehensive framework established by the roadmap effort serves to guide the research community to efficiently reach these critical goals.</p></section><section id="Sec49"><h2 class="pmc_sec_title">Supplementary Information</h2>
<section class="sm xbox font-sm" id="MOESM1"><div class="media p"><div class="caption">
<a href="/articles/instance/12366098/bin/13023_2025_3672_MOESM1_ESM.pdf" data-ga-action="click_feat_suppl" class="usa-link">Additional file1 (PDF 2193 KB)</a><sup> (2.1MB, pdf) </sup>
</div></div></section></section><section id="ack1" class="ack"><h2 class="pmc_sec_title">Acknowledgements</h2>
<p>Dr. Michael Hammer, Dr. Madeleine J. Oudin, Dr. Mark Fitzgerald (Children’s Hospital of Pennsylvania, Philadelphia, PA), Dr. Christopher B. Burge (MIT, Cambridge, MA), Gabi Connecker and JayEtta Hecker (International SCN8A Alliance) conceived and organized the meeting. The following individuals were Working Group Leaders and led scientific discussions on their respective topics: Anne Berg (The Inchstone Project, Decoding Developmental Epilepsies, Washington, DC), Joshua B. Hack (University of Arizona), Christopher D. Makinson (Columbia University, New York, NY), Manoj Patel (School of Medicine, University of Virginia, Charlottesville, VA), Steven Petrou (Praxis Precision Medicines, Boston, MA), Jeremy Prokop (Corewell Health), Alex Rotenberg (Boston Children’s Hospital, Boston, MA), John M. Schreiber (Children’s National, Washington DC), Wenxi Yu (University of Michigan), Dennis Lal (UT Health, Houston TX).</p>
<p>We also acknowledge participation of the following SCN8A Research Consortium members: Dylann Cordova-Martinez (Albert Einstein College of Medicine, Bronx, NY), Cristine Cukiert (Neurology and Neurophysiology Clinic, Sao Paulo, Brazil), Andrew Escayg and Jennifer Wong (Emory University, Atlanta, GA), Elena Gardella (Danish Epilepsy Hospital, Filadelfia, Dianalund, Denmark), Chellamani Harini (Boston Children's Hospital, Boston MA), Kelly Muzyczka (International SCN8A Alliance, Washington DC), Rima Nabbout (Université de Paris, Paris, France), Ingrid Scheffer (University of Melbourne, Melbourne Australia).</p>
<p>The following individuals contributed to Working Group and general discussions and to the running of the meeting:</p>
<p>Patient advocates Kristin Bejarano, Meghan Hilton, Tammy Kooistra, and Mary Tone (Ambassadors for the International SCN8A Alliance), Kacie Craig (The Cute Syndrome Foundation) and global SCN8A leaders Cinzia Scarcelli (SCN8A Italy), Vanessa Perez (SCN8A Spain) and Joanne Kelly (SCN8A Australia) contributed to discussion at the meeting.</p>
<p>Participating industry representatives included Fiona Scott (Neurocrine), Ian Miller (Longboard), James Fink (Quiver), Sharon O’Neill (Biogen), Stevie Rozkowski (Jazz).</p>
<p>We also acknowledge Elyse Tanzer (Shay Emma Hammer Research Foundation),
Charles Anderson (International SCN8A Alliance) and Sarah Wylie (MIT) for logistical
support.</p>
<p><strong>Affiliations</strong>:
<strong>1. Anne T. Berg</strong>, The Inchstone Project, Decoding Developmental Epilepsies,
Washington DC USA. <strong>2. Christopher Burge</strong>, Department of Biology, MIT, Boston MA USA. <strong>3. Gabi Conecker</strong> MPH, The International SCN8A Alliance, Washington DC USA. <strong>4. Dylann Cordova-Martinez</strong>, Department of Neuroscience, Albert Einstein College of Medicine, Bronx NY USA. <strong>5. Cristine Cukiert</strong> MD, Sao Paulo Epilepsy Clinic, Sao Paolo Brazil. <strong>6. Andrew Escayg</strong> PhD, Department of Human Genetics, Emory University School of Medicine, Atlanta GA USA. <strong>7. Mark Fitzgerald</strong> MD, Perelman School of Medicine, University of Pennsylvania, Philadelphia PA USA. <strong>8. Elena Gardella</strong> MD, The Epilepsyhospital Filadelfia, Dianalund Denmark. <strong>9. Joshua Hack</strong> MS, BIO5 Institute, University of Arizona, Tucson AZ USA. <strong>10. Michael F. Hammer</strong> PhD, BIO5 Institute, University of Arizona, Tucson AZ USA. <strong>11. Chellamani Harini</strong> MD, Boston Children’s Hospital, Boston MA USA. <strong>12. JayEtta Hecker</strong>, The International SCN8A Alliance, Washington DC USA. <strong>13. Dennis Lal</strong> PhD, Center for Neurogenetics, University of Texas Houston, Houston, TX USA. <strong>14. Christopher D. Makinson</strong> PhD, Departments of Neurology, Columbia University, New York NY USA. <strong>15. Ian Miller</strong> MD, Marinus Pharmaceuticals, Radnor, PA USA. <strong>16. Kelly Muzyczka</strong> PhD, International SCN8A Alliance, Washington DC USA. <strong>17. Rima Nabbout</strong> MD PhD, Pediatric Neurology, Paris Descartes University, Paris France. <strong>18. Madeleine Oudin</strong> PhD, Department of Biomedical Engineering, Tufts University, Medford MA. <strong>19. Manoj Patel</strong> PhD, Department of Anesthesiology, University of Virginia School of Medicine, Charlottesville, VA
<strong>20. Steve Petrou</strong> PhD, Praxis Precision Medicines, Boston, MA. <strong>21. Jeremy Prokop</strong> PhD, College of Human Medicine, Michigan State University, Grand Rapids, MI USA. <strong>22. Alex Rotenberg</strong> MD, Neuromodulation Department, Boston Children’s Hospital, Boston, MA. <strong>23. Ingrid Scheffer</strong> PhD, Paediatric Neurology, University of Melbourne, Melbourne Australia. <strong>24. John M Schreiber</strong> MD, Epilepsy Genetics Program, Children’s National Hospital, Washington DC USA. <strong>25. Jennifer Wong</strong> PhD, Department of Human Genetics, Emory University School of Medicine, Atlanta GA USA. <strong>26. Wenxi Yu</strong> PhD, Department of Human Genetics, University of Michigan, Ann Arbor MI USA.</p></section><section id="notes1"><h2 class="pmc_sec_title">Author contributions</h2>
<p>MFH, MJO, CBB, MF wrote the initial draft of the manuscript. MFH, MJO, CBB, WY, CDM, JP and JBH contributed to editing and approval of the final manuscript. MFH, MJO, KM contributed to data analysis and production of Figures.</p></section><section id="notes2"><h2 class="pmc_sec_title">Funding</h2>
<p>Funding in support of the Boston Meeting was provided by the International SCN8A Alliance, Praxis Precision Medicines, Neurocrine Biosciences, Longboard Pharmaceuticals, Jazz Pharmaceuticals, Biogen, and Madeleine Oudin and Christopher Burge.</p></section><section id="notes3"><h2 class="pmc_sec_title">Availability of data and materials</h2>
<p>The datasets supporting the conclusions of this article are included within the article and the supplementary figures. Additional information may be available from the corresponding author on reasonable request.</p></section><section id="notes4"><h2 class="pmc_sec_title">Declarations</h2>
<section id="FPar1"><h3 class="pmc_sec_title">Ethics approval and consent to participate</h3>
<p id="Par67">The study was approved by the University of Arizona Institutional Review Board (#1603487278). All caregivers of individuals with SCN8A consented to participate prior to providing their filling out the caregiver survey.</p></section><section id="FPar2"><h3 class="pmc_sec_title">Consent for publication</h3>
<p id="Par68">Not applicable.</p></section><section id="FPar3"><h3 class="pmc_sec_title">Competing interests</h3>
<p id="Par69">The authors declare that they have no competing interests.</p></section></section><section id="fn-group1" class="fn-group"><h2 class="pmc_sec_title">Footnotes</h2>
<div class="fn-group p font-secondary-light font-sm">
<div class="fn p" id="fn1"><p>The members of the SCN8A Research Consortium are listed in Acknowledgement section.</p></div>
<div class="fn p" id="fn2">
<p><strong>Publisher's Note</strong></p>
<p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p>
</div>
</div></section><section id="_ci93_" lang="en" class="contrib-info"><h2 class="pmc_sec_title">Contributor Information</h2>
<p>The SCN8A Research Consortium, mfh@email.arizona.edu, Email: Madeleine.Oudin@tufts.edu.</p>
<p>The SCN8A Research Consortium: </p>
<p><a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Berg%20AT%22%5BAuthor%5D" class="usa-link">Anne T. Berg</a>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Burge%20C%22%5BAuthor%5D" class="usa-link">Christopher Burge</a>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Conecker%20G%22%5BAuthor%5D" class="usa-link">Gabi Conecker</a>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Cordova-Martinez%20D%22%5BAuthor%5D" class="usa-link">Dylann Cordova-Martinez</a>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Cukiert%20C%22%5BAuthor%5D" class="usa-link">Cristine Cukiert</a>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Escayg%20A%22%5BAuthor%5D" class="usa-link">Andrew Escayg</a>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Fitzgerald%20M%22%5BAuthor%5D" class="usa-link">Mark Fitzgerald</a>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Gardella%20E%22%5BAuthor%5D" class="usa-link">Elena Gardella</a>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Hack%20J%22%5BAuthor%5D" class="usa-link">Joshua Hack</a>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Hammer%20MF%22%5BAuthor%5D" class="usa-link">Michael F. Hammer</a>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Harini%20C%22%5BAuthor%5D" class="usa-link">Chellamani Harini</a>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Hecker%20J%22%5BAuthor%5D" class="usa-link">JayEtta Hecker</a>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Lal%20D%22%5BAuthor%5D" class="usa-link">Dennis Lal</a>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Makinson%20CD%22%5BAuthor%5D" class="usa-link">Christopher D. Makinson</a>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Miller%20I%22%5BAuthor%5D" class="usa-link">Ian Miller</a>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Muzyczka%20K%22%5BAuthor%5D" class="usa-link">Kelly Muzyczka</a>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Nabbout%20R%22%5BAuthor%5D" class="usa-link">Rima Nabbout</a>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Oudin%20M%22%5BAuthor%5D" class="usa-link">Madeleine Oudin</a>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Patel%20M%22%5BAuthor%5D" class="usa-link">Manoj Patel</a>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Petrou%20S%22%5BAuthor%5D" class="usa-link">Steve Petrou</a>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Prokop%20J%22%5BAuthor%5D" class="usa-link">Jeremy Prokop</a>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Rotenberg%20A%22%5BAuthor%5D" class="usa-link">Alex Rotenberg</a>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Scheffer%20I%22%5BAuthor%5D" class="usa-link">Ingrid Scheffer</a>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Schreiber%20JM%22%5BAuthor%5D" class="usa-link">John M. Schreiber</a>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Wong%20J%22%5BAuthor%5D" class="usa-link">Jennifer Wong</a>, and <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Yu%20W%22%5BAuthor%5D" class="usa-link">Wenxi Yu</a></p></section><section id="Bib1" class="ref-list"><h2 class="pmc_sec_title">References</h2>
<section id="Bib1_sec2"><ul class="ref-list font-sm" style="list-style-type:none">
<li id="CR1">
<span class="label">1.</span><cite>Burgess DL, Kohrman DC, Galt J, Plummer NW, Jones JM, Spear B, Meisler MH. Mutation of a new sodium channel gene, Scn8a, in the mouse mutant “motor endplate disease.” Nat Genet. 1995;10(4):461–5.
</cite> [<a href="https://doi.org/10.1038/ng0895-461" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/7670495/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Burgess%20DL,%20Kohrman%20DC,%20Galt%20J,%20Plummer%20NW,%20Jones%20JM,%20Spear%20B,%20Meisler%20MH.%20Mutation%20of%20a%20new%20sodium%20channel%20gene,%20Scn8a,%20in%20the%20mouse%20mutant%20%E2%80%9Cmotor%20endplate%20disease.%E2%80%9D%20Nat%20Genet.%201995;10(4):461%E2%80%935." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR2">
<span class="label">2.</span><cite>Meisler MH, O’Brien JE, Sharkey LM. Sodium channel gene family: epilepsy mutations, gene interactions and modifier effects. J Physiol. 2010;588(Pt 11):1841–8.
</cite> [<a href="https://doi.org/10.1113/jphysiol.2010.188482" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2901972/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/20351042/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Meisler%20MH,%20O%E2%80%99Brien%20JE,%20Sharkey%20LM.%20Sodium%20channel%20gene%20family:%20epilepsy%20mutations,%20gene%20interactions%20and%20modifier%20effects.%20J%20Physiol.%202010;588(Pt%2011):1841%E2%80%938." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR3">
<span class="label">3.</span><cite>Veeramah KR, O’Brien JE, Meisler MH, Cheng X, Dib-Hajj SD, Waxman SG, Talwar D, Girirajan S, Eichler EE, Restifo LL, et al. De novo pathogenic SCN8A mutation identified by whole-genome sequencing of a family quartet affected by infantile epileptic encephalopathy and SUDEP. Am J Hum Genet. 2012;90(3):502–10.
</cite> [<a href="https://doi.org/10.1016/j.ajhg.2012.01.006" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3309181/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22365152/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Veeramah%20KR,%20O%E2%80%99Brien%20JE,%20Meisler%20MH,%20Cheng%20X,%20Dib-Hajj%20SD,%20Waxman%20SG,%20Talwar%20D,%20Girirajan%20S,%20Eichler%20EE,%20Restifo%20LL,%20et%20al.%20De%20novo%20pathogenic%20SCN8A%20mutation%20identified%20by%20whole-genome%20sequencing%20of%20a%20family%20quartet%20affected%20by%20infantile%20epileptic%20encephalopathy%20and%20SUDEP.%20Am%20J%20Hum%20Genet.%202012;90(3):502%E2%80%9310." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR4">
<span class="label">4.</span><cite>Andrews JG, Galindo MK, Hack JB, Watkins JC, Conecker GA, Hammer MF, Consortium SAR. The international SCN8A patient registry: a scientific resource to advance the understanding and treatment of a rare pediatric neurodevelopmental syndrome. J Registry Manag. 2023;50(1):4–10.
</cite> [<a href="/articles/PMC10414210/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37577282/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Andrews%20JG,%20Galindo%20MK,%20Hack%20JB,%20Watkins%20JC,%20Conecker%20GA,%20Hammer%20MF,%20Consortium%20SAR.%20The%20international%20SCN8A%20patient%20registry:%20a%20scientific%20resource%20to%20advance%20the%20understanding%20and%20treatment%20of%20a%20rare%20pediatric%20neurodevelopmental%20syndrome.%20J%20Registry%20Manag.%202023;50(1):4%E2%80%9310." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR5">
<span class="label">5.</span><cite>Hammer MF. The International SCN8A Registry. 2015; Available from: <a href="https://scn8a.net" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://scn8a.net</a>.</cite>
</li>
<li id="CR6">
<span class="label">6.</span><cite>Hammer MF, Xia M, and Schreiber JM, SCN8A-Related Epilepsy and/or Neurodevelopmental Disorders, in <em>GeneReviews((R))</em>, Adam MP, Mirzaa GM, Pagon RA, Wallace SE, Bean LJH, Gripp KW, and Amemiya A, Editors. 2023: Seattle (WA).</cite> [<a href="https://pubmed.ncbi.nlm.nih.gov/27559564/" class="usa-link">PubMed</a>]</li>
<li id="CR7">
<span class="label">7.</span><cite>Schreiber JM, Tochen L, Brown M, Evans S, Ball LJ, Bumbut A, Thewamit R, Whitehead MT, Black C, Boutzoukas E, et al. A multi-disciplinary clinic for SCN8A-related epilepsy. Epilepsy Res. 2019;159: 106261.
</cite> [<a href="https://doi.org/10.1016/j.eplepsyres.2019.106261" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31887642/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Schreiber%20JM,%20Tochen%20L,%20Brown%20M,%20Evans%20S,%20Ball%20LJ,%20Bumbut%20A,%20Thewamit%20R,%20Whitehead%20MT,%20Black%20C,%20Boutzoukas%20E,%20et%20al.%20A%20multi-disciplinary%20clinic%20for%20SCN8A-related%20epilepsy.%20Epilepsy%20Res.%202019;159:%20106261." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR8">
<span class="label">8.</span><cite>Talwar D, Hammer MF. SCN8A epilepsy, developmental encephalopathy, and related disorders. Pediatr Neurol. 2021;122:76–83.
</cite> [<a href="https://doi.org/10.1016/j.pediatrneurol.2021.06.011" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34353676/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Talwar%20D,%20Hammer%20MF.%20SCN8A%20epilepsy,%20developmental%20encephalopathy,%20and%20related%20disorders.%20Pediatr%20Neurol.%202021;122:76%E2%80%9383." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR9">
<span class="label">9.</span><cite>Chung KM, Hack J, Andrews J, Galindo-Kelly M, Schreiber J, Watkins J, Hammer MF. Clinical severity is correlated with age at seizure onset and biophysical properties of recurrent gain of function variants associated with SCN8A-related epilepsy<em>.</em> Epilepsia, 2023.</cite> [<a href="https://doi.org/10.1111/epi.17747" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37585367/" class="usa-link">PubMed</a>]</li>
<li id="CR10">
<span class="label">10.</span><cite>Gardella E, Marini C, Trivisano M, Fitzgerald MP, Alber M, Howell KB, Darra F, Siliquini S, Bolsterli BK, Masnada S, et al. The phenotype of SCN8A developmental and epileptic encephalopathy. Neurology. 2018;91(12):e1112–24.
</cite> [<a href="https://doi.org/10.1212/WNL.0000000000006199" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30171078/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Gardella%20E,%20Marini%20C,%20Trivisano%20M,%20Fitzgerald%20MP,%20Alber%20M,%20Howell%20KB,%20Darra%20F,%20Siliquini%20S,%20Bolsterli%20BK,%20Masnada%20S,%20et%20al.%20The%20phenotype%20of%20SCN8A%20developmental%20and%20epileptic%20encephalopathy.%20Neurology.%202018;91(12):e1112%E2%80%9324." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR11">
<span class="label">11.</span><cite>Gardella E, Moller RS. Phenotypic and genetic spectrum of SCN8A-related disorders, treatment options, and outcomes. Epilepsia. 2019;60(Suppl 3):S77–85.
</cite> [<a href="https://doi.org/10.1111/epi.16319" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31904124/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Gardella%20E,%20Moller%20RS.%20Phenotypic%20and%20genetic%20spectrum%20of%20SCN8A-related%20disorders,%20treatment%20options,%20and%20outcomes.%20Epilepsia.%202019;60(Suppl%203):S77%E2%80%9385." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR12">
<span class="label">12.</span><cite>Hebbar M, Al-Taweel N, Gill I, Boelman C, Dean RA, Goodchild SJ, Mezeyova J, Shuart NG, Johnson JP Jr, Lee J, et al. Expanding the genotype-phenotype spectrum in SCN8A-related disorders. BMC Neurol. 2024;24(1):31.
</cite> [<a href="https://doi.org/10.1186/s12883-023-03478-y" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10792783/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38233770/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Hebbar%20M,%20Al-Taweel%20N,%20Gill%20I,%20Boelman%20C,%20Dean%20RA,%20Goodchild%20SJ,%20Mezeyova%20J,%20Shuart%20NG,%20Johnson%20JP%20Jr,%20Lee%20J,%20et%20al.%20Expanding%20the%20genotype-phenotype%20spectrum%20in%20SCN8A-related%20disorders.%20BMC%20Neurol.%202024;24(1):31." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR13">
<span class="label">13.</span><cite>Hu C, Luo T, Wang Y. Phenotypic and genetic spectrum in Chinese children with SCN8A-related disorders. Seizure. 2022;95:38–49.
</cite> [<a href="https://doi.org/10.1016/j.seizure.2021.12.011" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34979445/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Hu%20C,%20Luo%20T,%20Wang%20Y.%20Phenotypic%20and%20genetic%20spectrum%20in%20Chinese%20children%20with%20SCN8A-related%20disorders.%20Seizure.%202022;95:38%E2%80%9349." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR14">
<span class="label">14.</span><cite>Johannesen KM, Gardella E, Encinas AC, Lehesjoki AE, Linnankivi T, Petersen MB, Lund ICB, Blichfeldt S, Miranda MJ, Pal DK, et al. The spectrum of intermediate SCN8A-related epilepsy. Epilepsia. 2019;60(5):830–44.
</cite> [<a href="https://doi.org/10.1111/epi.14705" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30968951/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Johannesen%20KM,%20Gardella%20E,%20Encinas%20AC,%20Lehesjoki%20AE,%20Linnankivi%20T,%20Petersen%20MB,%20Lund%20ICB,%20Blichfeldt%20S,%20Miranda%20MJ,%20Pal%20DK,%20et%20al.%20The%20spectrum%20of%20intermediate%20SCN8A-related%20epilepsy.%20Epilepsia.%202019;60(5):830%E2%80%9344." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR15">
<span class="label">15.</span><cite>Johannesen KM, Liu Y, Koko M, Gjerulfsen CE, Sonnenberg L, Schubert J, Fenger CD, Eltokhi A, Rannap M, Koch NA, et al., Genotype-phenotype correlations in SCN8A-related disorders reveal prognostic and therapeutic implications<em>.</em> Brain, 2021.</cite> [<a href="https://doi.org/10.1093/brain/awab321" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10147326/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34431999/" class="usa-link">PubMed</a>]</li>
<li id="CR16">
<span class="label">16.</span><cite>Larsen J, Carvill GL, Gardella E, Kluger G, Schmiedel G, Barisic N, Depienne C, Brilstra E, Mang Y, Nielsen JE, et al. The phenotypic spectrum of SCN8A encephalopathy. Neurology. 2015;84(5):480–9.
</cite> [<a href="https://doi.org/10.1212/WNL.0000000000001211" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4336074/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25568300/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Larsen%20J,%20Carvill%20GL,%20Gardella%20E,%20Kluger%20G,%20Schmiedel%20G,%20Barisic%20N,%20Depienne%20C,%20Brilstra%20E,%20Mang%20Y,%20Nielsen%20JE,%20et%20al.%20The%20phenotypic%20spectrum%20of%20SCN8A%20encephalopathy.%20Neurology.%202015;84(5):480%E2%80%939." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR17">
<span class="label">17.</span><cite>Lyu H, Bosselmann CM, Johannesen KM, Koko M, Ortigoza-Escobar JD, Aguilera-Albesa S, Garcia-Navas Nunez D, Linnankivi T, Gaily E, van Ruiten HJA, et al. Clinical and electrophysiological features of SCN8A variants causing episodic or chronic ataxia. EBioMedicine. 2023;98: 104855.
</cite> [<a href="https://doi.org/10.1016/j.ebiom.2023.104855" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10628346/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38251463/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Lyu%20H,%20Bosselmann%20CM,%20Johannesen%20KM,%20Koko%20M,%20Ortigoza-Escobar%20JD,%20Aguilera-Albesa%20S,%20Garcia-Navas%20Nunez%20D,%20Linnankivi%20T,%20Gaily%20E,%20van%20Ruiten%20HJA,%20et%20al.%20Clinical%20and%20electrophysiological%20features%20of%20SCN8A%20variants%20causing%20episodic%20or%20chronic%20ataxia.%20EBioMedicine.%202023;98:%20104855." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR18">
<span class="label">18.</span><cite>Hack JB, Horning K, Juroske Short DM, Schreiber JM, Watkins JC, Hammer MF. Distinguishing loss-of-function and gain-of-function SCN8A variants using a random forest classification model trained on clinical features. Neurol Genet. 2023;9(3): e200060.
</cite> [<a href="https://doi.org/10.1212/NXG.0000000000200060" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10160958/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37152443/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Hack%20JB,%20Horning%20K,%20Juroske%20Short%20DM,%20Schreiber%20JM,%20Watkins%20JC,%20Hammer%20MF.%20Distinguishing%20loss-of-function%20and%20gain-of-function%20SCN8A%20variants%20using%20a%20random%20forest%20classification%20model%20trained%20on%20clinical%20features.%20Neurol%20Genet.%202023;9(3):%20e200060." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR19">
<span class="label">19.</span><cite>Liu Y, Schubert J, Sonnenberg L, Helbig KL, Hoei-Hansen CE, Koko M, Rannap M, Lauxmann S, Huq M, Schneider MC, et al. Neuronal mechanisms of mutations in SCN8A causing epilepsy or intellectual disability. Brain. 2019;142(2):376–90.
</cite> [<a href="https://doi.org/10.1093/brain/awy326" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30615093/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Liu%20Y,%20Schubert%20J,%20Sonnenberg%20L,%20Helbig%20KL,%20Hoei-Hansen%20CE,%20Koko%20M,%20Rannap%20M,%20Lauxmann%20S,%20Huq%20M,%20Schneider%20MC,%20et%20al.%20Neuronal%20mechanisms%20of%20mutations%20in%20SCN8A%20causing%20epilepsy%20or%20intellectual%20disability.%20Brain.%202019;142(2):376%E2%80%9390." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR20">
<span class="label">20.</span><cite>Pan Y, Cummins TR. Distinct functional alterations in SCN8A epilepsy mutant channels. J Physiol. 2020;598(2):381–401.
</cite> [<a href="https://doi.org/10.1113/JP278952" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7216308/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31715021/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Pan%20Y,%20Cummins%20TR.%20Distinct%20functional%20alterations%20in%20SCN8A%20epilepsy%20mutant%20channels.%20J%20Physiol.%202020;598(2):381%E2%80%93401." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR21">
<span class="label">21.</span><cite>Wagnon JL, Barker BS, Ottolini M, Park Y, Volkheimer A, Valdez P, Swinkels MEM, Patel MK, Meisler MH. Loss-of-function variants of SCN8A in intellectual disability without seizures. Neurol Genet. 2017;3(4): e170.
</cite> [<a href="https://doi.org/10.1212/NXG.0000000000000170" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5499976/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28702509/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Wagnon%20JL,%20Barker%20BS,%20Ottolini%20M,%20Park%20Y,%20Volkheimer%20A,%20Valdez%20P,%20Swinkels%20MEM,%20Patel%20MK,%20Meisler%20MH.%20Loss-of-function%20variants%20of%20SCN8A%20in%20intellectual%20disability%20without%20seizures.%20Neurol%20Genet.%202017;3(4):%20e170." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR22">
<span class="label">22.</span><cite>Encinas AC, Moore IKM, Watkins JC, Hammer MF. Influence of age at seizure onset on the acquisition of neurodevelopmental skills in an SCN8A cohort. Epilepsia. 2019;60(8):1711–20.
</cite> [<a href="https://doi.org/10.1111/epi.16288" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31335965/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Encinas%20AC,%20Moore%20IKM,%20Watkins%20JC,%20Hammer%20MF.%20Influence%20of%20age%20at%20seizure%20onset%20on%20the%20acquisition%20of%20neurodevelopmental%20skills%20in%20an%20SCN8A%20cohort.%20Epilepsia.%202019;60(8):1711%E2%80%9320." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR23">
<span class="label">23.</span><cite>Encinas AC, Watkins JC, Longoria IA, Johnson JP Jr, Hammer MF. Variable patterns of mutation density among NaV1.1, NaV1.2 and NaV1.6 point to channel-specific functional differences associated with childhood epilepsy. PLoS ONE. 2020;15(8):e0238121.
</cite> [<a href="https://doi.org/10.1371/journal.pone.0238121" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7449494/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32845893/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Encinas%20AC,%20Watkins%20JC,%20Longoria%20IA,%20Johnson%20JP%20Jr,%20Hammer%20MF.%20Variable%20patterns%20of%20mutation%20density%20among%20NaV1.1,%20NaV1.2%20and%20NaV1.6%20point%20to%20channel-specific%20functional%20differences%20associated%20with%20childhood%20epilepsy.%20PLoS%20ONE.%202020;15(8):e0238121." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR24">
<span class="label">24.</span><cite>Hack J, Watkins HC, Schreiber JM, Hammer MF. Patients carrying pathogenic SCN8A variants with loss- and gain-of-function effects can be classified into five subgroups exhibiting varying developmental and epileptic components of encephalopathy. Epilepsia. 2024;65:1–11.
</cite> [<a href="https://doi.org/10.1111/epi.18118" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39556335/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Hack%20J,%20Watkins%20HC,%20Schreiber%20JM,%20Hammer%20MF.%20Patients%20carrying%20pathogenic%20SCN8A%20variants%20with%20loss-%20and%20gain-of-function%20effects%20can%20be%20classified%20into%20five%20subgroups%20exhibiting%20varying%20developmental%20and%20epileptic%20components%20of%20encephalopathy.%20Epilepsia.%202024;65:1%E2%80%9311." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR25">
<span class="label">25.</span><cite>Hack JB, Watkins JC, Hammer MF. Machine learning models reveal distinct disease subgroups and improve diagnostic and prognostic accuracy for individuals with pathogenic SCN8A gain-of-function variants<em>.</em> Biol Open, 2024; 13(4).</cite> [<a href="https://doi.org/10.1242/bio.060286" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11070785/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38466077/" class="usa-link">PubMed</a>]</li>
<li id="CR26">
<span class="label">26.</span><cite>Gillentine MA, Wang T, Eichler EE. Estimating the prevalence of de novo monogenic neurodevelopmental disorders from large cohort studies. Biomedicines. 2022;10(11):2865.
</cite> [<a href="https://doi.org/10.3390/biomedicines10112865" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9687899/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36359385/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Gillentine%20MA,%20Wang%20T,%20Eichler%20EE.%20Estimating%20the%20prevalence%20of%20de%20novo%20monogenic%20neurodevelopmental%20disorders%20from%20large%20cohort%20studies.%20Biomedicines.%202022;10(11):2865." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR27">
<span class="label">27.</span><cite>Osterman MJK, Hamilton BE, Martin JA, Driscoll AK, Valenzuela CP. Births: final data for 2021. Natl Vital Stat Rep. 2023;72(1):1–53.
</cite> [<a href="https://pubmed.ncbi.nlm.nih.gov/36723449/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Osterman%20MJK,%20Hamilton%20BE,%20Martin%20JA,%20Driscoll%20AK,%20Valenzuela%20CP.%20Births:%20final%20data%20for%202021.%20Natl%20Vital%20Stat%20Rep.%202023;72(1):1%E2%80%9353." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR28">
<span class="label">28.</span><cite>Conecker G, Xia MY, Hecker J, Achkar C, Cukiert C, Devries S, Donner E, Fitzgerald MP, Gardella E, Hammer M, et al. Global modified Delphi consensus on diagnosis, phenotypes, and treatment of SCN8A-related epilepsy and/or neurodevelopmental disorders. Epilepsia. 2024;65(8):2322–38.
</cite> [<a href="https://doi.org/10.1111/epi.17992" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38802994/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Conecker%20G,%20Xia%20MY,%20Hecker%20J,%20Achkar%20C,%20Cukiert%20C,%20Devries%20S,%20Donner%20E,%20Fitzgerald%20MP,%20Gardella%20E,%20Hammer%20M,%20et%20al.%20Global%20modified%20Delphi%20consensus%20on%20diagnosis,%20phenotypes,%20and%20treatment%20of%20SCN8A-related%20epilepsy%20and/or%20neurodevelopmental%20disorders.%20Epilepsia.%202024;65(8):2322%E2%80%9338." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR29">
<span class="label">29.</span><cite>Conecker G, Xia MY, Hecker J, Achkar C, Cukiert C, Devries S, Donner E, Fitzgerald M, Gardella E, Hammer M, et al. Global modified-Delphi consensus on comorbidities and prognosis of SCN8A-related epilepsy and/or neurodevelopmental disorders. Epilepsia. 2024;65(8):2308–21.
</cite> [<a href="https://doi.org/10.1111/epi.17991" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38802989/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Conecker%20G,%20Xia%20MY,%20Hecker%20J,%20Achkar%20C,%20Cukiert%20C,%20Devries%20S,%20Donner%20E,%20Fitzgerald%20M,%20Gardella%20E,%20Hammer%20M,%20et%20al.%20Global%20modified-Delphi%20consensus%20on%20comorbidities%20and%20prognosis%20of%20SCN8A-related%20epilepsy%20and/or%20neurodevelopmental%20disorders.%20Epilepsia.%202024;65(8):2308%E2%80%9321." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR30">
<span class="label">30.</span><cite>Meisler MH, Helman G, Hammer MF, Fureman BE, Gaillard WD, Goldin AL, Hirose S, Ishii A, Kroner BL, Lossin C, et al. SCN8A encephalopathy: research progress and prospects. Epilepsia. 2016;57(7):1027–35.
</cite> [<a href="https://doi.org/10.1111/epi.13422" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5495462/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27270488/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Meisler%20MH,%20Helman%20G,%20Hammer%20MF,%20Fureman%20BE,%20Gaillard%20WD,%20Goldin%20AL,%20Hirose%20S,%20Ishii%20A,%20Kroner%20BL,%20Lossin%20C,%20et%20al.%20SCN8A%20encephalopathy:%20research%20progress%20and%20prospects.%20Epilepsia.%202016;57(7):1027%E2%80%9335." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR31">
<span class="label">31.</span><cite>Wagnon JL, Korn MJ, Parent R, Tarpey TA, Jones JM, Hammer MF, Murphy GG, Parent JM, Meisler MH. Convulsive seizures and SUDEP in a mouse model of SCN8A epileptic encephalopathy. Hum Mol Genet. 2015;24(2):506–15.
</cite> [<a href="https://doi.org/10.1093/hmg/ddu470" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4275076/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25227913/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Wagnon%20JL,%20Korn%20MJ,%20Parent%20R,%20Tarpey%20TA,%20Jones%20JM,%20Hammer%20MF,%20Murphy%20GG,%20Parent%20JM,%20Meisler%20MH.%20Convulsive%20seizures%20and%20SUDEP%20in%20a%20mouse%20model%20of%20SCN8A%20epileptic%20encephalopathy.%20Hum%20Mol%20Genet.%202015;24(2):506%E2%80%9315." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR32">
<span class="label">32.</span><cite>Patel RR, Barbosa C, Xiao Y, Cummins TR. Human Nav1.6 channels generate larger resurgent currents than human Nav1.1 channels, but the Navbeta4 peptide does not protect either isoform from use-dependent reduction. PLoS ONE. 2015;10(7):e0133485.
</cite> [<a href="https://doi.org/10.1371/journal.pone.0133485" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4504674/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26182346/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Patel%20RR,%20Barbosa%20C,%20Xiao%20Y,%20Cummins%20TR.%20Human%20Nav1.6%20channels%20generate%20larger%20resurgent%20currents%20than%20human%20Nav1.1%20channels,%20but%20the%20Navbeta4%20peptide%20does%20not%20protect%20either%20isoform%20from%20use-dependent%20reduction.%20PLoS%20ONE.%202015;10(7):e0133485." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR33">
<span class="label">33.</span><cite>Tidball AM, Lopez-Santiago LF, Yuan Y, Glenn TW, Margolis JL, Clayton Walker J, Kilbane EG, Miller CA, Martina Bebin E, Scott Perry M, et al. Variant-specific changes in persistent or resurgent sodium current in SCN8A-related epilepsy patient-derived neurons. Brain. 2020;143(10):3025–40.
</cite> [<a href="https://doi.org/10.1093/brain/awaa247" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7780473/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32968789/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Tidball%20AM,%20Lopez-Santiago%20LF,%20Yuan%20Y,%20Glenn%20TW,%20Margolis%20JL,%20Clayton%20Walker%20J,%20Kilbane%20EG,%20Miller%20CA,%20Martina%20Bebin%20E,%20Scott%20Perry%20M,%20et%20al.%20Variant-specific%20changes%20in%20persistent%20or%20resurgent%20sodium%20current%20in%20SCN8A-related%20epilepsy%20patient-derived%20neurons.%20Brain.%202020;143(10):3025%E2%80%9340." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR34">
<span class="label">34.</span><cite>Wengert ER, Saga AU, Panchal PS, Barker BS, Patel MK. Prax330 reduces persistent and resurgent sodium channel currents and neuronal hyperexcitability of subiculum neurons in a mouse model of SCN8A epileptic encephalopathy. Neuropharmacology. 2019;158: 107699.
</cite> [<a href="https://doi.org/10.1016/j.neuropharm.2019.107699" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6745260/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31278928/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Wengert%20ER,%20Saga%20AU,%20Panchal%20PS,%20Barker%20BS,%20Patel%20MK.%20Prax330%20reduces%20persistent%20and%20resurgent%20sodium%20channel%20currents%20and%20neuronal%20hyperexcitability%20of%20subiculum%20neurons%20in%20a%20mouse%20model%20of%20SCN8A%20epileptic%20encephalopathy.%20Neuropharmacology.%202019;158:%20107699." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR35">
<span class="label">35.</span><cite>Meisler MH, Hill SF, Yu W. Sodium channelopathies in neurodevelopmental disorders. Nat Rev Neurosci. 2021;22(3):152–66.
</cite> [<a href="https://doi.org/10.1038/s41583-020-00418-4" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8710247/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33531663/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Meisler%20MH,%20Hill%20SF,%20Yu%20W.%20Sodium%20channelopathies%20in%20neurodevelopmental%20disorders.%20Nat%20Rev%20Neurosci.%202021;22(3):152%E2%80%9366." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR36">
<span class="label">36.</span><cite>Osorio-Mendez D, Miller A, Begeman IJ, Kurth A, Hagle R, Rolph D, Dickson AL, Chen CH, Halloran M, Poss KD, et al. Voltage-gated sodium channel scn8a is required for innervation and regeneration of amputated adult zebrafish fins. Proc Natl Acad Sci U S A. 2022;119(28): e2200342119.
</cite> [<a href="https://doi.org/10.1073/pnas.2200342119" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9282381/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35867745/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Osorio-Mendez%20D,%20Miller%20A,%20Begeman%20IJ,%20Kurth%20A,%20Hagle%20R,%20Rolph%20D,%20Dickson%20AL,%20Chen%20CH,%20Halloran%20M,%20Poss%20KD,%20et%20al.%20Voltage-gated%20sodium%20channel%20scn8a%20is%20required%20for%20innervation%20and%20regeneration%20of%20amputated%20adult%20zebrafish%20fins.%20Proc%20Natl%20Acad%20Sci%20U%20S%20A.%202022;119(28):%20e2200342119." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR37">
<span class="label">37.</span><cite>Bahramnejad E, Barney ER, Lester S, Hurtado A, Thompson T, Watkins JC, Hammer MF. Greater female than male resilience to mortality and morbidity in the Scn8a mouse model of pediatric epilepsy. Int J Neurosci. 2023;134:1–13.</cite> [<a href="https://doi.org/10.1080/00207454.2023.2279497" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37929583/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Bahramnejad%20E,%20Barney%20ER,%20Lester%20S,%20Hurtado%20A,%20Thompson%20T,%20Watkins%20JC,%20Hammer%20MF.%20Greater%20female%20than%20male%20resilience%20to%20mortality%20and%20morbidity%20in%20the%20Scn8a%20mouse%20model%20of%20pediatric%20epilepsy.%20Int%20J%20Neurosci.%202023;134:1%E2%80%9313." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR38">
<span class="label">38.</span><cite>Hammer MF, Krzyzaniak CT, Bahramnejad E, Smelser KJ, Hack JB, Watkins JC, Ronaldson PT. Sex differences in physiological response to increased neuronal excitability in a knockin mouse model of pediatric epilepsy. Clin Sci (Lond). 2024;138(4):205–23.
</cite> [<a href="https://doi.org/10.1042/CS20231572" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10881277/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38348743/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Hammer%20MF,%20Krzyzaniak%20CT,%20Bahramnejad%20E,%20Smelser%20KJ,%20Hack%20JB,%20Watkins%20JC,%20Ronaldson%20PT.%20Sex%20differences%20in%20physiological%20response%20to%20increased%20neuronal%20excitability%20in%20a%20knockin%20mouse%20model%20of%20pediatric%20epilepsy.%20Clin%20Sci%20(Lond).%202024;138(4):205%E2%80%9323." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR39">
<span class="label">39.</span><cite>Lopez-Santiago LF, Yuan Y, Wagnon JL, Hull JM, Frasier CR, O’Malley HA, Meisler MH, Isom LL. Neuronal hyperexcitability in a mouse model of SCN8A epileptic encephalopathy. Proc Natl Acad Sci U S A. 2017;114(9):2383–8.
</cite> [<a href="https://doi.org/10.1073/pnas.1616821114" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5338511/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28193882/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Lopez-Santiago%20LF,%20Yuan%20Y,%20Wagnon%20JL,%20Hull%20JM,%20Frasier%20CR,%20O%E2%80%99Malley%20HA,%20Meisler%20MH,%20Isom%20LL.%20Neuronal%20hyperexcitability%20in%20a%20mouse%20model%20of%20SCN8A%20epileptic%20encephalopathy.%20Proc%20Natl%20Acad%20Sci%20U%20S%20A.%202017;114(9):2383%E2%80%938." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR40">
<span class="label">40.</span><cite>Meisler MH. SCN8A encephalopathy: mechanisms and models. Epilepsia. 2019;60 Suppl 3(Suppl 3):S86–91.
</cite> [<a href="https://doi.org/10.1111/epi.14703" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6953611/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31904118/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Meisler%20MH.%20SCN8A%20encephalopathy:%20mechanisms%20and%20models.%20Epilepsia.%202019;60%20Suppl%203(Suppl%203):S86%E2%80%9391." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR41">
<span class="label">41.</span><cite>Wengert ER, Miralles RM, Wedgwood KCA, Wagley PK, Strohm SM, Panchal PS, Idrissi AM, Wenker IC, Thompson JA, Gaykema RP, et al. Somatostatin-positive interneurons contribute to seizures in SCN8A epileptic encephalopathy. J Neurosci. 2021;41(44):9257–73.
</cite> [<a href="https://doi.org/10.1523/JNEUROSCI.0718-21.2021" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8570835/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34544834/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Wengert%20ER,%20Miralles%20RM,%20Wedgwood%20KCA,%20Wagley%20PK,%20Strohm%20SM,%20Panchal%20PS,%20Idrissi%20AM,%20Wenker%20IC,%20Thompson%20JA,%20Gaykema%20RP,%20et%20al.%20Somatostatin-positive%20interneurons%20contribute%20to%20seizures%20in%20SCN8A%20epileptic%20encephalopathy.%20J%20Neurosci.%202021;41(44):9257%E2%80%9373." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR42">
<span class="label">42.</span><cite>Makinson CD, Tanaka BS, Lamar T, Goldin AL, Escayg A. Role of the hippocampus in Nav1.6 (Scn8a) mediated seizure resistance. Neurobiol Dis. 2014;68:16–25.
</cite> [<a href="https://doi.org/10.1016/j.nbd.2014.03.014" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4077284/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24704313/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Makinson%20CD,%20Tanaka%20BS,%20Lamar%20T,%20Goldin%20AL,%20Escayg%20A.%20Role%20of%20the%20hippocampus%20in%20Nav1.6%20(Scn8a)%20mediated%20seizure%20resistance.%20Neurobiol%20Dis.%202014;68:16%E2%80%9325." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR43">
<span class="label">43.</span><cite>O’Brien JE, Meisler MH. Sodium channel SCN8A (Nav1.6): properties and de novo mutations in epileptic encephalopathy and intellectual disability. Front Genet. 2013;4:213.
</cite> [<a href="https://doi.org/10.3389/fgene.2013.00213" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3809569/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24194747/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?O%E2%80%99Brien%20JE,%20Meisler%20MH.%20Sodium%20channel%20SCN8A%20(Nav1.6):%20properties%20and%20de%20novo%20mutations%20in%20epileptic%20encephalopathy%20and%20intellectual%20disability.%20Front%20Genet.%202013;4:213." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR44">
<span class="label">44.</span><cite>Zybura A, Hudmon A, Cummins TR. Distinctive properties and powerful neuromodulation of Na(v)1.6 sodium channels regulates neuronal excitability. Cells. 2021;10(7):1595.
</cite> [<a href="https://doi.org/10.3390/cells10071595" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8307729/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34202119/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Zybura%20A,%20Hudmon%20A,%20Cummins%20TR.%20Distinctive%20properties%20and%20powerful%20neuromodulation%20of%20Na(v)1.6%20sodium%20channels%20regulates%20neuronal%20excitability.%20Cells.%202021;10(7):1595." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR45">
<span class="label">45.</span><cite>Johnson JP, Focken T, Khakh K, Tari PK, Dube C, Goodchild SJ, Andrez JC, Bankar G, Bogucki D, Burford K, et al. NBI-921352, a first-in-class, Na(V)1.6 selective, sodium channel inhibitor that prevents seizures in Scn8a gain-of-function mice, and wild-type mice and rats. Elife. 2022;11:e72468.
</cite> [<a href="https://doi.org/10.7554/eLife.72468" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8903829/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35234610/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Johnson%20JP,%20Focken%20T,%20Khakh%20K,%20Tari%20PK,%20Dube%20C,%20Goodchild%20SJ,%20Andrez%20JC,%20Bankar%20G,%20Bogucki%20D,%20Burford%20K,%20et%20al.%20NBI-921352,%20a%20first-in-class,%20Na(V)1.6%20selective,%20sodium%20channel%20inhibitor%20that%20prevents%20seizures%20in%20Scn8a%20gain-of-function%20mice,%20and%20wild-type%20mice%20and%20rats.%20Elife.%202022;11:e72468." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR46">
<span class="label">46.</span><cite>Patel RR, Barbosa C, Brustovetsky T, Brustovetsky N, Cummins TR. Aberrant epilepsy-associated mutant Nav1.6 sodium channel activity can be targeted with cannabidiol. Brain. 2016;139(Pt 8):2164–81.
</cite> [<a href="https://doi.org/10.1093/brain/aww129" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4958898/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27267376/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Patel%20RR,%20Barbosa%20C,%20Brustovetsky%20T,%20Brustovetsky%20N,%20Cummins%20TR.%20Aberrant%20epilepsy-associated%20mutant%20Nav1.6%20sodium%20channel%20activity%20can%20be%20targeted%20with%20cannabidiol.%20Brain.%202016;139(Pt%208):2164%E2%80%9381." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR47">
<span class="label">47.</span><cite>Hammer MF, Bahramnejad E, Watkins JC, Ronaldson PT. Candesartan restores blood-brain barrier dysfunction, mitigates aberrant gene expression, and extends lifespan in a knockin mouse model of epileptogenesis. Clin Sci (Lond). 2024;138(17):1089–110.
</cite> [<a href="https://doi.org/10.1042/CS20240771" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39092536/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Hammer%20MF,%20Bahramnejad%20E,%20Watkins%20JC,%20Ronaldson%20PT.%20Candesartan%20restores%20blood-brain%20barrier%20dysfunction,%20mitigates%20aberrant%20gene%20expression,%20and%20extends%20lifespan%20in%20a%20knockin%20mouse%20model%20of%20epileptogenesis.%20Clin%20Sci%20(Lond).%202024;138(17):1089%E2%80%93110." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR48">
<span class="label">48.</span><cite>Wong JC, Escayg A. Carvedilol increases seizure resistance in a mouse model of SCN8A-derived epilepsy. Front Pharmacol. 2024;15:1397225.
</cite> [<a href="https://doi.org/10.3389/fphar.2024.1397225" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11184058/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38895634/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Wong%20JC,%20Escayg%20A.%20Carvedilol%20increases%20seizure%20resistance%20in%20a%20mouse%20model%20of%20SCN8A-derived%20epilepsy.%20Front%20Pharmacol.%202024;15:1397225." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR49">
<span class="label">49.</span><cite>Lenk GM, Jafar-Nejad P, Hill SF, Huffman LD, Smolen CE, Wagnon JL, Petit H, Yu W, Ziobro J, Bhatia K, et al. Scn8a antisense oligonucleotide is protective in mouse models of SCN8A encephalopathy and Dravet syndrome. Ann Neurol. 2020;87(3):339–46.
</cite> [<a href="https://doi.org/10.1002/ana.25676" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7064908/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31943325/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Lenk%20GM,%20Jafar-Nejad%20P,%20Hill%20SF,%20Huffman%20LD,%20Smolen%20CE,%20Wagnon%20JL,%20Petit%20H,%20Yu%20W,%20Ziobro%20J,%20Bhatia%20K,%20et%20al.%20Scn8a%20antisense%20oligonucleotide%20is%20protective%20in%20mouse%20models%20of%20SCN8A%20encephalopathy%20and%20Dravet%20syndrome.%20Ann%20Neurol.%202020;87(3):339%E2%80%9346." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR50">
<span class="label">50.</span><cite>Hill SF, Yu W, Ziobro J, Chalasani S, Reger F, Meisler MH. Long-term downregulation of the sodium channel gene Scn8a is therapeutic in mouse models of SCN8A epilepsy. Ann Neurol. 2023;95:754–9.</cite> [<a href="https://doi.org/10.1002/ana.26861" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11170564/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38113311/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Hill%20SF,%20Yu%20W,%20Ziobro%20J,%20Chalasani%20S,%20Reger%20F,%20Meisler%20MH.%20Long-term%20downregulation%20of%20the%20sodium%20channel%20gene%20Scn8a%20is%20therapeutic%20in%20mouse%20models%20of%20SCN8A%20epilepsy.%20Ann%20Neurol.%202023;95:754%E2%80%939." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR51">
<span class="label">51.</span><cite>Yu W, Hill SF, Zhu L, Demetriou Y, Reger F, Mattis J, Meisler MH. Dentate gyrus granule cells are a locus of pathology in Scn8a developmental encephalopathy. Neurobiol Dis. 2024;199: 106591.
</cite> [<a href="https://doi.org/10.1016/j.nbd.2024.106591" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38969233/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Yu%20W,%20Hill%20SF,%20Zhu%20L,%20Demetriou%20Y,%20Reger%20F,%20Mattis%20J,%20Meisler%20MH.%20Dentate%20gyrus%20granule%20cells%20are%20a%20locus%20of%20pathology%20in%20Scn8a%20developmental%20encephalopathy.%20Neurobiol%20Dis.%202024;199:%20106591." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR52">
<span class="label">52.</span><cite>Yu W, Hill SF, Huang Y, Zhu L, Demetriou Y, Ziobro J, Reger F, Jia X, Mattis J, Meisler MH. Allele-specific editing of a dominant SCN8A epilepsy variant protects against seizures and lethality in a murine model. Ann Neurol. 2024;96:958–69.
</cite> [<a href="https://doi.org/10.1002/ana.27053" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11496010/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39158034/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Yu%20W,%20Hill%20SF,%20Huang%20Y,%20Zhu%20L,%20Demetriou%20Y,%20Ziobro%20J,%20Reger%20F,%20Jia%20X,%20Mattis%20J,%20Meisler%20MH.%20Allele-specific%20editing%20of%20a%20dominant%20SCN8A%20epilepsy%20variant%20protects%20against%20seizures%20and%20lethality%20in%20a%20murine%20model.%20Ann%20Neurol.%202024;96:958%E2%80%9369." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR53">
<span class="label">53.</span><cite>Kahlig KM, Scott L, Hatch RJ, Griffin A, Martinez Botella G, Hughes ZA, Wittmann M. The novel persistent sodium current inhibitor PRAX-562 has potent anticonvulsant activity with improved protective index relative to standard of care sodium channel blockers. Epilepsia. 2022;63(3):697–708.
</cite> [<a href="https://doi.org/10.1111/epi.17149" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9304232/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35037706/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Kahlig%20KM,%20Scott%20L,%20Hatch%20RJ,%20Griffin%20A,%20Martinez%20Botella%20G,%20Hughes%20ZA,%20Wittmann%20M.%20The%20novel%20persistent%20sodium%20current%20inhibitor%20PRAX-562%20has%20potent%20anticonvulsant%20activity%20with%20improved%20protective%20index%20relative%20to%20standard%20of%20care%20sodium%20channel%20blockers.%20Epilepsia.%202022;63(3):697%E2%80%93708." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR54">
<span class="label">54.</span><cite>Vanoye CG, Abramova TV, DeKeyser JM, Ghabra NF, Oudin MJ, Burge CB, Helbig I, Thompson CH, George AL, Molecular and Cellular Context Influences SCN8A Variant Function<em>.</em> bioRxiv, 2023.</cite> [<a href="https://doi.org/10.1172/jci.insight.177530" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11383174/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38771640/" class="usa-link">PubMed</a>]</li>
<li id="CR55">
<span class="label">55.</span><cite>Cutts A, Savoie H, Hammer MF, Schreiber J, Grayson C, Luzon C, Butterfield N, Pimstone SN, Aycardi E, Harden C, et al. Clinical characteristics and treatment experience of individuals with SCN8A developmental and epileptic encephalopathy (SCN8A-DEE): findings from an online caregiver survey. Seizure. 2022;97:50–7.
</cite> [<a href="https://doi.org/10.1016/j.seizure.2022.03.008" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35325842/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Cutts%20A,%20Savoie%20H,%20Hammer%20MF,%20Schreiber%20J,%20Grayson%20C,%20Luzon%20C,%20Butterfield%20N,%20Pimstone%20SN,%20Aycardi%20E,%20Harden%20C,%20et%20al.%20Clinical%20characteristics%20and%20treatment%20experience%20of%20individuals%20with%20SCN8A%20developmental%20and%20epileptic%20encephalopathy%20(SCN8A-DEE):%20findings%20from%20an%20online%20caregiver%20survey.%20Seizure.%202022;97:50%E2%80%937." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR56">
<span class="label">56.</span><cite>Liu J, Barrett JS, Leonardi ET, Lee L, Roychoudhury S, Chen Y, Trifillis P. Natural history and real-world data in rare diseases: applications, limitations, and future perspectives. J Clin Pharmacol. 2022;62 Suppl 2(Suppl 2):S38–55.
</cite> [<a href="https://doi.org/10.1002/jcph.2134" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10107901/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36461748/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Liu%20J,%20Barrett%20JS,%20Leonardi%20ET,%20Lee%20L,%20Roychoudhury%20S,%20Chen%20Y,%20Trifillis%20P.%20Natural%20history%20and%20real-world%20data%20in%20rare%20diseases:%20applications,%20limitations,%20and%20future%20perspectives.%20J%20Clin%20Pharmacol.%202022;62%20Suppl%202(Suppl%202):S38%E2%80%9355." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR57">
<span class="label">57.</span><cite>Administration UFaD Real-World Data: Assessing Registries to Support Regulatory Decision-Making for Drug and Biological Products, Draft Guidance for Industry. 2021.</cite>
</li>
<li id="CR58">
<span class="label">58.</span><cite>Yu W, Smolen CE, Hill SF, Meisler MH. Spontaneous seizures and elevated seizure susceptibility in response to somatic mutation of sodium channel Scn8a in the mouse. Hum Mol Genet. 2021;30(10):902–7.
</cite> [<a href="https://doi.org/10.1093/hmg/ddab092" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8165645/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33822038/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Yu%20W,%20Smolen%20CE,%20Hill%20SF,%20Meisler%20MH.%20Spontaneous%20seizures%20and%20elevated%20seizure%20susceptibility%20in%20response%20to%20somatic%20mutation%20of%20sodium%20channel%20Scn8a%20in%20the%20mouse.%20Hum%20Mol%20Genet.%202021;30(10):902%E2%80%937." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR59">
<span class="label">59.</span><cite>Hill SF, Yu W, Ziobro J, Chalasani S, Reger F, Meisler MH. Long-term downregulation of the sodium channel gene scn8a is therapeutic in mouse models of SCN8A epilepsy. Ann Neurol. 2024;95(4):754–9.
</cite> [<a href="https://doi.org/10.1002/ana.26861" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11170564/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38113311/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Hill%20SF,%20Yu%20W,%20Ziobro%20J,%20Chalasani%20S,%20Reger%20F,%20Meisler%20MH.%20Long-term%20downregulation%20of%20the%20sodium%20channel%20gene%20scn8a%20is%20therapeutic%20in%20mouse%20models%20of%20SCN8A%20epilepsy.%20Ann%20Neurol.%202024;95(4):754%E2%80%939." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR60">
<span class="label">60.</span><cite>Liang L, Fazel Darbandi S, Pochareddy S, Gulden FO, Gilson MC, Sheppard BK, Sahagun A, An JY, Werling DM, Rubenstein JLR, et al. Developmental dynamics of voltage-gated sodium channel isoform expression in the human and mouse brain. Genome Med. 2021;13(1):135.
</cite> [<a href="https://doi.org/10.1186/s13073-021-00949-0" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8383430/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34425903/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Liang%20L,%20Fazel%20Darbandi%20S,%20Pochareddy%20S,%20Gulden%20FO,%20Gilson%20MC,%20Sheppard%20BK,%20Sahagun%20A,%20An%20JY,%20Werling%20DM,%20Rubenstein%20JLR,%20et%20al.%20Developmental%20dynamics%20of%20voltage-gated%20sodium%20channel%20isoform%20expression%20in%20the%20human%20and%20mouse%20brain.%20Genome%20Med.%202021;13(1):135." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR61">
<span class="label">61.</span><cite>Ludwig NN, Wojnaroski M, Suskauer SJ, Slomine BS, Kaiser A, Paltell K, Evans L, Tucker K, Chapman CAT, Conecker G, et al. Novel approaches to measuring cognition in individuals with severe to profound functional impairment: a pilot study in SCN2A-related disorder. Epilepsy Behav. 2024;160: 109975.
</cite> [<a href="https://doi.org/10.1016/j.yebeh.2024.109975" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39305725/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Ludwig%20NN,%20Wojnaroski%20M,%20Suskauer%20SJ,%20Slomine%20BS,%20Kaiser%20A,%20Paltell%20K,%20Evans%20L,%20Tucker%20K,%20Chapman%20CAT,%20Conecker%20G,%20et%20al.%20Novel%20approaches%20to%20measuring%20cognition%20in%20individuals%20with%20severe%20to%20profound%20functional%20impairment:%20a%20pilot%20study%20in%20SCN2A-related%20disorder.%20Epilepsy%20Behav.%202024;160:%20109975." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR62">
<span class="label">62.</span><cite>Auvin S, French J, Dlugos D, Knupp KG, Perucca E, Arzimanoglou A, Whalen E, Shellhaas RA. Novel study design to assess the efficacy and tolerability of antiseizure medications for focal-onset seizures in infants and young children: a consensus document from the regulatory task force and the pediatric commission of the International League against Epilepsy (ILAE), in collaboration with the Pediatric Epilepsy Research Consortium (PERC). Epilepsia Open. 2019;4(4):537–43.
</cite> [<a href="https://doi.org/10.1002/epi4.12356" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6885693/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31819909/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Auvin%20S,%20French%20J,%20Dlugos%20D,%20Knupp%20KG,%20Perucca%20E,%20Arzimanoglou%20A,%20Whalen%20E,%20Shellhaas%20RA.%20Novel%20study%20design%20to%20assess%20the%20efficacy%20and%20tolerability%20of%20antiseizure%20medications%20for%20focal-onset%20seizures%20in%20infants%20and%20young%20children:%20a%20consensus%20document%20from%20the%20regulatory%20task%20force%20and%20the%20pediatric%20commission%20of%20the%20International%20League%20against%20Epilepsy%20(ILAE),%20in%20collaboration%20with%20the%20Pediatric%20Epilepsy%20Research%20Consortium%20(PERC).%20Epilepsia%20Open.%202019;4(4):537%E2%80%9343." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR63">
<span class="label">63.</span><cite>Xian J, Thalwitzer KM, McKee J, Sullivan KR, Brimble E, Fitch E, Toib J, Kaufman MC, deCampo D, Cunningham K, et al. Delineating clinical and developmental outcomes in STXBP1-related disorders. Brain. 2023;146(12):5182–97.
</cite> [<a href="https://doi.org/10.1093/brain/awad287" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10689925/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38015929/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Xian%20J,%20Thalwitzer%20KM,%20McKee%20J,%20Sullivan%20KR,%20Brimble%20E,%20Fitch%20E,%20Toib%20J,%20Kaufman%20MC,%20deCampo%20D,%20Cunningham%20K,%20et%20al.%20Delineating%20clinical%20and%20developmental%20outcomes%20in%20STXBP1-related%20disorders.%20Brain.%202023;146(12):5182%E2%80%9397." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR64">
<span class="label">64.</span><cite>Gunasekera CL, Sirven JI, Feyissa AM. The evolution of antiseizure medication therapy selection in adults: Is artificial intelligence -assisted antiseizure medication selection ready for prime time? J Cent Nerv Syst Dis. 2023;15:11795735231209208.
</cite> [<a href="https://doi.org/10.1177/11795735231209209" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10586013/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37868934/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Gunasekera%20CL,%20Sirven%20JI,%20Feyissa%20AM.%20The%20evolution%20of%20antiseizure%20medication%20therapy%20selection%20in%20adults:%20Is%20artificial%20intelligence%20-assisted%20antiseizure%20medication%20selection%20ready%20for%20prime%20time?%20J%20Cent%20Nerv%20Syst%20Dis.%202023;15:11795735231209208." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR65">
<span class="label">65.</span><cite>Mayer B, Kringel D, Lotsch J. Artificial intelligence and machine learning in clinical pharmacological research. Expert Rev Clin Pharmacol. 2024;17(1):79–91.
</cite> [<a href="https://doi.org/10.1080/17512433.2023.2294005" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38165148/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Mayer%20B,%20Kringel%20D,%20Lotsch%20J.%20Artificial%20intelligence%20and%20machine%20learning%20in%20clinical%20pharmacological%20research.%20Expert%20Rev%20Clin%20Pharmacol.%202024;17(1):79%E2%80%9391." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR66">
<span class="label">66.</span><cite>Singh S, Kumar R, Payra S, Singh SK. Artificial intelligence and machine learning in pharmacological research: bridging the gap between data and drug discovery. Cureus. 2023;15(8): e44359.
</cite> [<a href="https://doi.org/10.7759/cureus.44359" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10539991/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37779744/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Singh%20S,%20Kumar%20R,%20Payra%20S,%20Singh%20SK.%20Artificial%20intelligence%20and%20machine%20learning%20in%20pharmacological%20research:%20bridging%20the%20gap%20between%20data%20and%20drug%20discovery.%20Cureus.%202023;15(8):%20e44359." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR67">
<span class="label">67.</span><cite>Michaelis R, Knake S, Rosenow F, Gronheit W, Hamer H, Schmitz B, Accarie A, Dedeken P, Immisch I, Habermehl L, et al. A multicenter randomized controlled feasibility trial of a digital self-management intervention for adults with epilepsy. Epilepsia Open. 2024;9(3):1021–33.
</cite> [<a href="https://doi.org/10.1002/epi4.12933" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11145620/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38689518/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Michaelis%20R,%20Knake%20S,%20Rosenow%20F,%20Gronheit%20W,%20Hamer%20H,%20Schmitz%20B,%20Accarie%20A,%20Dedeken%20P,%20Immisch%20I,%20Habermehl%20L,%20et%20al.%20A%20multicenter%20randomized%20controlled%20feasibility%20trial%20of%20a%20digital%20self-management%20intervention%20for%20adults%20with%20epilepsy.%20Epilepsia%20Open.%202024;9(3):1021%E2%80%9333." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR68">
<span class="label">68.</span><cite>Engel J Jr, Pitkanen A, Loeb JA, Dudek FE, Bertram EH 3rd, Cole AJ, Moshe SL, Wiebe S, Jensen FE, Mody I, et al. Epilepsy biomarkers. Epilepsia. 2013;54 Suppl 4(4):61–9.
</cite> [<a href="https://doi.org/10.1111/epi.12299" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4131763/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23909854/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Engel%20J%20Jr,%20Pitkanen%20A,%20Loeb%20JA,%20Dudek%20FE,%20Bertram%20EH%203rd,%20Cole%20AJ,%20Moshe%20SL,%20Wiebe%20S,%20Jensen%20FE,%20Mody%20I,%20et%20al.%20Epilepsy%20biomarkers.%20Epilepsia.%202013;54%20Suppl%204(4):61%E2%80%939." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR69">
<span class="label">69.</span><cite>Scheid BH, Bernabei JM, Khambhati AN, Mouchtaris S, Jeschke J, Bassett DS, Becker D, Davis KA, Lucas T, Doyle W, et al. Intracranial electroencephalographic biomarker predicts effective responsive neurostimulation for epilepsy prior to treatment. Epilepsia. 2022;63(3):652–62.
</cite> [<a href="https://doi.org/10.1111/epi.17163" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9887634/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34997577/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Scheid%20BH,%20Bernabei%20JM,%20Khambhati%20AN,%20Mouchtaris%20S,%20Jeschke%20J,%20Bassett%20DS,%20Becker%20D,%20Davis%20KA,%20Lucas%20T,%20Doyle%20W,%20et%20al.%20Intracranial%20electroencephalographic%20biomarker%20predicts%20effective%20responsive%20neurostimulation%20for%20epilepsy%20prior%20to%20treatment.%20Epilepsia.%202022;63(3):652%E2%80%9362." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR70">
<span class="label">70.</span><cite>Armstrong C, Marsh ED. Electrophysiological biomarkers in genetic epilepsies. Neurotherapeutics. 2021;18(3):1458–67.
</cite> [<a href="https://doi.org/10.1007/s13311-021-01132-4" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8609056/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34642905/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Armstrong%20C,%20Marsh%20ED.%20Electrophysiological%20biomarkers%20in%20genetic%20epilepsies.%20Neurotherapeutics.%202021;18(3):1458%E2%80%9367." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR71">
<span class="label">71.</span><cite>Banote RK, Akel S, Zelano J. Blood biomarkers in epilepsy. Acta Neurol Scand. 2022;146(4):362–8.
</cite> [<a href="https://doi.org/10.1111/ane.13616" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9790299/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35411571/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Banote%20RK,%20Akel%20S,%20Zelano%20J.%20Blood%20biomarkers%20in%20epilepsy.%20Acta%20Neurol%20Scand.%202022;146(4):362%E2%80%938." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR72">
<span class="label">72.</span><cite>Kobylarek D, Iwanowski P, Lewandowska Z, Limphaibool N, Szafranek S, Labrzycka A, Kozubski W. Advances in the potential biomarkers of epilepsy. Front Neurol. 2019;10:685.
</cite> [<a href="https://doi.org/10.3389/fneur.2019.00685" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6614180/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31312171/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Kobylarek%20D,%20Iwanowski%20P,%20Lewandowska%20Z,%20Limphaibool%20N,%20Szafranek%20S,%20Labrzycka%20A,%20Kozubski%20W.%20Advances%20in%20the%20potential%20biomarkers%20of%20epilepsy.%20Front%20Neurol.%202019;10:685." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR73">
<span class="label">73.</span><cite>Spencer ER, Shi W, Komorowski RW, Gilbert JP, Ostrowski LM, Bird LM, Thibert R, Bao C, Molloy F, Calhoun M, et al. Longitudinal EEG model detects antisense oligonucleotide treatment effect and increased UBE3A in Angelman syndrome. Brain Commun. 2022;4(3):fcac106.
</cite> [<a href="https://doi.org/10.1093/braincomms/fcac106" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9123847/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35611307/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Spencer%20ER,%20Shi%20W,%20Komorowski%20RW,%20Gilbert%20JP,%20Ostrowski%20LM,%20Bird%20LM,%20Thibert%20R,%20Bao%20C,%20Molloy%20F,%20Calhoun%20M,%20et%20al.%20Longitudinal%20EEG%20model%20detects%20antisense%20oligonucleotide%20treatment%20effect%20and%20increased%20UBE3A%20in%20Angelman%20syndrome.%20Brain%20Commun.%202022;4(3):fcac106." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR74">
<span class="label">74.</span><cite>Jannati A, Ryan MA, Kaye HL, Tsuboyama M, Rotenberg A. Biomarkers obtained by transcranial magnetic stimulation in neurodevelopmental disorders. J Clin Neurophysiol. 2022;39(2):135–48.
</cite> [<a href="https://doi.org/10.1097/WNP.0000000000000784" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8810902/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34366399/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Jannati%20A,%20Ryan%20MA,%20Kaye%20HL,%20Tsuboyama%20M,%20Rotenberg%20A.%20Biomarkers%20obtained%20by%20transcranial%20magnetic%20stimulation%20in%20neurodevelopmental%20disorders.%20J%20Clin%20Neurophysiol.%202022;39(2):135%E2%80%9348." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR75">
<span class="label">75.</span><cite>Tsuboyama M, Lee Kaye H, Rotenberg A. Biomarkers obtained by transcranial magnetic stimulation of the motor cortex in epilepsy. Front Integr Neurosci. 2019;13:57.
</cite> [<a href="https://doi.org/10.3389/fnint.2019.00057" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6837164/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31736722/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Tsuboyama%20M,%20Lee%20Kaye%20H,%20Rotenberg%20A.%20Biomarkers%20obtained%20by%20transcranial%20magnetic%20stimulation%20of%20the%20motor%20cortex%20in%20epilepsy.%20Front%20Integr%20Neurosci.%202019;13:57." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR76">
<span class="label">76.</span><cite>Wong JC, Makinson CD, Lamar T, Cheng Q, Wingard JC, Terwilliger EF, Escayg A. Selective targeting of Scn8a prevents seizure development in a mouse model of mesial temporal lobe epilepsy. Sci Rep. 2018;8(1):126.
</cite> [<a href="https://doi.org/10.1038/s41598-017-17786-0" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5760706/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29317669/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Wong%20JC,%20Makinson%20CD,%20Lamar%20T,%20Cheng%20Q,%20Wingard%20JC,%20Terwilliger%20EF,%20Escayg%20A.%20Selective%20targeting%20of%20Scn8a%20prevents%20seizure%20development%20in%20a%20mouse%20model%20of%20mesial%20temporal%20lobe%20epilepsy.%20Sci%20Rep.%202018;8(1):126." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR77">
<span class="label">77.</span><cite>CZ_CELLxGENE_Discover. A single-cell data platform for scalable exploration, analysis and modeling of aggregated data CZI Single-Cell Biology. 2023.</cite> [<a href="https://doi.org/10.1093/nar/gkae1142" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11701654/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39607691/" class="usa-link">PubMed</a>]</li>
<li id="CR78">
<span class="label">78.</span><cite>Makinson CD, Tanaka BS, Sorokin JM, Wong JC, Christian CA, Goldin AL, Escayg A, Huguenard JR. Regulation of thalamic and cortical network synchrony by Scn8a. Neuron. 2017;93(5):1165–79.
</cite> [<a href="https://doi.org/10.1016/j.neuron.2017.01.031" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5393918/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28238546/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Makinson%20CD,%20Tanaka%20BS,%20Sorokin%20JM,%20Wong%20JC,%20Christian%20CA,%20Goldin%20AL,%20Escayg%20A,%20Huguenard%20JR.%20Regulation%20of%20thalamic%20and%20cortical%20network%20synchrony%20by%20Scn8a.%20Neuron.%202017;93(5):1165%E2%80%9379." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR79">
<span class="label">79.</span><cite>Espino CM, Nagaraja C, Ortiz S, Dayton JR, Murali AR, Ma Y, Mann EL, Garlapalli S, Wohlgemuth RP, Brashear SE, et al., Differential encoding of mammalian proprioception by voltage-gated sodium channels<em>.</em> bioRxiv, 2024.</cite> [<a href="https://doi.org/10.1126/sciadv.ads6660" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11708877/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39772670/" class="usa-link">PubMed</a>]</li>
<li id="CR80">
<span class="label">80.</span><cite>Amin S, Majumdar A, Mallick AA, Patel J, Scatchard R, Partridge CA, Lux A. Caregiver’s perception of epilepsy treatment, quality of life and comorbidities in an international cohort of CDKL5 patients. Hippokratia. 2017;21(3):130–5.
</cite> [<a href="/articles/PMC6247997/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30479474/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Amin%20S,%20Majumdar%20A,%20Mallick%20AA,%20Patel%20J,%20Scatchard%20R,%20Partridge%20CA,%20Lux%20A.%20Caregiver%E2%80%99s%20perception%20of%20epilepsy%20treatment,%20quality%20of%20life%20and%20comorbidities%20in%20an%20international%20cohort%20of%20CDKL5%20patients.%20Hippokratia.%202017;21(3):130%E2%80%935." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR81">
<span class="label">81.</span><cite>Berg AT, Baca CB, Loddenkemper T, Vickrey BG, Dlugos D. Priorities in pediatric epilepsy research: improving children’s futures today. Neurology. 2013;81(13):1166–75.
</cite> [<a href="https://doi.org/10.1212/WNL.0b013e3182a55fb9" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3795602/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23966254/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Berg%20AT,%20Baca%20CB,%20Loddenkemper%20T,%20Vickrey%20BG,%20Dlugos%20D.%20Priorities%20in%20pediatric%20epilepsy%20research:%20improving%20children%E2%80%99s%20futures%20today.%20Neurology.%202013;81(13):1166%E2%80%9375." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR82">
<span class="label">82.</span><cite>Gallop K, Lloyd AJ, Olt J, Marshall J. Impact of developmental and epileptic encephalopathies on caregivers: a literature review. Epilepsy Behav. 2021;124: 108324.
</cite> [<a href="https://doi.org/10.1016/j.yebeh.2021.108324" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34607217/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Gallop%20K,%20Lloyd%20AJ,%20Olt%20J,%20Marshall%20J.%20Impact%20of%20developmental%20and%20epileptic%20encephalopathies%20on%20caregivers:%20a%20literature%20review.%20Epilepsy%20Behav.%202021;124:%20108324." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR83">
<span class="label">83.</span><cite>Neul JL, Benke TA, Marsh ED, Suter B, Silveira L, Fu C, Peters SU, Percy AK. and Rett syndrome Natural History Study G, Top caregiver concerns in Rett syndrome and related disorders: data from the US natural history study. J Neurodev Disord. 2023;15(1):33.
</cite> [<a href="https://doi.org/10.1186/s11689-023-09502-z" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10571464/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37833681/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Neul%20JL,%20Benke%20TA,%20Marsh%20ED,%20Suter%20B,%20Silveira%20L,%20Fu%20C,%20Peters%20SU,%20Percy%20AK.%20and%20Rett%20syndrome%20Natural%20History%20Study%20G,%20Top%20caregiver%20concerns%20in%20Rett%20syndrome%20and%20related%20disorders:%20data%20from%20the%20US%20natural%20history%20study.%20J%20Neurodev%20Disord.%202023;15(1):33." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR84">
<span class="label">84.</span><cite>Villas N, Meskis MA, Goodliffe S. Dravet syndrome: characteristics, comorbidities, and caregiver concerns. Epilepsy Behav. 2017;74:81–6.
</cite> [<a href="https://doi.org/10.1016/j.yebeh.2017.06.031" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28732259/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Villas%20N,%20Meskis%20MA,%20Goodliffe%20S.%20Dravet%20syndrome:%20characteristics,%20comorbidities,%20and%20caregiver%20concerns.%20Epilepsy%20Behav.%202017;74:81%E2%80%936." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR85">
<span class="label">85.</span><cite>Epi PMC. A roadmap for precision medicine in the epilepsies. Lancet Neurol. 2015;14(12):1219–28.
</cite> [<a href="https://doi.org/10.1016/S1474-4422(15)00199-4" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4663979/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26416172/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Epi%20PMC.%20A%20roadmap%20for%20precision%20medicine%20in%20the%20epilepsies.%20Lancet%20Neurol.%202015;14(12):1219%E2%80%9328." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR86">
<span class="label">86.</span><cite>Donahue MA, Herman ST, Dass D, Farrell K, Kukla A, Abend NS, Moura L, Buchhalter JR, Fureman BE. Establishing a learning healthcare system to improve health outcomes for people with epilepsy. Epilepsy Behav. 2021;117: 107805.
</cite> [<a href="https://doi.org/10.1016/j.yebeh.2021.107805" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33588319/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Donahue%20MA,%20Herman%20ST,%20Dass%20D,%20Farrell%20K,%20Kukla%20A,%20Abend%20NS,%20Moura%20L,%20Buchhalter%20JR,%20Fureman%20BE.%20Establishing%20a%20learning%20healthcare%20system%20to%20improve%20health%20outcomes%20for%20people%20with%20epilepsy.%20Epilepsy%20Behav.%202021;117:%20107805." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR87">
<span class="label">87.</span><cite>Gertler TS, Carvill GL. SCN8A: when neurons are so excited, they just can’t hide it. Epilepsy Curr. 2019;19(4):269–71.
</cite> [<a href="https://doi.org/10.1177/1535759719858338" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6891829/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31288536/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Gertler%20TS,%20Carvill%20GL.%20SCN8A:%20when%20neurons%20are%20so%20excited,%20they%20just%20can%E2%80%99t%20hide%20it.%20Epilepsy%20Curr.%202019;19(4):269%E2%80%9371." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR88">
<span class="label">88.</span><cite>Chopra M, Modi ME, Dies KA, Chamberlin NL, Buttermore ED, Brewster SJ, Prock L, Sahin M. GENE TARGET: a framework for evaluating Mendelian neurodevelopmental disorders for gene therapy. Mol Ther Methods Clin Dev. 2022;27:32–46.
</cite> [<a href="https://doi.org/10.1016/j.omtm.2022.08.007" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9478871/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36156879/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Chopra%20M,%20Modi%20ME,%20Dies%20KA,%20Chamberlin%20NL,%20Buttermore%20ED,%20Brewster%20SJ,%20Prock%20L,%20Sahin%20M.%20GENE%20TARGET:%20a%20framework%20for%20evaluating%20Mendelian%20neurodevelopmental%20disorders%20for%20gene%20therapy.%20Mol%20Ther%20Methods%20Clin%20Dev.%202022;27:32%E2%80%9346." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR89">
<span class="label">89.</span><cite>Hamiwka LD, Wirrell EC. Comorbidities in pediatric epilepsy: beyond "just’’ treating the seizures. J Child Neurol. 2009;24(6):734–42.
</cite> [<a href="https://doi.org/10.1177/0883073808329527" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/19359255/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Hamiwka%20LD,%20Wirrell%20EC.%20Comorbidities%20in%20pediatric%20epilepsy:%20beyond%20%22just%E2%80%99%E2%80%99%20treating%20the%20seizures.%20J%20Child%20Neurol.%202009;24(6):734%E2%80%9342." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR90">
<span class="label">90.</span><cite>Cardenal-Munoz E, Auvin S, Villanueva V, Cross JH, Zuberi SM, Lagae L, Aibar JA. Guidance on Dravet syndrome from infant to adult care: road map for treatment planning in Europe. Epilepsia Open. 2022;7(1):11–26.
</cite> [<a href="https://doi.org/10.1002/epi4.12569" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8886070/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34882995/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Cardenal-Munoz%20E,%20Auvin%20S,%20Villanueva%20V,%20Cross%20JH,%20Zuberi%20SM,%20Lagae%20L,%20Aibar%20JA.%20Guidance%20on%20Dravet%20syndrome%20from%20infant%20to%20adult%20care:%20road%20map%20for%20treatment%20planning%20in%20Europe.%20Epilepsia%20Open.%202022;7(1):11%E2%80%9326." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR91">
<span class="label">91.</span><cite>Hermann BP, Struck AF, Busch RM, Reyes A, Kaestner E, McDonald CR. Neurobehavioural comorbidities of epilepsy: towards a network-based precision taxonomy. Nat Rev Neurol. 2021;17(12):731–46.
</cite> [<a href="https://doi.org/10.1038/s41582-021-00555-z" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8900353/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34552218/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Hermann%20BP,%20Struck%20AF,%20Busch%20RM,%20Reyes%20A,%20Kaestner%20E,%20McDonald%20CR.%20Neurobehavioural%20comorbidities%20of%20epilepsy:%20towards%20a%20network-based%20precision%20taxonomy.%20Nat%20Rev%20Neurol.%202021;17(12):731%E2%80%9346." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR92">
<span class="label">92.</span><cite>Fernandes M, Donahue MA, Hoch D, Cash S, Zafar S, Jacobs C, Hosford M, Voinescu PE, Fureman B, Buchhalter J, et al. A replicable, open-source, data integration method to support national practice-based research &amp; quality improvement systems. Epilepsy Res. 2022;186: 107013.
</cite> [<a href="https://doi.org/10.1016/j.eplepsyres.2022.107013" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9810436/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35994859/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Fernandes%20M,%20Donahue%20MA,%20Hoch%20D,%20Cash%20S,%20Zafar%20S,%20Jacobs%20C,%20Hosford%20M,%20Voinescu%20PE,%20Fureman%20B,%20Buchhalter%20J,%20et%20al.%20A%20replicable,%20open-source,%20data%20integration%20method%20to%20support%20national%20practice-based%20research%20&amp;%20quality%20improvement%20systems.%20Epilepsy%20Res.%202022;186:%20107013." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR93">
<span class="label">93.</span><cite>Fitzgerald MP, Kaufman MC, Massey SL, Fridinger S, Prelack M, Ellis C, Ortiz-Gonzalez X, Fried LE, DiGiovine MP, Collaborative CPEP, et al. Assessing seizure burden in pediatric epilepsy using an electronic medical record-based tool through a common data element approach. Epilepsia. 2021;62(7):1617–28.
</cite> [<a href="https://doi.org/10.1111/epi.16934" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8637497/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34075580/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Fitzgerald%20MP,%20Kaufman%20MC,%20Massey%20SL,%20Fridinger%20S,%20Prelack%20M,%20Ellis%20C,%20Ortiz-Gonzalez%20X,%20Fried%20LE,%20DiGiovine%20MP,%20Collaborative%20CPEP,%20et%20al.%20Assessing%20seizure%20burden%20in%20pediatric%20epilepsy%20using%20an%20electronic%20medical%20record-based%20tool%20through%20a%20common%20data%20element%20approach.%20Epilepsia.%202021;62(7):1617%E2%80%9328." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR94">
<span class="label">94.</span><cite>Penn Miller I, Hecker J, Fureman B, Meskis MA, Roberds S, Jones M, Grabenstatter H, Vogel-Farley V, Lubbers L. Epilepsy community at an inflection point: translating research toward curing the epilepsies and improving patient outcomes. Epilepsy Curr. 2021;21(5):385–8.
</cite> [<a href="https://doi.org/10.1177/15357597211024392" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8655265/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34924843/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Penn%20Miller%20I,%20Hecker%20J,%20Fureman%20B,%20Meskis%20MA,%20Roberds%20S,%20Jones%20M,%20Grabenstatter%20H,%20Vogel-Farley%20V,%20Lubbers%20L.%20Epilepsy%20community%20at%20an%20inflection%20point:%20translating%20research%20toward%20curing%20the%20epilepsies%20and%20improving%20patient%20outcomes.%20Epilepsy%20Curr.%202021;21(5):385%E2%80%938." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR95">
<span class="label">95.</span><cite>Bar-Klein G, Lublinsky S, Kamintsky L, Noyman I, Veksler R, Dalipaj H, Senatorov VV Jr, Swissa E, Rosenbach D, Elazary N, et al. Imaging blood-brain barrier dysfunction as a biomarker for epileptogenesis. Brain. 2017;140(6):1692–705.
</cite> [<a href="https://doi.org/10.1093/brain/awx073" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28444141/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Bar-Klein%20G,%20Lublinsky%20S,%20Kamintsky%20L,%20Noyman%20I,%20Veksler%20R,%20Dalipaj%20H,%20Senatorov%20VV%20Jr,%20Swissa%20E,%20Rosenbach%20D,%20Elazary%20N,%20et%20al.%20Imaging%20blood-brain%20barrier%20dysfunction%20as%20a%20biomarker%20for%20epileptogenesis.%20Brain.%202017;140(6):1692%E2%80%93705." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR96">
<span class="label">96.</span><cite>Heinemann U, Kaufer D, Friedman A. Blood-brain barrier dysfunction, TGFbeta signaling, and astrocyte dysfunction in epilepsy. Glia. 2012;60(8):1251–7.
</cite> [<a href="https://doi.org/10.1002/glia.22311" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3615248/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22378298/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Heinemann%20U,%20Kaufer%20D,%20Friedman%20A.%20Blood-brain%20barrier%20dysfunction,%20TGFbeta%20signaling,%20and%20astrocyte%20dysfunction%20in%20epilepsy.%20Glia.%202012;60(8):1251%E2%80%937." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR97">
<span class="label">97.</span><cite>van Vliet EA, Aronica E, Gorter JA. Blood-brain barrier dysfunction, seizures and epilepsy. Semin Cell Dev Biol. 2015;38:26–34.
</cite> [<a href="https://doi.org/10.1016/j.semcdb.2014.10.003" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25444846/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?van%20Vliet%20EA,%20Aronica%20E,%20Gorter%20JA.%20Blood-brain%20barrier%20dysfunction,%20seizures%20and%20epilepsy.%20Semin%20Cell%20Dev%20Biol.%202015;38:26%E2%80%9334." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR98">
<span class="label">98.</span><cite>Vezzani A, Friedman A, Dingledine RJ. The role of inflammation in epileptogenesis. Neuropharmacology. 2013;69:16–24.
</cite> [<a href="https://doi.org/10.1016/j.neuropharm.2012.04.004" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3447120/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22521336/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Vezzani%20A,%20Friedman%20A,%20Dingledine%20RJ.%20The%20role%20of%20inflammation%20in%20epileptogenesis.%20Neuropharmacology.%202013;69:16%E2%80%9324." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR99">
<span class="label">99.</span><cite>Xu JC, Fan J, Wang X, Eacker SM, Kam TI, Chen L, Yin X, Zhu J, Chi Z, Jiang H, et al. Cultured networks of excitatory projection neurons and inhibitory interneurons for studying human cortical neurotoxicity. Sci Transl Med. 2016;8(333):333ra48.
</cite> [<a href="https://doi.org/10.1126/scitranslmed.aad0623" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5595216/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27053772/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Xu%20JC,%20Fan%20J,%20Wang%20X,%20Eacker%20SM,%20Kam%20TI,%20Chen%20L,%20Yin%20X,%20Zhu%20J,%20Chi%20Z,%20Jiang%20H,%20et%20al.%20Cultured%20networks%20of%20excitatory%20projection%20neurons%20and%20inhibitory%20interneurons%20for%20studying%20human%20cortical%20neurotoxicity.%20Sci%20Transl%20Med.%202016;8(333):333ra48." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR100">
<span class="label">100.</span><cite>Zsurka G, Kunz WS. Mitochondrial dysfunction and seizures: the neuronal energy crisis. Lancet Neurol. 2015;14(9):956–66.
</cite> [<a href="https://doi.org/10.1016/S1474-4422(15)00148-9" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26293567/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Zsurka%20G,%20Kunz%20WS.%20Mitochondrial%20dysfunction%20and%20seizures:%20the%20neuronal%20energy%20crisis.%20Lancet%20Neurol.%202015;14(9):956%E2%80%9366." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR101">
<span class="label">101.</span><cite>Bunton-Stasyshyn RKA, Wagnon JL, Wengert ER, Barker BS, Faulkner A, Wagley PK, Bhatia K, Jones JM, Maniaci MR, Parent JM, et al. Prominent role of forebrain excitatory neurons in SCN8A encephalopathy. Brain. 2019;142(2):362–75.
</cite> [<a href="https://doi.org/10.1093/brain/awy324" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6351781/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30601941/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Bunton-Stasyshyn%20RKA,%20Wagnon%20JL,%20Wengert%20ER,%20Barker%20BS,%20Faulkner%20A,%20Wagley%20PK,%20Bhatia%20K,%20Jones%20JM,%20Maniaci%20MR,%20Parent%20JM,%20et%20al.%20Prominent%20role%20of%20forebrain%20excitatory%20neurons%20in%20SCN8A%20encephalopathy.%20Brain.%202019;142(2):362%E2%80%9375." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR102">
<span class="label">102.</span><cite>Wong JC, Grieco SF, Dutt K, Chen L, Thelin JT, Inglis GAS, Parvin S, Garraway SM, Xu X, Goldin AL, et al. Autistic-like behavior, spontaneous seizures, and increased neuronal excitability in a Scn8a mouse model. Neuropsychopharmacology. 2021;46(11):2011–20.
</cite> [<a href="https://doi.org/10.1038/s41386-021-00985-9" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8429750/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33658654/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Wong%20JC,%20Grieco%20SF,%20Dutt%20K,%20Chen%20L,%20Thelin%20JT,%20Inglis%20GAS,%20Parvin%20S,%20Garraway%20SM,%20Xu%20X,%20Goldin%20AL,%20et%20al.%20Autistic-like%20behavior,%20spontaneous%20seizures,%20and%20increased%20neuronal%20excitability%20in%20a%20Scn8a%20mouse%20model.%20Neuropsychopharmacology.%202021;46(11):2011%E2%80%9320." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR103">
<span class="label">103.</span><cite>Meador KJ, French J, Loring DW, Pennell PB. Disparities in NIH funding for epilepsy research. Neurology. 2011;77(13):1305–7.
</cite> [<a href="https://doi.org/10.1212/WNL.0b013e318230a18f" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3265048/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21947534/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Meador%20KJ,%20French%20J,%20Loring%20DW,%20Pennell%20PB.%20Disparities%20in%20NIH%20funding%20for%20epilepsy%20research.%20Neurology.%202011;77(13):1305%E2%80%937." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR104">
<span class="label">104.</span><cite>Cohen SR, Helbig I, Kaufman MC, Schust Myers L, Conway L, Helbig KL. Caregiver assessment of quality of life in individuals with genetic developmental and epileptic encephalopathies. Dev Med Child Neurol. 2022;64(8):957–64.
</cite> [<a href="https://doi.org/10.1111/dmcn.15187" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10305579/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35229292/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Cohen%20SR,%20Helbig%20I,%20Kaufman%20MC,%20Schust%20Myers%20L,%20Conway%20L,%20Helbig%20KL.%20Caregiver%20assessment%20of%20quality%20of%20life%20in%20individuals%20with%20genetic%20developmental%20and%20epileptic%20encephalopathies.%20Dev%20Med%20Child%20Neurol.%202022;64(8):957%E2%80%9364." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR105">
<span class="label">105.</span><cite>Ding J, Li X, Tian H, Wang L, Guo B, Wang Y, Li W, Wang F, Sun T. SCN1A mutation-beyond dravet syndrome: a systematic review and narrative synthesis. Front Neurol. 2021;12: 743726.
</cite> [<a href="https://doi.org/10.3389/fneur.2021.743726" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8739186/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35002916/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Ding%20J,%20Li%20X,%20Tian%20H,%20Wang%20L,%20Guo%20B,%20Wang%20Y,%20Li%20W,%20Wang%20F,%20Sun%20T.%20SCN1A%20mutation-beyond%20dravet%20syndrome:%20a%20systematic%20review%20and%20narrative%20synthesis.%20Front%20Neurol.%202021;12:%20743726." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR106">
<span class="label">106.</span><cite>FamilieSCN2A_Foundation, Strategic Plan. 2022.</cite>
</li>
<li id="CR107">
<span class="label">107.</span><cite>Haque US, Yokota T. Recent progress in gene-targeting therapies for spinal muscular atrophy: promises and challenges. Genes (Basel). 2024;15(8):999.
</cite> [<a href="https://doi.org/10.3390/genes15080999" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11353366/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39202360/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Haque%20US,%20Yokota%20T.%20Recent%20progress%20in%20gene-targeting%20therapies%20for%20spinal%20muscular%20atrophy:%20promises%20and%20challenges.%20Genes%20(Basel).%202024;15(8):999." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR108">
<span class="label">108.</span><cite>Higurashi N, Broccoli V, Hirose S. Genetics and gene therapy in Dravet syndrome. Epilepsy Behav. 2022;131(Pt B): 108043.
</cite> [<a href="https://doi.org/10.1016/j.yebeh.2021.108043" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34053869/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Higurashi%20N,%20Broccoli%20V,%20Hirose%20S.%20Genetics%20and%20gene%20therapy%20in%20Dravet%20syndrome.%20Epilepsy%20Behav.%202022;131(Pt%20B):%20108043." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR109">
<span class="label">109.</span><cite>Klein P, Kaminski RM, Koepp M, Loscher W. New epilepsy therapies in development. Nat Rev Drug Discov. 2024;23(9):682–708.
</cite> [<a href="https://doi.org/10.1038/s41573-024-00981-w" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39039153/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Klein%20P,%20Kaminski%20RM,%20Koepp%20M,%20Loscher%20W.%20New%20epilepsy%20therapies%20in%20development.%20Nat%20Rev%20Drug%20Discov.%202024;23(9):682%E2%80%93708." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
</ul></section></section><section id="_ad93_" lang="en" class="associated-data"><h2 class="pmc_sec_title">Associated Data</h2>
<p class="font-secondary"><em>This section collects any data citations, data availability statements, or supplementary materials included in this article.</em></p>
<section id="_adsm93_" lang="en" class="supplementary-materials"><h3 class="pmc_sec_title">Supplementary Materials</h3>
<section class="sm xbox font-sm" id="db_ds_supplementary-material1_reqid_"><div class="media p"><div class="caption">
<a href="/articles/instance/12366098/bin/13023_2025_3672_MOESM1_ESM.pdf" data-ga-action="click_feat_suppl" class="usa-link">Additional file1 (PDF 2193 KB)</a><sup> (2.1MB, pdf) </sup>
</div></div></section></section><section id="_adda93_" lang="en" class="data-availability-statement"><h3 class="pmc_sec_title">Data Availability Statement</h3>
<p>The datasets supporting the conclusions of this article are included within the article and the supplementary figures. Additional information may be available from the corresponding author on reasonable request.</p></section></section></section><footer class="p courtesy-note font-secondary font-sm text-center"><hr class="headless">
<p>Articles from Orphanet Journal of Rare Diseases are provided here courtesy of <strong>BMC</strong></p></footer></section></article>

                      

                    </main>
                </div>
            </div>
        </div>

        



<!-- Secondary navigation placeholder -->
<div class="pmc-sidenav desktop:grid-col-4 display-flex">
    <section class="pmc-sidenav__container" aria-label="Article resources and navigation">
        <button type="button" class="usa-button pmc-sidenav__container__close usa-button--unstyled">
            <img src="/static/img/usa-icons/close.svg" role="img" alt="Close" />
        </button>
    <div class="display-none desktop:display-block">
       <section class="margin-top-4 desktop:margin-top-0">
              <h2 class="margin-top-0">ACTIONS</h2>
           <ul class="usa-list usa-list--unstyled usa-list--actions">
               
               <li>
                     <a
                             href="https://doi.org/10.1186/s13023-025-03672-w"
                             class="usa-button usa-button--outline width-24 font-xs display-inline-flex flex-align-center flex-justify-start padding-left-1"
                             target="_blank"
                             rel="noreferrer noopener"
                             data-ga-category="actions"
                             data-ga-action="click"
                             data-ga-label="publisher_link_desktop"
                     >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#launch"></use>
                         </svg>
                         <span class="display-inline-flex flex-justify-center flex-1 padding-right-2">View on publisher site</span>
                     </a>
               </li>
               
               
               <li>
                    <a
                            href="pdf/13023_2025_Article_3672.pdf"
                            class="usa-button usa-button--outline width-24 display-inline-flex flex-align-center flex-justify-start padding-left-1"
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="pdf_download_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#file_download"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1">PDF (1.4 MB)</span>
                    </a>
               </li>
               
                
               <li>
                   <button role="button" class="usa-button width-24 citation-dialog-trigger display-inline-flex flex-align-center flex-justify-start padding-left-1"
                        aria-label="Open dialog with citation text in different styles"
                        data-ga-category="actions"
                        data-ga-action="open"
                        data-ga-label="cite_desktop"
                        data-all-citations-url="/resources/citations/12366098/"
                        data-citation-style="nlm"
                        data-download-format-link="/resources/citations/12366098/export/"
                    >
                        <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                        </svg>
                       <span class="display-inline-flex flex-justify-center flex-1 button-label">Cite</span>
                    </button>
               </li>
                
               <li>

                        <button class="usa-button width-24 collections-dialog-trigger collections-button display-inline-flex flex-align-center flex-justify-start padding-left-1 collections-button-empty"
                              aria-label="Save article in MyNCBI collections."
                              data-ga-category="actions"
                              data-ga-action="click"
                              data-ga-label="collections_button_desktop"
                              data-collections-open-dialog-enabled="false"
                              data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC12366098%2F%3Freport%3Dclassic%23open-collections-dialog"
                              data-in-collections="false">
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                            <span class="display-inline-flex flex-justify-center flex-1">Collections</span>
                       </button>
               </li>
               <li class="pmc-permalink">
                    <button
                            type="button"
                            class="usa-button width-24 display-inline-flex flex-align-center flex-justify padding-left-1 shadow-none"
                            aria-label="Show article permalink"
                            aria-expanded="false"
                            aria-haspopup="true"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="permalink_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#share"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1 button-label">Permalink</span>
                    </button>
                   

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC12366098/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
               </li>
           </ul>
       </section>
     </div>

        <section class="pmc-resources margin-top-6 desktop:margin-top-4" data-page-path="/articles/PMC12366098/">
            <h2 class="margin-top-0">RESOURCES</h2>
            
                <div class="usa-accordion usa-accordion--multiselectable" data-allow-multiple>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-similar-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_similar_articles"
                        data-ga-label="/articles/PMC12366098/"
                        data-action-open="open_similar_articles"
                        data-action-close="close_similar_articles"
                        >
                            Similar articles
                        </button>
                    </h3>
                    <div
                            id="resources-similar-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/similar-article-links/40830973/"
                            
                    >
                        
                    </div>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-cited-by-other-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_cited_by"
                        data-ga-label="/articles/PMC12366098/"
                        data-action-open="open_cited_by"
                        data-action-close="close_cited_by"
                        >
                             Cited by other articles
                        </button>
                    </h3>
                    <div
                            id="resources-cited-by-other-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/cited-by-links/40830973/"
                            
                    >
                          
                    </div>
                    
                        <h3 class="usa-accordion__heading">
                            <button
                            type="button"
                            class="usa-accordion__button"
                            aria-expanded="false"
                            aria-controls="resources-links-to-ncbi-databases"
                            data-ga-category="resources_accordion"
                            data-ga-action="open_NCBI_links"
                            data-ga-label="/articles/PMC12366098/"
                            data-action-open="open_NCBI_links"
                            data-action-close="close_NCBI_link"
                            >
                                 Links to NCBI Databases
                            </button>
                        </h3>
                        <div
                                id="resources-links-to-ncbi-databases"
                                class="usa-accordion__content usa-prose"
                                data-source-url="/resources/db-links/12366098/"
                        >
                        </div>
                    
                    
                </div>
            
        </section>


        <section
        class="usa-in-page-nav usa-in-page-nav--wide margin-top-6 desktop:margin-top-4"
        data-title-text="On this page"
        data-title-heading-level="h2"
        data-scroll-offset="0"
        data-root-margin="-10% 0px -80% 0px"
        data-main-content-selector="main"
        data-threshold="1"
        hidden
        ></section>
    </section>
</div>


        

<div class="overlay" role="dialog" aria-label="Citation Dialog" hidden>
    <div class="dialog citation-dialog" aria-hidden="true">
        <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
            <h2 class="usa-modal__heading margin-0">Cite</h2>
             <button type="button" class="usa-button usa-button--unstyled close-overlay text-black width-auto"  tabindex="1">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
             </button>
        </div>

        

<div class="citation-text-block">
  <div class="citation-text margin-bottom-2"></div>
  <ul class="usa-list usa-list--unstyled display-inline-flex flex-justify width-full flex-align-center">
      <li>
        <button
          class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center copy-button dialog-focus"
          data-ga-category="save_share"
          data-ga-action="cite"
          data-ga-label="copy"
          tabindex="2">
            <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                <use xlink:href="/static/img/sprite.svg#content_copy"></use>
            </svg>
            <span>Copy</span>
        </button>
      </li>
      <li>
          <a
              href="#"
              role="button"
              class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center export-button"
              data-ga-category="save_share"
              data-ga-action="cite"
              data-ga-label="download"
              title="Download a file for external citation management software"
              tabindex="3">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                </svg>
                <span class="display-none mobile-lg:display-inline">Download .nbib</span>
                <span class="display-inline mobile-lg:display-none">.nbib</span>
            </a>
      </li>
      <li>
          

<div class="display-inline-flex flex-align-center">
  <label class="usa-label margin-top-0">Format:</label>
  <select aria-label="Format" class="usa-select citation-style-selector padding-1 margin-top-0 border-0 padding-right-4" tabindex="4" >
    
      <option data-style-url-name="ama"
              value="AMA"
              >
        AMA
      </option>
    
      <option data-style-url-name="apa"
              value="APA"
              >
        APA
      </option>
    
      <option data-style-url-name="mla"
              value="MLA"
              >
        MLA
      </option>
    
      <option data-style-url-name="nlm"
              value="NLM"
              selected="selected">
        NLM
      </option>
    
  </select>
</div>
      </li>
  </ul>
</div>
    </div>
</div>

        <div class="overlay" role="dialog" hidden>
  <div id="collections-action-dialog" class="dialog collections-dialog" aria-hidden="true">
   <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
        <h2 class="usa-modal__heading margin-0">Add to Collections</h2>
    </div>
    <div class="collections-action-panel action-panel">
      


<form id="collections-action-dialog-form"
      class="usa-form maxw-full collections-action-panel-form action-panel-content action-form action-panel-smaller-selectors"
      data-existing-collections-url="/list-existing-collections/"
      data-add-to-existing-collection-url="/add-to-existing-collection/"
      data-create-and-add-to-new-collection-url="/create-and-add-to-new-collection/"
      data-myncbi-max-collection-name-length="100"
      data-collections-root-url="https://www.ncbi.nlm.nih.gov/myncbi/collections/">

    <input type="hidden" name="csrfmiddlewaretoken" value="GNsm8YMzeo4bxZzGBPr6f8IJDFFaqf5yA36ZJaCRviMHjmaGgzr7Hos5oI1vl7GI">

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-new"
            class="usa-radio__input usa-radio__input--tile collections-new  margin-top-0"
            name="collections"
            value="new"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_new" />
            <label class="usa-radio__label" for="collections-action-dialog-new">Create a new collection</label>
        </div>
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-existing"
            class="usa-radio__input usa-radio__input--tile collections-existing"
            name="collections"
            value="existing"
            checked="true"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_existing" />
            <label class="usa-radio__label" for="collections-action-dialog-existing">Add to an existing collection</label>
        </div>
    </fieldset>

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="action-panel-control-wrap new-collections-controls">
           <label for="collections-action-dialog-add-to-new" class="usa-label margin-top-0">
                Name your collection
               <abbr title="required" class="usa-hint usa-hint--required text-no-underline">*</abbr>
          </label>
          <input
            type="text"
            name="add-to-new-collection"
            id="collections-action-dialog-add-to-new"
            class="usa-input collections-action-add-to-new"
            pattern="[^&quot;&amp;=&lt;&gt;/]*" title="The following characters are not allowed in the Name field: &quot;&amp;=&lt;&gt;/"
            maxlength=""
            data-ga-category="collections_button"
            data-ga-action="create_collection"
            data-ga-label="non_favorties_collection"
            required
          />
        </div>
        <div class="action-panel-control-wrap existing-collections-controls">
             <label for="collections-action-dialog-add-to-existing" class="usa-label margin-top-0">
                Choose a collection
              </label>
              <select id="collections-action-dialog-add-to-existing"
                      class="usa-select collections-action-add-to-existing"
                      data-ga-category="collections_button"
                      data-ga-action="select_collection"
                      data-ga-label="($('.collections-action-add-to-existing').val() === 'Favorites') ? 'Favorites' : 'non_favorites_collection'">
              </select>
              <div class="collections-retry-load-on-error usa-input-error-message selection-validation-message">
                Unable to load your collection due to an error<br>
                <a href="#">Please try again</a>
              </div>
        </div>
    </fieldset>

    <div class="display-inline-flex">
        <button class="usa-button margin-top-0 action-panel-submit"
            type="submit"
            data-loading-label="Adding..."
            data-pinger-ignore
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="add">
          Add
        </button>
        <button class="usa-button usa-button--outline margin-top-0 action-panel-cancel"
                aria-label="Close 'Add to Collections' panel"
                ref="linksrc=close_collections_panel"
                data-ga-category="collections_button"
                data-ga-action="click"
                data-ga-label="cancel">
          Cancel
        </button>
    </div>
</form>
    </div>
  </div>
</div>

        

      </div>
    </div>
  </div>



        
    
    

<footer class="ncbi-footer ncbi-dark-background " >
    
        <div class="ncbi-footer__icon-section">
            <div class="ncbi-footer__social-header">
                Follow NCBI
            </div>

            <div class="grid-container ncbi-footer__ncbi-social-icons-container">
                
                    <a href="https://twitter.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="40"
                             height="40"
                             viewBox="0 0 40 40"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on X (formerly known as Twitter)</span>
                    </a>
                

                
                    <a href="https://www.facebook.com/ncbi.nlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="16"
                             height="29"
                             focusable="false"
                             aria-hidden="true"
                             viewBox="0 0 16 29"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg">
                            <path d="M3.8809 21.4002C3.8809 19.0932 3.8809 16.7876 3.8809 14.478C3.8809 14.2117 3.80103 14.1452 3.54278 14.1492C2.53372 14.1638 1.52334 14.1492 0.514288 14.1598C0.302626 14.1598 0.248047 14.0972 0.248047 13.8936C0.256034 12.4585 0.256034 11.0239 0.248047 9.58978C0.248047 9.37013 0.302626 9.30224 0.528931 9.3049C1.53798 9.31688 2.54837 9.3049 3.55742 9.31555C3.80103 9.31555 3.8809 9.26097 3.87957 9.00272C3.87158 8.00565 3.85428 7.00592 3.90753 6.00884C3.97142 4.83339 4.31487 3.73115 5.04437 2.78467C5.93095 1.63318 7.15699 1.09005 8.56141 0.967577C10.5582 0.79319 12.555 0.982221 14.5518 0.927641C14.7102 0.927641 14.7462 0.99287 14.7449 1.13664C14.7449 2.581 14.7449 4.02668 14.7449 5.47104C14.7449 5.67604 14.6517 5.68669 14.4946 5.68669C13.4523 5.68669 12.4113 5.68669 11.3703 5.68669C10.3506 5.68669 9.92057 6.10868 9.90593 7.13904C9.89661 7.7647 9.91525 8.39303 9.89794 9.01869C9.88995 9.26364 9.96583 9.31822 10.2015 9.31688C11.7204 9.30623 13.2393 9.31688 14.7595 9.3049C15.0257 9.3049 15.0723 9.3728 15.0444 9.62439C14.89 10.9849 14.7515 12.3467 14.6144 13.7085C14.5691 14.1571 14.5785 14.1585 14.1458 14.1585C12.8386 14.1585 11.5313 14.1665 10.2254 14.1518C9.95119 14.1518 9.89794 14.2317 9.89794 14.4899C9.90593 19.0799 9.89794 23.6752 9.91125 28.2612C9.91125 28.5674 9.8407 28.646 9.53186 28.6433C7.77866 28.6273 6.02414 28.6366 4.27094 28.634C3.82499 28.634 3.87158 28.6992 3.87158 28.22C3.87602 25.9472 3.87913 23.6739 3.8809 21.4002Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on Facebook</span>
                    </a>
                

                
                    <a href="https://www.linkedin.com/company/ncbinlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="25"
                             height="23"
                             viewBox="0 0 26 24"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M14.6983 9.98423C15.6302 9.24808 16.5926 8.74754 17.6762 8.51991C19.673 8.09126 21.554 8.30824 23.1262 9.7526C24.2351 10.7723 24.7529 12.1115 25.0165 13.5612C25.1486 14.3363 25.2105 15.1218 25.2015 15.9081C25.2015 18.3043 25.2015 20.6898 25.2082 23.0806C25.2082 23.3468 25.1549 23.444 24.8621 23.4414C23.1297 23.4272 21.3992 23.4272 19.6704 23.4414C19.4041 23.4414 19.3429 23.3588 19.3442 23.1019C19.3535 20.5194 19.3442 17.9368 19.3442 15.3543C19.3442 14.0005 18.3258 12.9448 17.0266 12.9488C15.7273 12.9528 14.6983 14.0071 14.6983 15.361C14.6983 17.9328 14.6917 20.5047 14.6983 23.0753C14.6983 23.3708 14.6198 23.444 14.3296 23.4427C12.6185 23.4294 10.9079 23.4294 9.19779 23.4427C8.93155 23.4427 8.86099 23.3735 8.86232 23.1086C8.8783 19.7619 8.88628 16.4144 8.88628 13.066C8.88628 11.5688 8.87874 10.0708 8.86365 8.57182C8.86365 8.3575 8.90758 8.27896 9.14054 8.28029C10.9048 8.29094 12.6687 8.29094 14.4321 8.28029C14.6464 8.28029 14.6983 8.34818 14.6983 8.54653C14.6903 9.00047 14.6983 9.45441 14.6983 9.98423Z">
                            </path>
                            <path d="M6.55316 15.8443C6.55316 18.2564 6.55316 20.6699 6.55316 23.082C6.55316 23.3629 6.48127 23.4388 6.19906 23.4374C4.47737 23.4241 2.75568 23.4241 1.03399 23.4374C0.767751 23.4374 0.69986 23.3629 0.701191 23.1006C0.709178 18.2648 0.709178 13.4281 0.701191 8.59053C0.701191 8.34026 0.765089 8.27237 1.01669 8.2737C2.74991 8.28435 4.48048 8.28435 6.20838 8.2737C6.47462 8.2737 6.5465 8.33627 6.54517 8.6065C6.54783 11.0186 6.55316 13.4308 6.55316 15.8443Z">
                            </path>
                            <path d="M3.65878 0.243898C5.36804 0.243898 6.58743 1.45529 6.58743 3.1406C6.58743 4.75801 5.32145 5.95742 3.60819 5.96807C3.22177 5.97614 2.83768 5.90639 2.47877 5.76299C2.11985 5.61959 1.79344 5.40546 1.51897 5.13334C1.24449 4.86123 1.02755 4.53668 0.881058 4.17902C0.734563 3.82136 0.661505 3.43788 0.666231 3.05141C0.67555 1.42601 1.9362 0.242566 3.65878 0.243898Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on LinkedIn</span>
                    </a>
                

                
                    <a href="https://github.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="28"
                             height="27"
                             viewBox="0 0 28 28"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M16.7228 20.6334C17.5057 20.5527 18.2786 20.3944 19.0301 20.1608C21.3108 19.4193 22.5822 17.8259 22.963 15.4909C23.1228 14.5112 23.1814 13.5287 22.9883 12.5437C22.8106 11.6423 22.4013 10.8028 21.8007 10.1076C21.7526 10.0605 21.7197 10 21.7064 9.934C21.6931 9.86799 21.7 9.79952 21.7262 9.73748C22.0856 8.6206 21.9711 7.51969 21.601 6.42677C21.582 6.3497 21.5345 6.2827 21.468 6.23923C21.4016 6.19577 21.3211 6.17906 21.2429 6.19248C20.7329 6.21649 20.2313 6.33051 19.7611 6.52928C19.1103 6.7908 18.4899 7.12198 17.9104 7.51703C17.84 7.56996 17.7581 7.60551 17.6713 7.62078C17.5846 7.63605 17.4954 7.6306 17.4112 7.60489C15.2596 7.05882 13.0054 7.06203 10.8554 7.61421C10.7806 7.63586 10.7018 7.63967 10.6253 7.62534C10.5487 7.611 10.4766 7.57892 10.4148 7.53167C9.64788 7.03247 8.85171 6.58918 7.96368 6.33359C7.65781 6.24338 7.34123 6.19458 7.02239 6.18849C6.94879 6.17986 6.87462 6.19893 6.81432 6.242C6.75402 6.28507 6.71191 6.34904 6.69621 6.42145C6.32342 7.51437 6.2209 8.61527 6.56307 9.73348C6.59635 9.84264 6.64694 9.93316 6.54177 10.0516C5.47666 11.2604 5.09988 12.6834 5.19574 14.2676C5.2663 15.4244 5.46201 16.5466 6.01454 17.5769C6.84399 19.1171 8.21664 19.9119 9.85158 20.3352C10.3938 20.4706 10.9444 20.5698 11.4998 20.632C11.5384 20.7492 11.4506 20.7798 11.408 20.8291C11.1734 21.1179 10.9894 21.4441 10.8634 21.7942C10.7622 22.0458 10.8315 22.4039 10.6065 22.5516C10.263 22.7766 9.83827 22.8485 9.42421 22.8871C8.17936 23.0056 7.26471 22.4877 6.6283 21.4348C6.25552 20.8184 5.76956 20.3325 5.08523 20.0663C4.76981 19.9325 4.42139 19.8967 4.08537 19.9638C3.7898 20.029 3.73788 20.1901 3.93891 20.4111C4.03639 20.5234 4.14989 20.6207 4.27575 20.6999C4.9796 21.1318 5.51717 21.7884 5.80152 22.5636C6.37002 23.9973 7.48039 24.5697 8.93825 24.6323C9.43741 24.6575 9.93768 24.615 10.4254 24.5058C10.5892 24.4672 10.6531 24.4872 10.6517 24.6762C10.6451 25.4936 10.6637 26.3123 10.6517 27.131C10.6517 27.6635 10.1684 27.9297 9.58663 27.7393C8.17396 27.2671 6.84977 26.5631 5.66838 25.656C2.59555 23.2891 0.720966 20.1861 0.217704 16.3376C-0.357453 11.9127 0.911353 8.00824 3.98551 4.73881C6.11909 2.42656 8.99932 0.939975 12.1203 0.540191C16.5351 -0.0601815 20.4347 1.14323 23.7232 4.16373C26.2449 6.47869 27.724 9.37672 28.1048 12.7726C28.5828 17.0325 27.3686 20.7945 24.4768 23.9827C22.9762 25.6323 21.0956 26.8908 18.9982 27.6488C18.8783 27.6927 18.7585 27.738 18.636 27.7726C18.0356 27.9404 17.6189 27.6395 17.6189 27.0098C17.6189 25.7452 17.6308 24.4806 17.6295 23.2159C17.6329 22.9506 17.6128 22.6856 17.5696 22.4238C17.4325 21.6664 17.3419 21.484 16.7228 20.6334Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on GitHub</span>
                    </a>
                

                
                    <a href="https://ncbiinsights.ncbi.nlm.nih.gov/"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="26"
                             height="26"
                             viewBox="0 0 27 27"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M23.7778 26.4574C23.1354 26.3913 22.0856 26.8024 21.636 26.3087C21.212 25.8444 21.4359 24.8111 21.324 24.0347C19.9933 14.8323 14.8727 8.80132 6.09057 5.85008C4.37689 5.28406 2.58381 4.99533 0.779072 4.99481C0.202773 4.99481 -0.0229751 4.83146 0.00455514 4.21479C0.0660406 3.08627 0.0660406 1.95525 0.00455514 0.826734C-0.0413285 0.0815827 0.259669 -0.0193618 0.896534 0.00266238C6.96236 0.222904 12.3693 2.24179 16.9889 6.16209C22.9794 11.2478 26.1271 17.7688 26.4372 25.648C26.4629 26.294 26.3179 26.5271 25.6609 26.4684C25.0827 26.417 24.4991 26.4574 23.7778 26.4574Z">
                            </path>
                            <path d="M14.8265 26.441C14.0924 26.441 13.2371 26.6795 12.6626 26.3786C12.0092 26.0372 12.3781 25.0644 12.246 24.378C11.1154 18.5324 6.6849 14.5497 0.74755 14.1001C0.217135 14.0615 -0.0104482 13.9422 0.0134113 13.3659C0.0519536 12.1454 0.0482829 10.9213 0.0134113 9.69524C-0.00127145 9.14464 0.196946 9.03268 0.703502 9.04736C9.21217 9.27128 16.5994 16.2511 17.2804 24.7231C17.418 26.4446 17.418 26.4446 15.6579 26.4446H14.832L14.8265 26.441Z">
                            </path>
                            <path d="M3.58928 26.4555C2.64447 26.4618 1.73584 26.0925 1.06329 25.4289C0.39073 24.7653 0.00933763 23.8617 0.0030097 22.9169C-0.00331824 21.9721 0.365937 21.0635 1.02954 20.3909C1.69315 19.7184 2.59675 19.337 3.54156 19.3306C4.48637 19.3243 5.39499 19.6936 6.06755 20.3572C6.7401 21.0208 7.1215 21.9244 7.12782 22.8692C7.13415 23.814 6.7649 24.7226 6.10129 25.3952C5.43768 26.0677 4.53409 26.4491 3.58928 26.4555Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI RSS feed</span>
                    </a>
                
            </div>
        </div>
    

    <div data-testid="gridContainer"
         class="grid-container ncbi-footer__container">
        <div class="grid-row ncbi-footer__main-content-container"
             data-testid="grid">
            
                <div class="ncbi-footer__column">
                    
                        <p class="ncbi-footer__circled-icons-heading">
                            Connect with NLM
                        </p>
                    

                    <div class="ncbi-footer__circled-icons-list">
                        
                            <a href=https://twitter.com/nlm_nih class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="32"
                                     height="32"
                                     viewBox="0 0 40 40"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on X (formerly known as Twitter)</span>
                            </a>
                        

                        
                            <a href=https://www.facebook.com/nationallibraryofmedicine class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="13"
                                     height="24"
                                     viewBox="0 0 13 24"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M4.11371 23.1369C4.11371 23.082 4.11371 23.0294 4.11371 22.9745V12.9411H0.817305C0.6709 12.9411 0.670898 12.9411 0.670898 12.8016C0.670898 11.564 0.670898 10.3287 0.670898 9.09341C0.670898 8.97903 0.705213 8.95158 0.815017 8.95158C1.8673 8.95158 2.91959 8.95158 3.97417 8.95158H4.12057V8.83263C4.12057 7.8055 4.12057 6.7738 4.12057 5.74897C4.1264 4.92595 4.31387 4.11437 4.66959 3.37217C5.12916 2.38246 5.94651 1.60353 6.95717 1.1921C7.64827 0.905008 8.3913 0.764035 9.13953 0.778051C10.0019 0.791777 10.8644 0.830666 11.7268 0.860404C11.8869 0.860404 12.047 0.894717 12.2072 0.90158C12.2964 0.90158 12.3261 0.940469 12.3261 1.02968C12.3261 1.5421 12.3261 2.05452 12.3261 2.56465C12.3261 3.16857 12.3261 3.7725 12.3261 4.37642C12.3261 4.48165 12.2964 4.51367 12.1912 4.51138C11.5369 4.51138 10.8804 4.51138 10.2261 4.51138C9.92772 4.51814 9.63058 4.5526 9.33855 4.61433C9.08125 4.6617 8.84537 4.78881 8.66431 4.97766C8.48326 5.16652 8.3662 5.40755 8.32972 5.66661C8.28476 5.89271 8.26027 6.1224 8.25652 6.35289C8.25652 7.19014 8.25652 8.02969 8.25652 8.86923C8.25652 8.89439 8.25652 8.91955 8.25652 8.95615H12.0219C12.1797 8.95615 12.182 8.95616 12.1614 9.10714C12.0768 9.76596 11.9876 10.4248 11.9029 11.0813C11.8312 11.6319 11.7626 12.1824 11.697 12.733C11.6719 12.9434 11.6787 12.9434 11.4683 12.9434H8.26338V22.899C8.26338 22.979 8.26338 23.0591 8.26338 23.1392L4.11371 23.1369Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on Facebook</span>
                            </a>
                        

                        
                            <a href=https://www.youtube.com/user/NLMNIH class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="21"
                                     height="15"
                                     viewBox="0 0 21 15"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M19.2561 1.47914C18.9016 1.15888 18.5699 0.957569 17.2271 0.834039C15.5503 0.678484 13.2787 0.655608 11.563 0.65332H9.43556C7.71987 0.65332 5.4483 0.678484 3.77151 0.834039C2.43098 0.957569 2.097 1.15888 1.74242 1.47914C0.813665 2.32097 0.619221 4.62685 0.598633 6.89384C0.598633 7.31781 0.598633 7.74101 0.598633 8.16345C0.626084 10.4121 0.827391 12.686 1.74242 13.521C2.097 13.8412 2.4287 14.0425 3.77151 14.1661C5.4483 14.3216 7.71987 14.3445 9.43556 14.3468H11.563C13.2787 14.3468 15.5503 14.3216 17.2271 14.1661C18.5676 14.0425 18.9016 13.8412 19.2561 13.521C20.1712 12.6929 20.3725 10.451 20.3999 8.22064C20.3999 7.74025 20.3999 7.25986 20.3999 6.77946C20.3725 4.54907 20.1689 2.30724 19.2561 1.47914ZM8.55942 10.5311V4.65201L13.5601 7.50005L8.55942 10.5311Z"
                                          fill="white" />
                                </svg>
                                <span class="usa-sr-only">NLM on YouTube</span>
                            </a>
                        
                    </div>
                </div>
            

            
                <address class="ncbi-footer__address ncbi-footer__column">
                    
        <p>
            <a class="usa-link usa-link--external"
            href="https://www.google.com/maps/place/8600+Rockville+Pike,+Bethesda,+MD+20894/%4038.9959508,
            -77.101021,17z/data%3D!3m1!4b1!4m5!3m4!1s0x89b7c95e25765ddb%3A0x19156f88b27635b8!8m2!3d38.9959508!
            4d-77.0988323"
            rel="noopener noreferrer" target="_blank">National Library of Medicine
            <br/> 8600 Rockville Pike<br/> Bethesda, MD 20894</a>
        </p>
    
                </address>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/web_policies.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Web Policies
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nih.gov/institutes-nih/nih-office-director/office-communications-public-liaison/freedom-information-act-office" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            FOIA
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.hhs.gov/vulnerability-disclosure-policy/index.html" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            HHS Vulnerability Disclosure
        

        
    </a>


                        </li>
                    
                </ul>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://support.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Help
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/accessibility.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Accessibility
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/careers/careers.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Careers
        

        
    </a>


                        </li>
                    
                </ul>
            
        </div>

        
            <div class="grid-row grid-col-12" data-testid="grid">
                <ul class="ncbi-footer__bottom-links-list">
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            NLM
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            NIH
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.hhs.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            HHS
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.usa.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            USA.gov
        

        
    </a>


                        </li>
                    
                </ul>
            </div>
        
    </div>
</footer>

    


        
        
    
  <script  type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/pinger/pinger.js"> </script>


    
        

<button class="back-to-top" data-ga-category="pagination" data-ga-action="back_to_top">
    <label>Back to Top</label>
    <svg class="usa-icon order-0" aria-hidden="true" focusable="false" role="img">
        <use xlink:href="/static/img/sprite.svg#arrow_upward"></use>
    </svg>
</button>
    


        
    
    
    
        
    <script type="application/javascript">
    window.ncbi = window.ncbi || {};
    window.ncbi.pmc = window.ncbi.pmc || {};
    window.ncbi.pmc.options = {
        logLevel: 'INFO',
        
        staticEndpoint: '/static/',
        
        citeCookieName: 'pmc-cf',
    };
</script>
    <script type="module" crossorigin="" src="/static/assets/base-133c6271.js"></script>
    
    <script type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/jquery/jquery-3.6.0.min.js">&#xA0;</script>
    <script type="text/javascript">
        jQuery.getScript("https://cdn.ncbi.nlm.nih.gov/core/alerts/alerts.js", function () {
            galert(['div.nav_and_browser', 'div.header', '#universal_header', '.usa-banner', 'body > *:nth-child(1)'])
        });
    </script>


    <script type="text/javascript">var exports = {};</script>
     <script src="/static/CACHE/js/output.13b077bc3ffd.js"></script>

    <script type="module" crossorigin="" src="/static/assets/article-44d04358.js"></script>
    
    

    </body>
</html>
